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ABSTRACT 
The present studies describe our recent progress in target oriented synthesis of 
complex organic molecules from aromatic precursors. The latest synthetic approaches 
toward vinca alkaloids are described and include the construction of model substrates for 
the investigation into Diels-Alder, radical cascade, and tandem Michael addition 
reactions as possible routes to the family of alkaloids. Also described are the 
chemoenzymatic syntheses of the natural product (-)-idesolide and unnatural 
polyhydroxylated pyrrolidines generated from the biotransformation of benzoic acid with 
Ralstonia eutropha B9. 
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1. Introduction 
 In 1975 Hendrickson stated that the “ideal synthesis” creates complex molecules 
in such a way that construction of the skeleton and functionality involves no intermediate 
transformations and leads directly to the target.1 Since Hendrickson’s rather systematic 
assessment for synthetic design many economy metrics have been designed to guide the 
practitioner toward an efficient synthesis. Three main classes of synthetic economies can 
be defined: step economy, atom economy, and redox economy. The ideas are simple and 
obvious from the names. Step economy implies that by minimization of the number of 
steps leads to an efficient synthesis in terms of both cost and time.2 Strategic reaction 
sequences in the early development stages dictate the success in achieving a step-
economical synthesis. This is the design space in which creativity and efficiency are 
manifested. Atom economy, a term first defined by Trost,3 states that an efficient 
chemical reaction incorporates all of the atoms of the starting materials into the desired 
product. In other words, the percentage of the molecular weight (MW) of the starting 
materials should be present in the molecular weight of the desired product after several 
chemical transformations. However, catalysts, solvents, and reagentexcesses are not 
usually included in atom economy analyses.  A good example of this metric is the Diels-
Alder reaction (100% atom economy). Atom economy is arguably one of the major 
metrics considered in the chemical industries given the cost of raw materials, production 
and waste treatment. Redox economy is an ideal in which non-strategic redox 
manipulations are minimized and a synthetic target is approached in such a way that the 
oxidation states of intermediates should not fluctuate but increase or decrease steadily,4 
the consequence of which is also step economic. 
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 The use of biocatalysis to generate a chiral pool of raw materials, synthons, or to 
efficiently transform a reaction center exemplifies many of the reaction metrics 
previously mentioned. Enzymes are capable of performing chemical transformations with 
extraordinarily high levels of stereo-, regio-, and chemoselectivity. The efficiency with 
which nature’s catalysts can perform chemical transformations and the selectivity 
possessed is unmatched by modern chemical methods. For these reasons biocatalysis is 
being utilized to a greater extent and is now considered as a viable option when a 
synthetic route is being developed. Several academic groups have adopted the use of 
mutant organisms to access enantioenriched intermediates for use in synthesis. 
 Gibson’s development of the mutant strain P. putida 39D, and of the engineered 
strain E. coli JM109 (pDTG601), allowed metabolizing haloarenes 1 to cis-dihydrodiols 
2 by toluene dioxygenase (TDO). The process is high-yielding and stereo- and 
chemoselective. Metabolites derived from arenes have been used extensively for the 
synthesis of complex molecules, Figure1. 
 
Figure 1. Metabolism of arenes by toluene dioxygenase. 
 In 1971, Reiner and coworkers described the use of a mutant microorganism 
Ralstonia eutrophus B9 that was capable of metabolizing of benzoic acid (3) into ipso 
substituted cis-dihydrodiol 4, Figure 2, by the action of benzoate dioxygenase (BZDO). 
To date, metabolite 4 has not been used to the same extent as the TDO-derived 
metabolites. However, many research groups have recognized the utility of BZDO-
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derived 4 for its unique substitution pattern, the quaternary center, and the fact that it is 
produced in enantioenriched form (> 95% ee). In this dissertion the utility of cis-
dihydrodiol 4 in enantioselective synthesis will be described, in particular, the synthesis 
of natural product (-)-idesolide (5), the synthesis of iminosugar derivative 6, and general 
strategies toward the synthesis of highly oxidized vinca alkaloids, such as vindoline (7).  
 
Figure 2. The projected use of ipso dihydrodiol 4 in synthesis. 
 Idesolide (5) contains unique structural architecture that has attracted the interest 
of organic chemists since its isolation in 2005.5 Idesolide contains a spirocyclic motif that 
was accessible via the dimerization of monomer 8. The resemblance of enzymatically 
derived dihydro diol 4 with that of idesolide led us to pursue the synthesis based on the 
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analysis below, Figure 3. The details of the synthesis and its comparison to the two other 
total syntheses will be discussed. 
 
Figure 3. Idesolide approaches and syntheses. 
  Iminosugar derivatives are attractive targets in many medicinal chemistry 
programs and are known to be potent inhibitors of many enzymes, such as 
glycosyltransferases, glycosidases, and glycogen phosphorylases. Our approach to the 
synthesis of iminosugar 6 originates with metabolite 4 based on the ipso substitution 
pattern in 4 and the opportunity to oxidatively functionalize the molecule. The synthesis 
of the oxidized pyrrolidine 6 will be approached as shown in Figure 4. 
 
Figure 4. Retrosynthetic analysis of pyrrolidine 6. 
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 The final portion of this thesis will describe the 
general approaches toward a Vinca alkaloid of type 12 
that is contained as a structural unit in the marketed 
drugs vinblastine (13) and vincristine (14), Figure 5. 
The versatile intermediate 4, derived enzymatically 
through whole-cell biocatalysis, is pre-installed with an 
enantioenriched quaternary center (> 95% ee)  and oxidation states that match those of 
the natural product vindoline (7). It is envisaged that the tightly functionalized vindoline 
skeleton could be accessed by a generic tricyclic intermediate 15 by using a Fischer 
indolization, similar to Storks 1963 approach to rac-aspidospermine, Figure 6.6 Several 
approaches will be outlined that include a thermally induced Diels-Alder approach of a 1-
azadiene,7 an amidyl radical approach,8 and a tandem conjugate addition – alkylation 
approach.9  
 
Figure 6. Retrosynethic analysis of Vindoline and Vinca derivative 12. 
 
  
Figure 5. Vinca drugs. 
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2 Historical 
 The following historical chapter is divided into four separate sections that cover: 
1. aromatic dioxygenase, 2. Idesia Polycarpa natural products, 3. iminosugars, and 4. 
Vinca and aspidosperma alkaloids. An overview of the individual fields will be presented 
along with selected syntheses and general synthetic strategies. A general discussion as to 
the biological significance of certain Vinca alkaloids, iminosugar mimics, and Idesia 
Polycarpa natural products will be addressed, as along with biosynthetic considerations.  
2.1 Aromatic Dioxygenases 
 During the investigation into the metabolism of aromatic substrates by 
Pseudomonas putida, David Gibson isolated a cis-dihydrodiol metabolite from the 
ferment broth when p-chlorotoluene was fed as a substrate. Extensive research effort 
identified toluene dioxygenase (TDO) as the enzyme responsible for this 
biotransformation. The following chapter will review the more prominent organisms that 
express dioxygenase enzymes, namely toluene dioxygenase (TDO), naphthalene 
dioxygenase (NDO), and benzoate dioxygenase (BZDO). A historical prospective will 
precede a discussion of the substrate specificity and application of the biocatalytically 
derived metabolites in enantioselective synthesis. 
 2.1.1 History 
 An exact time at which the process of fermentation was founded remains 
uncertain. It can be discerned that at the time when mankind was developing the skills 
needed for sustainment, e.g. the domestication of livestock and the cultivation of crops, 
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the Neolithic man was simultaneously witnessing the natural processes of fermentation. 
The particular time period (ca. 5400–5000 BC) can be substantiated by excavations of a 
Neolithic village in the Zagros mountains of northern Iran in which a jar was unearthed 
that contained the calcium salt of tartaric acid and oleoresin.10 The addition of additives, 
in particular the alcohol-soluble terebinth resin, alludes to the intent in preserving the 
contents of the vessel by inhibiting bacterial (Acetobacter) growth, thus preventing 
oxidation of ethanol to acetic acid. The realization that a natural process was occurring 
was evident to the early man and as civilizations developed the oxidizing nature of 
fermentation was harnessed to include such beneficial utilities as the production of 
alcoholic beverages, cheese, bread, yogurt, and other consumables to supplement dietary 
consumption.  
 Fast forward thousands of years through the evolution of culture, thought, and the 
development of the sciences, and you will find the founders of modern-day biology and 
chemistry seeking to answer fundamental questions to the transformations they observed. 
As early as the mid-18th century the conversion of starch to sugars by plant extracts was 
known and in 1752 the French scientist René Antoine Ferchault de Réaumur observed the 
digestion of meat by hawk stomach secretions.11 By the 1830’s the role of yeast was a 
heavily debated scientific topic as to whether it was a living organism equipped with self-
embodied machinery or a chemical phenomenon (oxidation) made possible by the 
exposure of “plant juices” to air. Proponents of the former theory were scientists such as 
Cagniard de Latour, Schwann, and Kutzing who observed yeast cells under microscopic 
magnification as spherical particles capable of reproduction.12 They regarded the 
alcoholic fermentation as a process of vegetative existence. Schwann even concluded that 
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yeast gained nourishment from the sugar while the remaining elements of the broth were 
not consumed as nutrient and would combine to form alcohol. He went on to denote yeast 
as “sugar fungus.” Kützing postulated that yeast was, in fact, an organized body and not 
an individual compound. In 1833, French chemists Anselme Payen and Jean-Francois 
Persoz isolated a white precipitate from a barley malt extract. They noted that the water 
soluble material was able to convert starch to maltose and, thus, reported the first in vitro 
enzymatic transformation. They coined their malt extract “diastase” and established the 
nomenclature for naming enzymes, with the suffix –ase.13  
 Two decades later in 1856, Louis Pasteur was approached by a distillery and 
asked to help solve a problem with alcohol production via their sugar beetroot 
fermentation. Pasteur analyzed the questionable batches of ferment material and found 
them to contain a considerable amount of lactic acid instead of alcohol. He observed the 
samples under a microscope and found that the containers in which the alcoholic 
fermentation occurred contained a large amount of yeast cells. In contrast, the 
contaminated vessels that contained lactic acid contained much smaller cells than the 
yeast and he hypothesized that there were two separate types of fermentation involved, 
alcoholic and lactic acid, that occur by two distinct processes: alcoholic fermentation by 
the action of yeast and lactic acid fermentation by the action of bacteria.14, 15 Not long 
after Pasteur identified yeast cells as the responsible entity that possessed the mysterious 
“ferments” did Dumas demonstrate the ability of yeast to reduce sulfur to hydrogen 
sulfide.16 In 1877, the German physiologist William Kühne designated the term 
“enzyme” (Greek: to leaven) in order to differentiate the actual process from the 
organism (bacteria).17 By 1886 Adrian J. Brown had reported his experimentation with 
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Bacterium aceti (now called Acetobacter) and the conversion of various chemical 
substances, including the transformation of ethanol to acetic acid, propanol to propanoic 
acid, and mannitol into fructose.18 Brown’s early accomplishments with 
biotransformations have been stated as a landmark with respect to the discipline of 
biocatalysis.19  
 In 1894 H. Emil Fischer described the “lock and key” model to depict the 
substrate (key)/enzyme (lock) interaction at the active site. Fischer’s postulation provided 
a good qualitative analogy – the piecing together of geometric shapes – but failed to 
address the more detailed interactions responsible for promiscuous size and shape 
selectivity.20 Daniel Koshland extended Fischer’s model by suggesting that a dynamic 
relationship existed between the substrate and active site. His “induced fit” hypothesis of 
enzyme action was based on the ability of an enzyme to adopt different conformational 
changes in order to accommodate substrate and environmental interactions, such as pH 
and van der Waals forces.21 The key features of the induced fit model are attractive and 
are generally accepted today, such as localized assistance of amino acid side chains 
through non-covalent bonding and the inheritent flexibility associated with large peptidic 
structures. The modern concept of the “induced fit” has evolved based on the premise 
that electrostatic effects of the active site play a large role in predefinition of a latent 
transition state. The ultimate result of these interactions are the stabilization of the 
transition state, lowering of the activation energy (Ea), and an increase in rate of 
reaction.22-24  
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 All of the more than 4000 identified enzymes have been grouped into the Enzyme 
Nomenclature Classification System and are organized on the basis of the type of 
reaction they catalyze, Table 1.25 
Table 1. Enzyme categories based on types of reactions they catalyze. 
Enzyme Class Selected reactions 
Oxidoreductases  Reduction of C=O, C=C; reductive amination; oxidation of C-
H, C=C, C-N, C-O; cofactor reduction/oxidation 
Transferases Functional group transfers such as acyl, amino, phosphoryl, 
methyl, glycosyl, nitro, sulfur groups 
Hydrolases Hydrolysis of esters, amides, lactones, lactams, epoxides, 
nitriles; esterification, amidation, lactonization, epoxidation 
Lyases (synthases) Addition of small molecules to C=C, C=N, C=O (no energy 
requirement from ATP) 
Isomerases Isomerizations, epimerizations, rearrangements 
Ligases (synthetases) Formation of complex chemical compounds (energy 
requirement from ATP cleavage) 
 
 Enzymes and the processes they catalyze have been a topic of extensive research 
both academically and industrially for the past half century. Modern analytical techniques 
are continuously improving and the technological growth of the past 50 years has allowed 
for great strides in the understanding of microbiology, in particular the paradigm shift 
from anaerobic culture (static cultures) to aerobic culture (shaking cultures and air-fed 
bioreactors) in the mid-twentieth century.26 In addition, screening for microbial diversity 
has been adopted as a foundation to finding, or improving on, the best producers of an 
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enzymatic process and the introduction of new techniques, such as directed evolution and 
the engineering of metabolic pathways, have emerged as a result. 
 There is no doubt in the efficiency of biological systems to perform complex 
chemical transformations. It has been demonstrated that enzymatic systems are adaptable 
for the use in a wide range of industries that include environmental issues, food 
production, fine chemicals, pharmaceuticals, and many more. Some interesting and 
impressive examples of such robust processes will be briefly examined in section 2.1.5 of 
this document. Of interest to the readers of this thesis is the application of biocatalysis to 
the synthesis of complex molecules. Specifically, the use of cis-dihydrodiols isolated 
from the whole cell fermentation of aromatic substrates and used as raw materials for 
organic synthesis. 
 2.1.2 Arene Oxidation by Oxidoreductase Enzymes 
 Enzymes that are capable of dioxygen activation are divided into two 
subcategories: oxidases and oxygenases. Oxidases use oxygen as their oxidant and are 
reduced to hydrogen peroxide (H2O2) and water (H2O). Oxygenases can either 
incorporate one of the oxygen atoms of dioxygen (mono-oxygenase) or both of the 
oxygen atoms of dioxygen (dioxygenase) into the substrate/product during the enzymatic 
transformation. Most of the known dioxygenase enzymes require a metal cofactor, 
usually iron(II) or iron(III), in order to establish the oxidation-reduction cycle. Eukaryotic 
organisms apply numerous cytochromes to perform their oxidative processes while 
prokaryotes utilize dioxygenase enzymes to deliver dioxygen to the substrate and affect 
oxidation. Of the six classes of enzymatic processes, Table 1, oxidoreductases are the 
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second most commonly used type of enzyme in organic synthesis, trailing hydrolases in 
their frequency of use toward synthetic application.  
 The connection between the microbial influences on aromatic compounds dates 
back to 1908 when Stormer reported the isolation of an organism, Bacillus 
hexacarovorum, that was capable of the assimilation of toluene and xylene.27 Six years 
later Wagner reported the metabolism of toluene, xylene, benzene, and other aliphatic 
hydrocarbons by Bacterium benzoli a and b. B. benzoli a was also found to grow on 
phenol and pyrocatechol. Wagner also observed the quantitative “destruction” of crude 
oil samples presumed to contain naphthenic aromatic and aliphatic hydrocarbons.28 In 
1957 pyrocatechol was isolated as the major constituent of the fermentation of benzene 
with Nocardia coralline and the debate as to which intermediates were present during the 
oxidation followed.29 On the basis of previous studies conducted by Ayenger et al.,30 
where mammalian dehydrogenation of 3,5-cyclohexadiene-1,2-diol (16) was observed to 
give pyrocatechol (17) and Young31 where 1,2-dihydronaphthalene-1,2-diol (18) was 
isolated from the urine of naphthalene (19)-fed rats, Marr and Stone proposed  that trans-
cyclohexa-3,5-diene-1,2-diol (20) was a likely intermediate in the bacterial oxidation of 
benzene (21), Table 2.32 They were able to chromatographically identify pyrocatechol 
obtained from culture medium of Pseudomonas aeruginosa that was grown on benzene 
as the sole carbon source. It was argued that the oxidation of benzene followed the same 
general metabolic pathway found in bacteria capable of the metabolism of other aromatic 
compounds such as phenol, benzoic acid, and naphthalene and did not include phenol or 
o-benzoquinone as probable intermediates. The proposition of an epoxide precursor in the 
metabolic pathway leading to various catechols33, 34 had been stated prior to Gibson’s 
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1968 reports on the oxidative degradation of benzene with Pseudomonas putida.35 
Despite reports from Holtzman et al., indicating that only a singley incorporated oxygen 
atom (18O labeled) is incorporated into trans-1,2-dihydro-1,2-dihydroxynaphthalene (22) 
using mouse liver microsomes fed with naphthalene,36 Gibson alluded to the cis addition 
of dioxygen to benzene as was previously suggested by Kobayashi and coworkers in the 
enzymatic formation of catechol from anthranilic acid (23), Table 2.37 Gibson’s studies 
dismissed the idea that catechol is generated via the epoxidation pathway stating that 
hydrolysis of epoxides invariably occur with formation of trans-glycols and upon feeding 
washed cell suspensions of P. putida with trans-3,5-cyclohexadiene-1,2-diol (20) 
insignificant rate of consumption was observed. In addition, Gibson was never able to 
detect the formation of phenol in the ferment broth and subsequent experiments with cell 
extracts that were unable to metabolize phenol as a carbon source, discrediting the notion 
of a monohydroxylation pathway.35 In his follow-up communication that same year 
(1968), Gibson demonstrated that P. putida was able to oxidize halobenzene substrates to 
the respective 3-halogenated catechol derivatives.38 Upon treatment of ferment broth with 
p-chlorotoluene (24) he was able to isolate two metabolites that were identified as (+)-
cis-4-chloro-2,3-dihydroxy-1-methylcyclohexa-4,6-diene (25) and 4-chloro-2,3-
dihydroxy-1-methylbenzene (26), Figure 7. The incubation with 18O-labeled dioxygen 
indicated the incorporation of two atoms of atmospheric oxygen that presumably 
originated in the same molecule. These findings were substantiated by mass spectral 
analysis. It was also suggested that the dihydroxylation was iron-mediated and involved 
molecular oxygen.  
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Figure 7. Metabolism of p-chlrotoluene 24 by P. putida. (Gibson) 
 The development of mutant strain P. putida 39/D by the Gibson group allowed for 
the accumulation of (+)-cis-2,3-dihydroxy-1-methylcyclohexa-4,6-diene (29) from the 
culture media when grown in the presence of toluene (30), Figure 8.39 
 
Figure 8. Metabolism of toluene by P. putida 39/D. (Gibson) 
 Analysis of metabolite 29 by nuclear magnetic resonance (NMR) did not provide 
unequivocal proof as to the vicinal diol stereochemistry. Gibson and coworkers prepared 
the cycloadduct 1-methyl-2,3-diacetoxybicyclo[2.2.2]-7-hexene-5,6-dicarboxylic 
anhydride (31)  via acetylation and subsequent treatment with maleic anhydride, Figure 9. 
The hydrogenation of 31 provided the fully saturated derivative 32 and NMR analysis 
indicated a cis relationship between protons Ha and Hb (Jab = Jba = 8.5 Hz) and provided 
proof of relative stereochemistry. 
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Figure 9. Relative stereochemical proof of metabolite 29, from fermentation of toluene 
with P. putida 39/D. (Gibson) 
 The absolute stereochemistry of the cis-dihydrodiol 29 was later established40 
through a series of transformations that led to a known compound, namely (R)-(–)-
methyladipic acid (33), whose absolute stereochemistry had been previously established, 
Figure 10.41 The hydrogenation of 29 provided a mixture of cis,trans- and cis,cis-3-
methylcyclohexane-1,2-diols, 34a and 34b respectively, that were separable upon 
derivatization as the C1 monobenzoates. The hydrolysis of the monobenzoate of 34b and 
subsequent oxidative cleavage of the vic-diols with Jones reagent yielded (33). The 
degradation of 29 to the known 33 confirmed the stereochemistry as 1S,2R.  
 
Figure 10. Absolute stereochemical proof of P. putida 39/D metabolite 29. (Gibson) 
 The pioneering work by Gibson, which is historically relevant in the field 
microbiology, chemistry, and biotechnology, spurred the onset of growth toward the 
acceptance and applications of biocatalysis. The search for practical substrates, for both 
synthetically useful and environmentally applicable purposes, was initiated by many 
academic groups and some industrial establishments. In particular, Albey M. Reiner at 
the University of California at Berkeley began studies involving the mutant strain 
Alcaligene eutrophus B9 (now called Ralstonia eutrophus B9) that was blocked in 
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benzoic acid (3) catabolism and accumulated (–)-3,5-cyclohexadiene-1,2-diol-1-
carboxylic acid [1,2-dihydro-1,2-dihydroxybenzoic acid (DHB)] (4) in the ferment broth, 
Figure 11.42  
 
Figure 11. Metabolism of benzoic acid by mutant strains. 
Reiner and coworkers confirmed the incorporation of both oxygen atoms from molecular 
oxygen by mass spectroscopy 18O-labeling studies. He further hinted to the cis 
relationship of the vicinal hydroxyl groups by performing chemical oxidations (periodate) 
on the derived metabolite 4 and making rate comparisons with reference standards (trans- 
and mixed trans- and cis-cyclohexane-1,2-diol). It wasn’t until 24 years after Reiner’s 
(1971) work that the absolute stereochemistry was confirmed. Ribbons and Widdowson 
were implementing biocatalysis techniques, namely the mutants R. eutrophus B9 and P. 
putida U109,43 for the production of useful chiral synthons. Widdowson recognized the 
advantage that was inherent in these enzymes for synthetic application. The absolute 
stereochemistry of DHB (4) was established by derivatization as the p-
bromobenzoylmethyl ester 36 and analysis by X-ray diffraction indicated a 1S,2R 
configuration, Figure 12.44 
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Figure 12. Absolute stereochemistry determination of DHB (4) 
 The evolution of suggested intermediates that occur during the biocatalytic 
oxidation of arenes have been extensively discussed. A chronological representation is 
presented in Table 2 and a more detailed mechanistic survey will be described in the 
following section. 
Table 2. Chronological evolution of selected arene dioxygenase metabolites 
Young 
(1947) 
Haccius, Helfrich
(1957) 
Ayenger et al. 
(1958) 
Booth 
(1960) 
Marr, Stone 
(1961) 
OH
OH
Nocardia
coralline
pyrocatechol (17)benzene (21)
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Kobayashi et al. 
(1964) 
O’Connor et al. 
(1964) 
 
Holtzman et al. 
(1967) 
 
Gibson et al. 
(1968) 
Gibson et al. 
(1968) 
Gibson et al. 
(1970) 
Reiner, Hegeman
(1971) 
* All bracketed intermediates were suggested and were not established by rigorous 
scientific methods. 
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 2.1.3 Benzoate dioxygenase (BZDO) and Mechanistic Insight 
 Rieske dioxygenases (non-heme) catalyze the stereo- and regiospecific, O2-
dependent transformation of unactivated aromatic derivatives to cis-dihydrodiols, as 
discussed in Section 2.1.2. The enzymatic process provides a useful carbon source for 
bacterial growth. There has been much literary discussion as to how the transformation 
proceeds from an energetically stable aromatic molecule to a non-aromatic, chemically 
labile vic-diol.  Several mechanisms have been postulated and include such processes as 
dioxetane 39 formation via singlet oxygen (1O2),45 [3+2]-type cycloaddition involving an 
iron(V) peroxide species possibly going through intermediates 40 – 42,19 and, as a more 
generally accepted pathway, an iron(II)/iron(III) peroxide incorporation of molecular 
oxygen to yield transient iron(III) peroxo species 43 leading to cis-dihydrodiol 2, Figure 
13.46-48 Some of these mechanistic approaches have been studied on model enzyme 
systems, in particular naphthalene dioxygenase (NDO), and have implications for many 
other dioxygenases. 
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Figure 13. Mechanistic hypotheses of dioxygenases. 
 Benzoate dioxygenase (BZDO) is a typical Rieske dioxygenase system. The 
overall stoichiometry requires a single molecule of O2 and two electrons from NADH to 
form the cis-dihydrodiol products, Figure 14. The benzoate dioxygenase system 
(BZDOS) consists of a reductase (BZDR) and an oxygenase (BZDO) component. BZDR 
is a 38 kDa protein that contains a flavin adenine dinucleotide (FAD) cofactor and a 
[2Fe-2S] cluster with all cysteine ligation.49 BZDO is a 200 kDa protein of (αβ)3 
quaternary structure50 and each α subunit contains a mononuclear non-heme iron active 
site and a Rieske-type [2Fe-2S] cluster. BZDR is reduced by NADH and transfers 
electrons stepwise to the Rieske cluster of the BZDO component.47 Spectroscopic 
investigations indicate that oxygen activation and substrate binding occur at the 
mononuclear iron center of BZDO.  
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Figure 14. Benzoate dioxygenase 
 It is not feasible that dioxygenase enzymes could access the 1O2 excited state on 
the basis of the 22 kcal/mol energy difference above the ground state of 3O2. Three 
proposals were suggested for the mechanisms involving the activation of dioxygen to be 
legitimate: orbital overlap with a transition metal ion, single electron transfer (SET), 
and/or reaction with a substrate radical.51 Singlet oxygen readily reacts with alkenes and 
dienes using its lone pair of valence electrons, Figure 15. The complexation of molecular 
oxygen to a transition metal ion containing unpaired 3d electrons could facilitate the 
interaction with a singlet organic reagent, in a similar way as to how sensitizers (Rose 
Bengal, tetraphenylporphyrin, etc.) are used in [4+2] cycloadditions (44 → 45).  
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Figure 15. (A) Molecular orbital diagrams for 3O2 and 1O2. (B) Reactions of 1O2. 
 For a single electron transfer to occur the metals found in dioxygen activating 
metallo-enzymes must have two consecutive available oxidation states (e.g. 
Fe(II)/Fe(III)) in order to affect the electron transfer to 3O2 ground state and form 
superoxide. Uncertainty of this theory lies in the reduction potential difference between 
O2/O2- (Eh = -0.16 V in H2O)52 and Fe(III)/Fe(II) (Eh = +0.77). The activation of dioxygen 
to superoxide by Fe(II) reduction potential is -0.93 V. Although this reduction potential is 
low and presents a seemingly unfavorable possibility for an event, it is likely that the 
active site of metallo-enzymes (redox enzymes) would influence the reduction potential 
of bound cofactors favorably. Examples of dioxygen activation to superoxide can be 
found with hemoglobin.53 Alternatively, SET can occur with dioxygen from organic 
reagents that are able to form stable radical species, for instance, the formation of 
superoxide by reduced flavin, Figure 16. 
3O2 1O2
*2pz
*2px,y
2px,y
2pz
*2pz
*2px,y
2px,y
2pz
R R'
H H
R R'
OOH
O
O1O2
1O2
A.
B.
44 45
23 
 
 
Figure 16. Dioxygen activation by reduced flavin. 
 Last is the possibility of a substrate radical attack onto dioxygen. This is a spin-
allowed process and is proposed a mechanism for intradiol catechol dioxygenases.54 A 
semiquinone intermediate reacts with dioxygen to form a hydroperoxide radical, Figure 
17.  
 
Figure 17. Substrate radical attack on dioxygen. Intradiol catechol dioxygenase example. 
 The mechanistic features of the BZDOS are further complicated, as in all Rieske 
dioxygenase systems, by the mononuclear iron center capable of multivariate ligations, 
i.e. able to coordinate to different amino acid residues. The variability of the iron 
coordination environment is what distinguishes the Rieske systems from the heme-based 
oxygenases and, thus, increases the number of possible mechanisms by which dioxygen 
can be activated toward oxidation of arenes. 
 To date, the best analogy regarding the mechanism of dioxygenases is drawn from 
Gibson’s work on naphthalene dioxygenase (NDO). In 2003, he published the crystal 
structure of NDO in which the so called “side-on binding” of dioxygen to iron took place 
and was responsible for both of the oxygen atoms delivery to the aromatic substrate.46  
His suggested mechanism is depicted below, Figure 18, and involves a pathway 
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consistent with other iron(III) peroxide-like species proposed. Ultimately, the mechanism 
for NDO remains unsolved. However, important parallels for other dioxygenase 
enzymes, in particular BZDO, can be established on the basis on Gibson’s work with 
NDO.  
 
Figure 18. Gibson's mechanism based on the crystal structure of NDO. 
 
 2.1.4 Diversity of Dihydroarenediols 
 Boyd has derived a useful qualitative model to help predict the facial selectivity 
of enzymatic dihydroxylations using P. putida UV4, Figure 19.55 The model depicts an 
environment upon which absolute stereochemistry and regiochemistry of  mono- and 1,4-
disubstituted benzene substrates can be estimated with good probability. The model has 
been successfully implemented in other dioxygenase enzymes and substituent size has 
proven to be a dominant factor in the selection of which bond is oxidized in the microbial 
system.  
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Figure 19. Boyd's model for regio- and stereochemical outcome of dioxygenase. 
 There are numerous examples of substrates that demonstrate scope and tolerance 
for selected dioxygenase enzymes.19, 56 One of the most established systems with respect 
to scope is TDO, partially due to the recombinant nature of the organism, in which 
induction is performed from a “non-natural” inducer where metabolite contamination is 
avoided. Selected examples are depicted in Figure 20.  
  
Figure 20. Selected cis-dihydrodiols derived from microbial oxidation (TDO, NDO). 
 Studies to probe the enzymatic pocket of BZDO have not been performed directly 
or indirectly by extensive substrate screening. The consensus that can be derived from the 
substrates published indicates that mono- and di-substituted benzoic acids are acceptable 
substrates for BZDO. Ortho- and para-substitution patterns are typically only tolerated 
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when fluorine is the substituent while meta-substitution undergoes comparatively high 
metabolic rates, Figure 21.  
 
Figure 21. Selected ipso, cis-dihydrodiols derived from microbial oxidation (BZDO). 
 
 2.1.5 Utility of Dihydroarenediols in Organic Synthesis and 
Industrial Applications  
 Oxidoreductase enzymes are ideal for industrial processes where chemical 
oxidations/reductions methods are limited. Several factors contribute to the avoidance of 
redox steps in process chemistry, namely the ability to control thermal change 
(exotherms), toxicity or hazardous reagents that are typical of redox reagents, the 
financial expense to achieve selectivity through reagent control (reductions), and 
hazardous byproducts or waste stream generation. So why hasn’t the chemical industry 
opted for more biocatalytic transformations? The reasons, as to the lack of acceptance in 
the synthetic chemistry community,  have been discussed at length. However, the attitude 
toward biotechnology as a viable alternative in a synthetic sequence has seen much 
improvement in the past decade, especially in the field of agrochemicals and 
pharmaceutical development.  
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 The United States Environmental Protection Agency (EPA) established the 
“Presidential Green Chemistry Challenge Awards” in 1995 in order to encourage and 
award individuals and businesses to innovate more environmentally friendly processes in 
their respective industries. The governing committee has established standards based on 
Anastas and Warner’s definition of “green chemistry,” Table 3.57 
Table 3. The 12 principles of green chemistry as defined by Anastas and Warner. 
1.    Prevent waste  
2.    Design safer chemicals and products 
3.    Design less hazardous chemical syntheses 
4.    Use renewable feedstocks: Use raw materials and feedstocks 
5.    Use catalysts, not stoichiometric reagents 
6.    Avoid chemical derivatives 
7.    Maximize atom economy 
8.    Use safer solvents and reaction conditions 
9.    Increase energy efficiency 
10.  Minimize the potential for accidents 
11.  Design chemicals and products to degrade after use 
12.  Analyze in real time to prevent pollution 
 The 2010 winner of the Greener Reaction Conditions Award exemplifies the 
maturity of the field of applied biocatalysis. Merck and Codexis collaborated in the 
implementation of a transaminase-catalyzed formation of chiral amine 77 in their 
synthesis of sitagliptin phosphate (78), an oral type 2 diabetes drug, Figure 22.58 
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Extensive enzyme modification was performed on the transaminase by substituting 27 
amino acids in order to accommodate the large substrate 79 in the active site, stabilize the 
enzyme to the reaction conditions, and to increase the rate of reaction. The addition of 
this biotransformation step eliminated four chemical steps that included a costly 
asymmetric hydrogenation using a rhodium catalyst in a high-pressure reactor. This 
example highlights the interdisciplinary cooperation between faculty in microbiology and 
chemistry in order to customize a chemical transformation. 
 
Figure 22. Merck/Codexis chemoenzymatic synthesis of sitagliptin phosphate (78). 
 The Merck – Codexis example shown in Figure 22 represents the state of the art 
in applied biocatalysis. The use of biotechnology in order to effect a chemical 
transformation has been slow to gain acceptance. It wasn’t until Imperial Chemical 
Industries (ICI, now AkzoNobel) used meso, cis-dihydrodiol 38 derived from by 
microbial oxidation of benzene for the preparation of polyphenylene in 1983, Figure 23.59 
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Figure 23. ICI polyphenylene synthesis using meso-diol 38. 
 Since the ICI synthesis in 1983 several academic groups have utilized the 
technology to produce cis-dihydrodiols and implemented their versatile reactivity 
patterns in synthetic chemistry. Ley’s group was the first academic group to take 
advantage of a cis-dihydrodiol synthon in his synthesis of (±)-pinitol (83).60 His synthesis 
was a demonstration on how a densely oxygenated cyclohexane ring can be built through 
variation in synthetic construction and mode of operation. Not long after Ley’s 1987 
synthesis of (±)-pinitol (83) Hudlicky and coworkers published a concise formal 
synthesis of prostaglandin (PGE2α, 84) in significantly shorter steps than any other 
synthesis of PGE.61 Other, more elaborate, syntheses using microbial metabolites were to 
follow by a select group of academics and a representative selection is depicted below, 
Figure 24.62-65 
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Figure 24. Diversity of synthetic targets. 
 The use of ipso diol 4 derived enzymatically from benzoic acid (3) has found less 
exposure as a synthon than the cis-dihydrodiols derived from halogen substituted arenes, 
Figure 25. However, since A. Myers’ 2001 publication where he demonstrated the 
versatility of 2 with the generation of several useful intermediates,66 the ipso substituted 
diol 4 has been used in several synthetic endeavors by a number of research groups, 
Figure 25.67-73 The substitution pattern, namely the presence of the quaternary carbon, 
provides access to chemical entities otherwise difficult to obtain with good 
stereoselectivity. 
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Figure 25. Diversity of synthetic targets derived from ipso metabolite 4. 
 A more extensive survey of the application of microbial oxidation products can be 
found in several recent reviews and books on the topic.19, 74-77 
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2.2 Idesia Polycarpa Natural Products 
   Idesia polycarpa Maxim. is a seasonal, deciduous tree, of the Flacourtiaceae 
family that is native to the Asian countries of Korea, China, Japan, and Taiwan.78 The 
tree is typically found at medium altitudes and a variety of compounds are present in its 
fruits, including fatty acids, phenazine (97) and derivatives,79 pyrocatechol (17) , benzyl 
alcohol (98), phenethyl alcohol (99), idesin (100) and other glucopyranosides, idesolide 
(5) and its monomer 8,5 and flavonoids, Figure 26.80 It bears red-colored fruit in the 
winter that are noticeably left untouched by wildlife. This observation is what has 
prompted the investigation into what compounds are present in its fruit.  
 
Figure 26. Compounds extracted from the fruits of I. polycarpa. 
 In 2005, Kim and coworkers from Seoul National University elucidated the 
structure of (-)-idesolide (5) by X-ray crystallography and established the relative 
stereochemistry, Figure 27.5 Following the isolation of (-)-idesolide (5) one report on the 
synthesis of the monomeric unit 881of idesolide was reported and two total syntheses82, 83 
were published. All three reports, in addition to the synthesis by the Hudlicky group, will 
be discussed in the following sections. 
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Figure 27. ORTEP rendering of X-ray crystallographic data for (-)-idesolide (5). 
  
 2.2.1 Isolation and Characterization 
 Although no reports indicate that idesolide 5 is found in any other natural source 
other than I. polycarpa, its monomeric unit 8 has been isolated from the leaves of 
Dovyalis abyssinica native to Central Africa and northern South America84 and from the 
twigs and stems of Homalium ceylanicum found in Thailand.85 
The monomeric unit has been known since 1970 when Darling 
et al. isolated and characterized glucopyranosides salicortin 
(101) and the benzoate derivative tremulacin (102) from the 
bark and leaves of Salix purpurea, Figure 28.86, 87 The monomer 
8 is present as a subunit of the glucosides but was never isolated 
in its pure form in the studies performed by Darling. It was 
suggested as transient intermediate when salicortin (101) was subjected to base-catalyzed 
hydrolysis to produce pyrocatechol (17) via decarboxylation and aromatization. 
 In 1993 the cyclohexenyl monomer 8 was isolated in pure form from the alcoholic 
(n-BuOH) extracts of Homalium ceylanicum and a structure was assigned based on high 
Figure 28. Monomer 8
derivatives. 
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resolution mass spectrometry (HRMS m/z 171.0576, C8H7O3) and NMR data. The effort 
to establish the absolute stereochemistry was hampered by the amount of material 
available for their investigation.85 The S-configuration of 8 was not elucidated until 2010 
when Iwabuchi and coworkers published their report on (-)-idesolide (5) by means of 
enantioselective synthesis.82 
 Idesolide was obtained from the methanol (MeOH) extracts of the fruits of I. 
polycarpa. Several iterations of chromatographic purifications were required to obtain an 
analytically pure sample of the natural product. Idesolide was fully characterized by 
NMR, mass spectrometry (MS), infrared spectroscopy (IR), and X-ray crystallography, 
Figure 27. The following physical characteristics were attributed to idesolide (5): melting 
point (mp) = 141 – 143 ˚C, [α]25D = -230.0 (c 1.0, CHCl3).5 As with the monomer 8, 
idesolide (5) was not assigned an absolute configuration until Iwabuchi’s enantioselective 
synthesis was reported. 
 2.2.2 Biological Activity Profile 
 Upon screening of natural products capable of exhibiting anti-inflammatory 
properties, Kim and coworkers identified the methanol extracts of I. polycarpa to 
effectively inhibit nitric oxide (NO) production induced by lipopolysaccharide (LPS) in 
BV2 microglial cells.5 Lipopolysaccharides are the prototypical example of an endotoxin 
and consist of a polysaccharide and lipid portion joined together covalently. They form 
the outer membrane of Gram-negative bacteria and are a crucial aspect in terms of the 
structural integrity of the bacteria. Endotoxins elicit a strong immune response by binding 
to receptors on immune cells upon which cause a signaling chain in the form of 
cytokines, in particular pro-inflammatory cytokines in B cells, and nitric oxide 
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production. B cells are critical to the immune system because of their role in making 
antibodies in response to antigens and subsequent development into “memory B cells.” 
After activation by an antigen, the memory B cell is capable of rapidly recognizing the 
same pathogen and can quickly produce the antibody in order to defend against future 
infection. Compromising the ability of the immune system to properly regulate antibody 
production is a dangerous situation, particularly in microglial cells (inflammatory cells) 
which act as the front line defenders of the central nervous system (CNS). Idesolide (10 
µM) was reportedly able to decrease nitric oxide production in BV2 microglial cells that 
were exposed to LPS (100 ng/mL) for 24 hours from 19.1 µM concentration (LPS 
reference standard) to 4.9 µM, Table 4, thus, showing suppressed microglial cell activity 
indicating an improved role on the brain immune system.  
Table 4. Effect of idesolide on LPS-induced NO production in BV2 microglial cells.5 
Substrate Concentration (µM) Nitrite (µM) 
control -   1.7 ± 0.2 
LPS - 19.1 ± 1.3 
idesolide 0.1 17.6 ± 0.7 
idesolide 1.0  16.4 ± 1.5 
idesolide 10.0    4.9 ± 0.1 
 Prolonged or excessive activation of microglial cells,  through brain injury, for 
example, is reported to play a pivotal role in the initiation and progression of 
neurodegenerative diseases such as Alzheimer’s and Parkinson’s.88 Effort has been 
devoted to improve human cognitive function while minimizing side effects. Some of this 
research has utilized herbal medicines such as Ginko biboba and Ginseng and the effects 
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of these extracts on neurons, synaptic functions, and the brain have shown some 
promise.89 Kaang and coworkers hypothesized that idesolide, having shown inhibitory 
nitric oxide (NO) production in microglial cells, might be capable of improving 
hippocampus-dependent memory recognition in rodents.90 Researchers used the “novel 
object recognition task” method91 to gauge cognitive memory enhancements after 
injecting mice with idesolide (40 µg/kg). During the “sample phase” of this method the 
mice are exposed to two identical inanimate objects for 15 minutes (post injection). 
Twenty four hours after the sample phase the mice were subjected to the “retention 
phase” in which two objects were brought to the mice for 10 minutes, one of the objects 
was identical to the sample phase. The amount of time the mice spent exploring the two 
objects were recorded separately and, typically, preference to the novel object is observed 
and is perceived as an indicator of memory extent. In this study the outcome revealed that 
the mice treated with idesolide had a significantly higher level of recognition memory in 
the retention phase manifested as an increased exploration time of the novel object (49.1 
min ± 6.1% for idesolide treated mice vs. 19.8 min ± 2.8%). The mechanisms of the 
effect of idesolide was not elucidated but the study suggests that idesolide may have 
some memory-enhancing effects without adverse side effects. The anti-inflammatory 
action of idesolide on the neural immune system might be the underlying facet to its 
therapeutic potency. 
 Other studies that have probed the biological activity of idesolide include its 
ability to increase resistance to hydrogen peroxide (H2O2)-induced oxidative stress in 
muscle cells.92  
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 A 2012 study investigated the ability of idesolide to inhibit nitric oxide production 
and its effect on adipocyte differentiation.93 Obesity has been linked to many additional 
health problems, including diabetes, hypertension, and atherosclerosis. Adipose tissue 
(body fat) serves as a site of calorie storage. Aside from adipose tissue’s central role as 
lipid storage it also serves as a component of the endocrine system by secreting 
adipokines, such as leptin and adiponectin, that are involved in the lipid metabolism 
process, insulin sensitivity, and energy regulation.94 Adipocyte differentiation is regulated 
by sequential activation of many transcription factors, including peroxisome proliferator-
activated receptor γ (PPARγ). Inducible nitric oxide synthase (iNOS) and endothelial 
nitric oxide synthase (eNOS) are involved in the NO production in adipose tissue and 
expression has been shown to increase for adipose, muscle, and liver tissues in obese 
animal models.95 The idea was to determine if blockage of adipocyte differentiation 
would be beneficial for the treatment of metabolic disorders. The results of the study, in 
fact, showed that idesolide significantly suppressed adipogenic differentiation by 
inhibition of NO production via the suppression of iNOS gene expression and the authors 
suggest idesolide as a potential compound for anti-obesity therapy. 
 
 
 
 2.2.3 Syntheses 
Snider (2007) 
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 Snider reported the first synthetic approach to idesolide on the premise that α-
hydroxyketones undergo dimerization under mild conditions, Figure 29.81 The spiro-bis-
pinnaketal 103 was elucidated by X-ray crystallography and was determined to be an 
artifact of silica-gel promoted dimerization of laurencione (104) and not a natural 
product, Figure 29.96 However, the structure of 103 was analogous to idesolide (5) and 
prompted a synthetic strategy targeting idesolide’s monomeric unit 8.  
 
Figure 29. Dimerization of α-hydroxyketones. 
 Snider’s synthesis started with the Birch reduction/oxidation protocol using 
camphorsulfonyl oxaziridine (CSO) as the hydroxylation source, a method developed by 
Schultz to perform asymmetric oxidations.97 The authors noted the unstable nature of 8 
and the tendency of non-conjugated diene of type 107/110/113 to aromatize, the enol 
ether protecting group selection became a pivotal decision on the basis of the projected 
deprotection conditions, Figure 30.  
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Figure 30. Protecting group selection for Birch reduction/oxidation. 
 The 2-(trimethylsilyl)ethoxy methyl (SEM) ether 112 underwent the Birch 
reduction/hydroxylation sequence in moderate yield but with lower enantiomeric excess 
(nearly racemic, [α]D = – 7; natural 8 [α]D = –185) than was observed with methyl ether 
107 (30% e.e.). Monomer 8 was confirmed by X-ray analysis. 
 
Scheme 1. Snider's synthesis of α-hydroxyketone 8. 
  Unfortunately, Snider and coworkers were unable to observe the expected 
dimerization of 8 under a variety of conditions, both as the racemate and with an optically 
enriched 8 (85% e.e.): neat (0 – 100 ˚C), D2O, D2O and magnesium chloride (MgCl2). 
Optically pure 8 was obtained in 10% yield through hydrolytic kinetic resolution using 
pig liver esterase (PLE), Scheme 2.98  
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Scheme 2. Kinetic resolution of 8. 
Iwabuchi (2010) 
 The Iwabuchi group at Tohoku University investigated the synthesis of idesolide 
and had encountered the same difficulty that Snider et al. observed with the dimerization 
of 8.82 Iwabuchi’s synthesis utilized an enantioselective oxidative kinetic resolution 
(OKR) with a chirally modified 2-azaadamantane N-oxyl (AZADO) based oxidant 
developed in his laboratory.99 The chiral AZADO derivatives have shown good 
selectivity for the oxidation of secondary alcohols using trichloroisocyanuric acid 
(TCCA) as secondary oxidant, Figure 31.  
 
Figure 31. Iwabuchi AZADO oxidative kinetic resolution. 
 The synthesis demonstrates the use of chiral organocatalysis (AZADO-H) 
derivative 118 toward OKR and provides enantiomerically enriched key intermediate (+)-
127. Commin’s reagent was used to generate the enol triflate of (+)-127 (not shown) and 
palladium catalyzed reduction with formic acid and subsequent hydrolysis of the 
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dioxolane provided cis-diol 129. Oxidation of 129 was stated as being troublesome but 
was achieved with AZADO (115) with polymer-supported bis(acetoxy)iodobenzene (PS-
BAIB)100 as the bulk oxidant to afford monomer (-)-8. Apparently the use of non-
polymer-supported bis(acetoxy)iodobenzene (BAIB) caused oxidative cleave of the 
vicinal diols in 129.  
 
Scheme 3. Iwabuchi's synthesis of monomer (-)-8. 
 Iwabuchi and coworkers confirmed the lack of tendency of monomer 8 to 
dimerize under neutral conditions. They subjected the monomer to ultrahigh pressure (0.8 
GPa) with no success. The treatment of 8 under acidic conditions (p-TsOH, BF3·OEt3) 
only induced dehydration to methyl salicylate 130 and basic conditions (NaH, NaOMe, 
DBU) led to decomposition. The serendipitous discovery of crystalline idesolide in a 
flask that contained monomer (-)-8 and was contaminated with AZADO (115) led to the 
investigation of the N-oxyl radical species as a promoter for the dimerization, Table 5.  
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Table 5. Dimerization of monomer (-)-8.82 
 
Entry Additive (equiv) Solvent (CDCl3) Idesolide (%) 
1 none none 0 
2 AZADO (1.0) 0.1 M 6 
3 AZADO (1.0) 0.4 M 35 
4 AZADO (1.0) 2 M 62 
5 AZADO (1.0) 10 M 68 
6 AZADO (1.0) none 73 
7 AZADO (0.1) none 38 
8 AZADO-H (1.0) none 38 
9 1-Me- AZADO (1.0) none 63 
10 TEMPO (1.0) none 0 
11 DMAP (1.0) none 65 
12 pyridine (1.0) none 0 
13 Et3N (1.0) none 65 
14 i-Pr2NEt (1.0) none 50 
15 DMAPO·H2O none 22 
16 NMO (1.0) none 11 
       * All yields are based on 1H NMR calculation. 
 As Table 5 indicates, a good conversion of monomer to its dimer is observed with 
stoichiometric amounts of AZADO (115) (entries 5 and 6). It also appeared as if AZADO 
was exhibiting catalytic activity (entry 7) while the reduced form AZADO-H displayed 
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diminished productivity (entry 8). TEMPO appeared to be too bulky about the N-oxyl 
group to be an effective oxidant (entry 10). Triethylamine (Et3N), diisopropyl ethylamine 
(i-Pr2NEt), and dimethylamino pyridine (DMAP) all showed the preponderance to induce 
dimerization while pyridine (py) did not, implicating hybridization (sp3 vs. sp2) as an 
important factor in the process. Iwabuchi attributed the effectiveness of AZADO in the 
dimerization of monomer 8 to idesolide (5) (34% isolated yield) to the less-hindered and 
basic nature of the N-oxyl moiety. The absolute stereochemistry of idesolide (-)-5 was 
also established during the course of this investigation as 2R,2’S,3aS,7aR, Figure 21.  
Kuwahara (2010) 
 Kuwahara and coworkers83 followed Iwabuchi’s synthesis shortly after in 2010 
with a strategy based on the introduction of chirality via the Sharpless asymmetric 
epoxidation, Figure 32.101 The starting material 131 was prepared by Baylis-Hillman 
reaction of 2-cyclohexenone and formaldehyde.102 
 
Figure 32. Kuwahara retrosynthetic analysis of (-)-idesolide. 
 The initial strategy was to quickly assemble monomer 8 through a ring opening 
elimination reaction of 132, prepared by a Sharpless asymmetric epoxidation of 131 
(92% e.e.), oxidation of the primary alcohol to the carboxylic acid, and the subsequent 
esterification with diazomethane to yield 133, Scheme 4. Unfortunately, the expeditious 
route was unsuccessful and complex mixtures were generated when 133 was subjected to 
a variety of basic and Lewis acidic conditions. Trace amounts of the desired 8 were 
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observed in some of the reaction mixtures that contained methyl salicylate 130, an 
indication that ketone enolization and subsequent aromatization was occuring, i.e. 136 → 
130, Figure 33.  
 
Figure 33. (A) Attempts at the conversion of 133 to (-)-8. (B) Suggested intermediate for 
decomposition of 136 to 130.  
 Alternatively, the ketone in 133 was reduced in order to circumvent the problem 
of enolization that was suspected to be the driving force behind rearomatization. The 
reduction of 133 was performed in good stereoselectivity using L-Selectride (LiB(s-
Bu)3H) providing stereoisomers 137β and 137α in a 5.2:1 ratio that were separable by 
chromatographic techniques, Scheme 4. The distal hydroxyl group in 137β was protected 
as the silyl ether, the epoxide was opened upon treatment with in situ generated phenyl 
selenide anion to generate 138.103 A one-pot oxidative elimination of selenide 138, 
desilylation, and subsequent oxidation of the secondary alcohol of 139 yielded the 
enantioenriched monomer 8. Diastereomer 137α could be subjected to the same reaction 
O
O
CO2Me
133
OH
CO2Me
O
(-)-8
lithiated amine
bases
or
Lewis acids
-elimination -
ring opening
O
CO2Me
134
OTBS
O
CO2Me
OR
X
(-)-8
E2 or [O] / E2
135a: X = Cl, R = H
135b: X = Cl, R=TMS
135c: X = I, R = TMS
135d: X = PhSe, R = H
OH
CO2Me
OR
OH
CO2Me
130136
A. B.
45 
 
sequence as 137β to provide 8 in somewhat lower overall yield, partially because of the 
tendency of the vicinal cis-diol 129 to oxidatively cleave upon oxidation. 
 
Scheme 4. Synthesis of monomer (-)-8. 
 In contrast to Iwabuchi’s dimerization studies, in which amine bases were 
primarily used, Kuwahara focused on the use of inorganic salts as a dimerization 
promoter, Table 6. Their investigation used inorganic additives under neat reaction 
conditions suggested that the site of reaction is ascribable to an increase in the interfacial 
area between the substrate oil/liquid and solid additive, as there was a correlation with 
increased yield as the amount of sodium bicarbonate was increased.  
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Table 6. Dimerization of (-)-8 to 5.83 
Entry Additive (equiv) Temp Time 5 (%) 140 (%) 141 (%) 
1 none 5 ˚C 48 h 0 0 0 
2 NH4Cl (1.0) 5 ˚C 20 h 0 0 0 
3 NaHCO3 (1.0) 5 ˚C 20 h 39 3 7 
4 NaHCO3 (1.0) rt 20 h 51 5 8 
5 NaHCO3 (2.0) rt 20 h 65 4 7 
 All of the syntheses presented suffered from non stereoselective transformations. 
Although good selectivity is achieved in the cases of Iwabuchi and Kuwahara, the 
enantiopure material is generated by chemical resolutions and separations. The syntheses 
of idesolide lack the benefit of an enantiopure raw material and instead rely on 
stereoselective chemical transformations.
47 
 
2.3 Iminosugars 
   Iminosugars can be defined as sugars in which the endocyclic oxygen atom has 
been replaced by a basic nitrogen atom. This simple substitution has arguably formed the 
most attractive class of carbohydrate mimics reported and has raised many synthetic 
challenges in their preparation. Many names have been used to describe the iminosugar 
framework, such as azasugar and iminocyclitol. In the context of this document 
“iminosugar” will be used exclusively as “azasugar” and “iminocyclitol” are used in a 
technically incorrect manner to describe these hetero-sugar derivatives. The prefix aza is 
used when describing a molecule in which a carbon atom has been replaced with a 
nitrogen atom. The term “iminocyclitol” should be abandoned, as well, for it describes a 
completely different class of compounds, namely carbon-based polyhydroxylated 
compounds, e.g. inositols. Using the standard rules for carbohydrate nomenclature it is 
possible to name these nitrogen analogues of sugars without special descriptors, Figure 
34.104 
 
Figure 34. Iminosugars and nomenclature. 
 From the point of view of synthesis, the history of iminosugars only dates back to 
the 1960’s when several reports from different groups surfaced.105-109 In 1966, Inouye et 
al. isolated nojirimycin (144) from bacteria (Streptomyces),110 with a follow-up synthesis 
in 1968, 111 and indicated its antibiotic properties.  Also in 1966, Paulsen published the 
first synthesis of 1-deoxynojirimycin (145).112, 113 It wasn’t until Bayer AG scientist 
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recognized the potent ability of 1-deoxynojirimycin to slow carbohydrate degradation by 
inhibition of α-glucosidases and, thus, become a viable anti-diabetic target, did the 
iminosugar surge take off.114 Eventually a derivative of 1-deoxynojirimycin was 
developed and today is marketed as Glyset™ (146). Iminosugars are still very actively 
pursued as medicinal targets and several examples are represented in Figure 35. A 
categorical assessment based on ring – skeletal structure will be presented below with 
indication of biological significance. 
 
Figure 35. Iminosugar examples.115-119 
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 2.3.1 Structural Diversity, Natural Sources, and Biological 
Activity 
Piperidines 
Nojirimycin 144 was the first naturally occurring iminosugar to be discovered and was 
isolated from the microorganism Streptomyces roseochromogene R-468.120 Its common 
name was given after its isolation from Streptomyces nojiriensis.121, 122 It had previously 
been ascertained that nojirimycin (144) had antimicrobial properties. It was also found to 
have potent inhibitory activity toward α- and β-glucosidases, as one might expect on the 
basis of structural similarity to glucose (153).123 It was the initial discovery of 
nojirimycin and its biological activity that led to the findings of two other iminosugars 
from the culture broths of both species of Streptomyces: 5-amino-5-deoxy-D-
manopyranose (nojirimycin B, 154)124 and 5-amino-5-deoxy-D-glactopyranose 
(galactostatin 155), Figure 36.125 Chemists interested in heterocyclic chemistry soon 
began isolating polyhydroxylated piperidine derivatives from plants. The first 
iminosugars to be isolated from a plant source was fagomine (156), from Fagopyrum 
esculentum (buckwheat),126 and moranoline (a compound prepared up to this point 
synthetically, 1-deoxynojirimycin 145), from a species of Morus (Mulberry trees).127 
Fagomine is also found in all parts of the mulberry tree cultivated in China, Korea, and 
Japan. The leaves of the mulberry tree have traditionally been used to cure and prevent 
“Xiao-ke” (diabetes) in Chinese herbal medicine. The root bark of the mulberry has also 
been used in Chinese herbal medicine for anti-inflammatory, diuretic, antitussive, and 
antipyretic purposes, while the fruits of the tree have been used as a tonic and sedative.114  
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Figure 36. The first iminosugars isolated. 
 
Pyrrolidines  
 Naturally occurring polyhydroxylated pyrrolidines first 
appeared in the scientific literature in 1976 with the isolation of 2,5-
dihydromethyl-3,4-dihydroxypyrrolidine (DMDP, 157) from species 
of the legume genus Derris elliptica.128 The active pursuit of 
biologically active and naturally occurring pyrrolidine glycosidase 
inhibitors remained idle until DMDP (157) was re-isolated from the 
legume genus Lonchocarpus129 and was shown to be have α- and β-
glucosidase inhibition at 3.3 and 7.8 µM concentrations, respectively.130 The absolute 
stereochemistry was not determined until 1987 when Fleet and coworkers report the 
enantiospecific synthesis, Figure 37.131 
Figure 37. 
Natural DMDP.
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Indolizidines  
 The first polyhydroxylated bicyclic alkaloid discovered was swainsonine (159) 
from the Australian legume Swainsona canescens132 and was followed closely with the 
report of the more heavily oxidized castanospermine (160).133 Swainsonine has been 
shown to be an inhibitor of Golgi α-mannosidse II, an enzyme involved in the N-linked 
polysaccharide (glycan) processing and has shown some possibilities toward 
chemotherapeutic therapies by means of anti-metastatic immunomodulation of melanoma 
cells.134 The biosynthesis has been investigated in the fungus Rhizoctonia leguminicola 
and involves the initial conversion of lysine (161) to pipecolic acid (162), Figure 38.135 
The pyrrolidine portion of swainsonine is constructed by the contribution of two carbons 
atoms from acetate that eventually forms 1-oxoindolizidine 163. A reduction of 163 
occurs followed by hydroxylation at C-2 to give 165. An unusual epimerization of 165 
then occurs with subsequent hydroxylation to yield swainsonine (159).  
 
Figure 38. (A) Natural indolizidines. (B) Proposed biosynthetic pathways for 
swainsonine. 
 Castanospermine, on the other hand, has been shown to be biologically active as a 
potent glucosidase inhibitor and antiviral agent. Castanospermine inhibits lysosomal α-
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glucosidase and disturbs the lysosomal catabolism of glycogen, thus, causing the 
accumulation of glycogen in the lysosome leading to muscle and nerve cell damage 
(Pompe disease).136 The castanospermine containing legume Castanospermum austral 
was recognized as the toxic source for livestock, leading to the Pompe-like symptoms, 
which led to its initial isolation. The antiviral activity exhibited by castanospermine 
comes as a result of the disruption of structural protein folding that is critical to viral 
secretion. These findings were  substantiated in both in vitro and in vivo studies.137  
Pyrrolizidines 
 Australine (166)138 and alexine (167)139 were the first two 
polyhydroxypyrrolizidines (containing more than two hydroxyl groups) discovered and 
were both reported in 1988, Figure 39. The species Castanospermum austral is native to 
the northeastern part of Australia and has been introduced into the Indian subcontinent, 
South Africa, and mild climate areas of North America as ornamental trees. 
Castanospermine (160) is the major component of the chestnut-like seed that australine  
(166) was isolated from. Identification and absolute 
stereochemical assignment for 166 was accomplished 
by NMR, mass spectrometry, and X-ray 
crystallography. It was determined that australine is a 
potent and specific inhibitor of α-glucosidase (5.2 
µM). 
 Alexine (167) is epimeric to australine (166) at the bridgehead position and is 
isolated from Alexa leiopetala, trees native to the wet lands of Guyana, Surinam, 
Figure 39. First isolated pyrroliz-
idines. 
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Venezuela, and the Amazon basin. The structure of alexine was assigned by NMR and X-
ray crystallography. The biological activity of this alkaloid was less impressive in 
comparison to to the epimer 167 and showed a weak inhibition of β-glucosidase and β-
galactosidase. 
Nortropanes 
 The most recently recognized members of the iminosugar group are the tri-, tetra-, 
and pentahydroxy nortropane alkaloids, the calystegines 168 – 177, and are differentiated 
from the tropane alkaloids by the lack of N-methyl substituent and the presence of 
hydroxyl group at the bicyclic ring bridgehead, Figure 40. These alkaloids were isolated 
from the roots of Calystegia sepium in efforts to identify substances with selective effects 
on plant – microbial relationship.140 It was found that the calystegines, released from the 
roots of C. sepium, acted as nutritional mediators for microbial growth. The study 
identified the plasmid of Rhizobium meliloti that encodes for catabolism of these uniquely 
structured alkaloids. No biological activity has been reported for this series of natural 
products, only catabolism studies relating to soil bacteria. 
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Figure 40. Nortropane alkaloids (calystegines). 
Glycosides 
 Of the five classes of alkaloids presented above four are known to exist as 
glycosides. Indolizidines are the only class not known to form glycosides. Piperidine 
glycosides are by far the most numerous. The glycoside of fagomine was isolated early 
on from the legume of Xanthocercis zambesiaca.141 Other glycosides have remained 
undetected until recently, when technological advances made the isolation of such species 
more achievable. Known iminosugar-producing natural sources have thus been re-
examined to identify other glycoside derivatives. The renewed interest in the 
identification of the glycosidic derivatives of iminosugars has been successful in the 
identification of seven glucosides and two galactosides of 1-deoxynojirimycin (145) from 
the species of Morus.142 Only one example is known of a polyhydroxylated pyrrolizidine, 
belonging in the nortropane class, glucosides of casuarine143 and calystegine B1 (177)144 
respectively.  
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 The wide distribution of iminosugar-producing plants dictates the large variation 
of these alkaloids observed from natural sources.145 Several plant families have been 
identified that produce such chemical species and include Moraceae, Euphorbiaceae, 
Leguminosae, Campanulaceae, Polygonaceae, Myrtaceae, Araceae, Hyacinthaceae, 
Casuarinaceae, Convolvulaceae, and Solanaceae.146 Equally as distributed is the range of 
biological activities that iminosugars exhibit and can be summarized by a few enzymatic 
processes that include glycosidases, glycosyltransferases, nucleoside-processing 
enzymes, glycogen phosphorylases, and metalloproteinases, Table 7.147 The therapies that 
are targeted are just as broad in scope and are also depicted below. 
Table 7. Enzyme and therapeutic targets. 
Enzymatic targets Therapeutic targets 
Glycosidases (mid-1970’s) Diabetes (mid-1970’s) 
Glycosyltransferases  (1992) Viral diseases (1980’s) 
Nucleoside-processing enzymes (1993) Cancers (1980’s) 
UDP galactopyranose mutase (1997) Lysosomal diseases (1990’s) 
Glycogen phosphorylaes (1997) Psoriasis (2000’s) 
Metalloproteinases (2004) Cystic fibrosis (2006) 
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 2.3.2 Selected Syntheses and General Strategies 
 The vast amount of iminosugar derivatives, their skeletal features, and the various 
ring sizes make any strategic synthetic analysis difficult. As a consequence, this section 
will focus on the synthetic strategies focused at the formation of pyrrolidine based 
iminosugars that contain a tertiary alcohol at C-2 (carbohydrate numbering). Many 
reviews have been published that cover pyrrolidine and iminosugar construction 
strategies.147-151  
Bols (1996) 
 In 1996 Bols and coworkers set forth the hypothesis that if a predictable transition 
state analogue could be constructed, specific glycoside hydrolases could be inhibited by 
structural modifications – certainly not a new concept by any means (structure-activity 
relationship).152 However, no structural modification in the sense of a pyrrolidine 
analogue had been reported for the powerful glucoside hydrolase (β-glucosidase, Ki = 
110 nM) isofagomine (178).153 By doing so they hypothesized that a pyrrolidine analogue 
could selectively inhibit a pentofuranoside cleaving enzyme, such as purine nucleoside 
phosphorylase (PNP), over other pyranoside glycosidases. PNP catalyzes the conversion 
of ribonucleotides to purine and α-D-ribofuranose-1-phosphate 179 through a 
ribofuranosyl cation 180, Figure 41. The iminosugar moiety is thought to inhibit 
glycosidases via amine protonation such as depicted in 181, protonated isofagomine, or 
as an example of a more structurally similar derivative the ribofuranosyl analogue 182. 
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Figure 41. Transition state mimics – isofagomine 181 and ribo-isofagomine 182. 
 To test this hypothesis Bols and coworkers prepared a pyrrolidine analogue 182 
that contained an additional hydroxy group at the 4-position in the belief that the 4-OH 
was less important for biological activity and because both enantiomers could be 
prepared more readily from the chiral pool. Pyrrolidine 182 was thus prepared from D-
mannose (183) using Ho’s aldolcondensation procedure154, 155 that installed the 
quaternary carbon, via hydroxymethylation and stereo definition, Scheme 5. Ho’s 
procedure consisted of bis isopropylidene formation and treatment with potassium 
carbonate (K2CO3) to form the hydroxymethylated intermediate 184. The more sterically 
exposed acetonide in 184 was selectively hydrolyzed and the resulting vicinal diols were 
oxidatively cleaved with sodium periodate (NaIO4) to give aldehyde-hydrate 185. The 
amination of 185 to yield 186 was performed under stringent reaction conditions in order 
to avoid competitive reaction pathways (high pressure H2 and low concentrations of 
NH3).  Subsequently, the acetonide in 186 was hydrolyzed under acidic conditions to 
yield iminosugar 182.  
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Scheme 5. Synthesis of iminosugar 182. 
 Alternatively, the synthesis of enantiomer 187 proceeded from D-ribose (188) by 
an acetonation by a method first reported by Hughes and Speakman156 and subsequent Ho 
hydroxymethylation154, 155 to yield 189. For iminosugar 187 chemistry analogous to that 
performed in the preparation of 182 was used, followed by the oxidative cleavage of a 
“masked” vicinal diol of 189 using NaIO4 to produce aldehyde-hydrate 190, amination to 
give acetonide protected pyrrolidine 191, and acid hydrolysis to provide 187, Scheme 6.  
 
Scheme 6. Synthesis of iminosugar 187. 
 Bols and coworkers prepared a set of enantiomerically pure, polyhydroxylated, 
pyrrolidines 182 and 187 by a series of transformations that included a stereospecific 
aldol condensation to install the quaternary chiral center at C-2 (sugar numbering) that, if 
not for the anomeric nature of the sugar derivative and the cis-diol functionality that was 
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Reagents: (i) H2SO4, acetone (59%); (ii) K2CO3, HCOH (37% aq), MeOH, 85 °C (yield not reported);
(iii) NaIO4, H2O, 25 °C, 18 h (94%); (iv) NH4OH (0.25 M), Pd/C (5%), H2 (102 atm), EtOH (92%); (v)
HCl (4 M aq), 25 °C, 18 h (51%).
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sequestered as an acetonide, would have been difficult to prepare. The iminosugars were 
tested for inhibition of α-glucosidase from bakers yeast and β-glucosidase from almonds 
but showed no significant activity and were non-specific.  
Fleet (2010) 
 Pyrrolidine 192 was isolated from Arachniodes standishii and Angylocalyx 
boutiqueanus in 1985157-159 and showed strong inhibition of α-glucosidase and weaker 
inhibition of other glucosidases. The unnatural enantiomer 193 was prepared and 
demonstrated stronger and more selective α-glucosidase inhibition than 192, as often the 
unnatural iminosugar isomers have been shown to do.160, 161 Analogues of both 
iminosugar enantiomers 192 and 193 were prepared as iminosugars 194 and 195 from the 
chiral pool, D-ribose (188) and D-tagatose (196), respectively. Biological studies 
indicated that 194 was active in glucosidase inhibition, the first example of a branched 
iminosugar pyrrolidine showing significant glucosidase activity, Figure 42.162 
 
Figure 42. Synthesis of natural and unnatural iminosugars 194 and 195. 
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 The synthesis of 194 is an eight step preparation from D-ribose consisting of only 
a single use of a protecting group, and proceeding with an overall yield of 37%, Scheme 
7. Fleet and coworkers utilized Ho’s hydroxymethylation procedure154, 155 that provided a 
mixture of hemiacetal 189 and tetrol 197 that was treated with NaBH4 to effect full 
reduction of the mixture to 197. Oxidative cleavage of 197 to 198 followed by oxidation 
with Br2/H2O, activation of the primary alcohol and subsequent displacement of the 
mesylate with azide provided azide 200. The final amination sequence started by re-
forming the hemiacetal via reduction of γ-lactone 200 with diisobutylaluminum hydride 
(DIBAL-H) yielding 201, hydrolysis of the isopropylidine in 201 with Dowex resin, and 
reduction of the azide with concomitant cyclization of the amine via condensation yielded 
iminosugar 194.   
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Scheme 7. Fleet’s synthesis of iminosugar 194. 
 Compound 195, the enantiomer of 194, was prepared from D-tagatose (196) and 
the synthesis was started with a Kiliani-Fischer reaction to introduce the C-2 
hydroxymethyl group via treatment of tagatose with sodium cyanide (NaCN) in water 
followed by acid hydrolysis and acetonation to yield diacetonide 203,163 a common 
chiron used in the field of sugar chemistry. The activation of primary alcohol 203 with 
triflic anhydride (Tf2O), displacement of the triflate group with azide, and the two step 
reduction with DIBAL-H/NaBH4 afforded azido diol 205. Sodium periodate was used to 
oxidatively cleave the C-4 and C-5 bonds which allowed for cyclization to occur and 
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yield azido pentose 207. The final cyclization to pyrrolidine 195 was performed as a one-
pot procedure, in which acid hydrolysis of 207 cleaved the isopropylidene to yield the vic 
diol (not shown). The reaction mixture was then treated with palladium/charcoal (Pd/C) 
under an atmosphere of hydrogen in order to reduce the azido group to an amine, which 
underwent spontaneous cyclization to pyrrolidine 195. The practical and simple 
procedure led to the preparation of polyhydroxylated pyrrolidine 195, achieved in 47% 
overall yield from 203.  
 
Scheme 8. Fleet’s synthesis of enantiomer 194. 
Kotian (2010) 
 In 2010 BioCryst Pharmaceuticals, Inc. reported two syntheses of iminosugar 
151. Two other iminosugars, 208 and 209, have been previously reported by BioCryst 
Pharmaceuticals and were used in the preparation of compounds 210 and 211, 
63 
 
respectively, in their effort to identify potent inhibitors of human purine nucleoside 
phosphorylase (PNP), Figure 43.119  
 
Figure 43. BioCryst Pharmaceuticals PNP inhibitors. 
 The strategy that was employed for the synthesis of 151 is unique for this class of 
quaternary center–containing pyrrolidines in that the establishment of the quaternary 
center was performed by a stereoselective addition of methyl magnesium bromide to 
ketone 212 (prepared from D-ribose), Scheme 9, and, alternatively, through 
stereoinduction derived from protected D-serine derivative 213, Scheme 10. 
 The first approach to 151 started from protected pyrrolidine 214, derived from D-
ribose (188) in several steps,164, 165 and involved multiple protecting group manipulations 
to single out the secondary hydroxyl group in 215 for oxidation to 212 and 216, Scheme 
9.166 The initial attempts at a stereoselective addition of methyl Grignard to the β-face of 
216 was mediated by titanium(IV) chloride (TiCl4) and found to be selective toward α-
addition, presumably due to nucleophilic approach from outside the concave face of 
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bicycle 216. The addition of methyl magnesium bromide to ketone 212 was only slightly 
more selective towards β-addition and gave 218 as the major component in a mixture of 
products that also contained 219 and 220 (218/219/220 2:1:1). The benzylation of the 
mixture containing 218 followed by separation and subsequent global deprotection 
yielded pyrrolidine 151. The pitfall of this particular route was the loss of stereo control 
during the TiCl4–mediated addition of methyl magnesium bromide to ketone 212 and 
prompted an alternative approach to 151. 
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Scheme 9. Synthesis of pyrrolidine 151 from D-ribose. 
 The second approach reported by Kotian et al. utilized a derivatized D-serine 
derivative 213167 to establish the stereochemical control needed to generate 
enantiomerically pure polyhydroxylate lactam 223. The isopropylidine derivatives 224 
and 225 were separated and intermediate 224 was reduced with lithium aluminum 
hydride (LiAlH4) to pyrrolidine 226. Acid hydrolysis of 226 furnished iminosugar 151. 
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This synthetic route proved to be more direct and was less reliant on protecting group 
strategies than the first synthetic route, Scheme 9. 
 
Scheme 10. Synthesis of pyrrolidine 151 from D-serine. 
 The field of sugar chemistry has a long history. The duration at which the field of 
study has had to mature has enabled the  development of many creative and practical 
methods for the synthesis of sugars and sugar-like compounds. Generally, most of the 
synthetic endeavors toward these kinds of structures take advantage of the chiral pool as 
raw materials and rely on the manipulation of functionalities for both chemo- and stereo-
induced transformations.  
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2.4 Vinca and Aspidosperma Alkaloids 
 The terpene indole alkaloids constitute a diverse class of natural products that 
contains over 2000 members.168 A range of diverse biological activities is exhibited by 
this class of alkaloids and includes anti-cancer, anti-malarial, and anti-arrhythmic 
activities. Relatively few reports of the isolation of new monoterpenoid alkaloids are seen 
each year. The focus of modern research activity for these natural products is in the field 
of synthetic organic chemistry as the biosynthetic pathways have been well established. 
The structural complexity of the monoterpenoid indole alkaloids is such that it has 
provided a realm of new synthetic strategies and the development of chemical methods. 
Numerous research programs have been aimed at tackling the challenge of an efficient 
synthetic strategy and, more academically, devising methodologies for regio-, enantio-, 
and chemoselectivity. 
 Vindoline (7), a major alkaloidal constituent of Cantharanthus roseus (C. roseus), 
represents the lower portion of vinblastine (13) and serves as its biosynthetic precursor, 
Figure 44. Vinblastine (13) and vincristine (14) are the most widely recognized members 
of the vinca alkaloids because of their clinical use as antitumor drugs (Velban®/Velbe® 
and Oncovin®, respectively). Other vinca alkaloids that have been investigated include 
desoxyvincaminol 227, vincaminol 228, and vinburnine 229. Semisynthetic vinca 
derivatives have been developed as antitumor drugs, such as Eldesin® (230),169 
Navelbine® (231),170, 171 and Javlor® (232),172, 173 and contain a contracted velbanamine 
(233) upper subunit compared to the parent natural products. Vincristine (14) was one of 
the first natural products whose structural elucidation was done by x-ray crystallography 
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and, also, among the first compounds in which a heavy atom derivative was used to 
determine the absolute configuration.174  
 In the following sections biosynthetic consideration will be depicted for this class 
of alkaloids with emphasis on biological activities and general strategies toward the 
synthesis of vindoline (7) and closely related natural products. The large literature 
compilation of monoterpenoid indole alkaloids research prevents a comprehensive 
analysis of the entire field. As a result, a limited survey of vinca alkaloids, namely 
vindoline (7), will follow with a mention of related synthetic strategies to other 
aspidosperma and vinca alkaloids. 
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Figure 44. Natural vinca alkaloids and unnatural derivatives. 
 
 2.4.1 Biosynthesis of Aspidosperma – Vinca Alkaloids 
 It is well understood that the biosynthesis of many monoterpene indole alkaloids 
originates in the condensation of the iridoid terpene secologanin (236) and tryptamine 
(237) to form strictosidine (238) via strictosidine synthase, Figure 45. Tryptophan (239) 
undergoes decarboxylation to form tryptamine (237) through tryptophan 
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decarboxylase.175 The enzyme tryptophan decarboxylase has been extensively studied, 
isolated and its cDNA sequence cloned.176  
 
Figure 45. Biosynthetic Pictet-Spengler reaction of secologanin and trypamine. 
 Until recently, the classical mevalonic acid (MVA) pathway was thought to be the 
only biosynthetic process and, thus, the source of isoprene diphosphate (IPP) (240). It is 
now well understood and proven that plants, periwinkle in particular, use a mevalonate–
independent pathway to produce IPP (240) that was first identified in bacteria and is 
called the 2-C-methyl-D-erythritol 4-phosphate (MEP) 241 pathway.177-179 Pyruvic acid 
242 and glyceraldehyde 3-phosphate 243 initiate the sequence leading to IPP (240) and 
all enzymes of the MEP pathway have been encoded by single genes with the exception 
of one, 1-deoxy-D-xylulose 5-phophate synthase (DXS), Scheme 11.180 
71 
 
 
Scheme 11. MEP pathway for the biosynthesis of IPP. 
The biosynthesis of secologanin (236) continues upon coupling of IPP (240) and 
dimethylallyl pyrophosphate (249) to form the monoterpene geraniol pyrophosphate 
(250). The first committed step toward an iridoid skeleton is the hydroxylation of 
geraniol (251) to 10-hydroxygeraniol (252) by geraniol-10-hydroxylase (G10H), Scheme 
12. Geraniol-10-hydroxylase has been expressed in yeast and was shown to hydroxylate 
geraniol (251) in vitro.181, 182 3H-labeled terpene experiments performed by Uesato et al. 
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suggest that 10-hydroxygeraniol (252), iriodial (254), and iridotrial (256) are all 
intermediates in biosynthesis of secologanin (236).183, 184 
 
Scheme 12. Continuation of the non-mevalonate biosynthesis of secologanin from IPP. 
 Nearly all of the enzymes involved in the MVA, MEP and iridoid pathways in C. 
roseus have been characterized.180 In plants, the MEP pathway is responsible for the 
generation of monoterpenes, diterpenes, and the prenyl side chains of chlorophylls and 
carotenoids. Once secologanin (236) is formed strictosidine synthase catalyzes the 
condensation of tryptamine (237) and secologanin (236) to generate strictosidine (238) 
via a stereoselective Pictet-Spengler cyclization, Figure 45. The formation of strictosidine 
(238) provides a biosynthetic intermediate that leads to several diverse classes of terpene 
indole alkaloids, Figure 46. Strictosidine synthase was first isolated, cloned, and its 
substrate specificity examined by Kutchan et al. in the late 1980’s and early 1990’s.185, 186 
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Figure 46. Major classes of terpene indole alkaloids derived from strictosidine. 
  The deglycosylation of strictosidine (238) by strictosidine β-D-glucosidase reveals 
a reactive intermediate that serves as a point for biosynthetic divergence, Scheme 13.187 
Very little is known about the enzymatic catalysis after the deglycosylation of 
strictosidine (238) and leading up to tabersonine (259). The construction of the strychnos, 
corynanthe, iboga, and aspidosperma skeletons has been elucidated based on feeding 
studies of isotopically labeled substrates to seedlings and/or shoots and are thought to be 
derivatives of the corynanthe alkaloids.188 These studies, conducted mainly in the 1960’s 
and 1970’s, have provided enough chemical structure information for a suggested 
biosynthetic pathway.188-197 It is worth noting that Wenkert speculated that a general 
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biogenetic route to aspidosperma and iboga alkaloids occurred by a intramolecular Diels-
Alder reaction of acrylic acid–enamine 271 years prior to any evidence that substantiated 
the claim.193 
 
Scheme 13. Suggested biosynthetic pathway for strychnos, corynanthe, and 
aspidosperma type alkaloids. 
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 Much more detail is known about the last six steps of the biosynthesis of 
vindoline (7) from tabersonine (259), Scheme 14. The hydroxylation of tabersonine (259) 
to 16-hydroxytabersonine 272 is performed by the cytochrome P450 monooxygenase 
tabersoninie-16-hydroxylase (T16H). The P450 enzyme T16H that is responsible for the 
oxidation of the indole nucleus has been cloned.198, 199 Next the 16-hydroxy group is O-
methylated to yield 16-methoxy-tabersonine 273 via 16-hydroxytabersonine-16-O-
methyltransferase (HTOM), an enzyme that have been purified200 and subsequently 
cloned.201 The hydration of the acrylic double bond in 273 is to give 16-methoxy-2,3-
dihydro-3-hydroxytabersonine 274 is currently an unknown enzymatic process, 
presumably some kind of hydratase. An S-adenosyl-L-methionine (SAM) – dependent N-
methyltransferase (NMT) recently characterized and cloned is responsible for the methyl 
group transfer to the indole nitrogen to yield desacetoxyvindoline 275.202 The penultimate 
intermediate deacetylvindoline 276 is oxidized by the dioxygenase enzyme 
desacetoxyvindoline 4-hydroxylase (D4H) which has also been cloned.203 The last 
biosynthetic step that yields vindoline (227) occurs by the acetylation of 276 by 
deacetylvindoline O-acetyltransferase (DAT).204 
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Scheme 14. Vindoline biosynthesis from tabersonine. 
 The biochemistry involved in aspidosperma biosynthesis has been well 
established with several of the late-stage enzymes fully characterized and cloned, e.g. 
T16H, HTOM, NMT, D4H, DAT. Arguably, with regards to the biology of these 
processes, the most important discoveries have not been the biosynthetic pathways 
themselves but the localization of the pathways in the plants. These biosynthetic 
pathways do not exist within a single location in a plant cell or even within a single plant 
cell type. For example, aspidosperma alkaloids in C. roseus are produced in at least three 
cell types. The first few steps of the iridoid pathway take place in the internal phloem leaf 
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cells, phloem being the internally located tissue responsible for the transport of nutrients 
to all parts of the plant. The main set of biosynthetic transformations leading up to 
vindoline (7) occur in the leaf epidermis while the last two steps of the biosynthesis 
occurs in laticifer and idioblasts cells, cells typically found in leaves and bark where they 
have the function of storing non-living substances used for defense, excretion, and/or 
storage of reserves.205  
 Vinblastine (13) and vincristine (14) occur in extremely low levels in the 
periwinkle plant and enormous quantities of raw plant material are required for 
commercial production. Nearly 500 kg (dry weight) of plant material are needed for one 
gram of a mixture of active alkaloids. Vincristine (13) alone constitutes only 0.0003% by 
weight of dry plant material.206 The structural complexity of the monoterpene indole 
alkaloids, in particular the bisindole alkaloids, and low natural abundance of these 
substances exemplify the need for the understanding of biosynthesis for eventual use in 
biotechnology. In terms of producing complex chemical entities on a commerically viable 
scale, the gap between chemistry and biology is being reduced by advances in 
microbiology and biotechnology. The future of synthetic biology, where recombinant 
microorganisms are designed to perform a series of molecular transformations, is gaining 
momentum with continued academic and industrial acceptance. 
 
 2.4.2 Biological Activity Profiles  
 Catharanthus roseus was initially investigated for its biological activity due, in 
part, to the reputation and folklore it has received from indigenous medicine in various 
parts of the world. In 1910 Peckholt described the use of C. roseus in Brazil as an 
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infusion of the leaves to control hemorrhage and scurvy, as a mouthwash to ease the pain 
of toothaches, and to clean and help heal chronic wounds.207 In the Philippines the plant 
was reported as an effective oral hypoglycemic agent and in the former British West 
Indies as a treatment for diabetic ulcer. In South Africa and England the plant extracts 
were marketed under the names “Covinca” and “Vin-q-lin” as a treatment for diabetes.208 
 Two independent research groups began programs into the phytochemical 
properties of this plant, one at the Collip Laboratories at the University of Western 
Ontario and the other at Lilly Research Laboratories. The research group at Collip Labs. 
observed peripheral granulocytopenia and bone marrow depression in rats from certain 
alkaloidal fractions. This study eventually led to the isolation and identification of the 
sulfate of vinblastine (13), which was deemed the alkaloid responsible for the previous 
physiological observations as well as the causes for producing severe leukopenia, or 
lowering of white blood cell count, in rats.209 Lilly researchers had been using mixtures 
that contained vinca alkaloids on mice with P-1534 leukemia. The studies showed a 
prolongation of life in mice that were subjected to the vinca alkaloid containing 
mixtures.210 These initial studies led to the identification of additional alkaloids with 
potent biological activities of which vinblastine (13) and vincristine (14) will be 
discussed. 
 Although vindoline (7) exhibits weak inhibition of tubulin polymerization and 
high micromolar IC50 values for the inhibition of ATPase, a class of enzymes responsible 
for the degradation of adenosine triphosphate (ATP) to adenosine diphosphate (ADP), its 
bisindole alkaloid cousins overshadows its biological activity. Some of the biochemical 
effects observed from treatment of cells and tissues with bisindole alkaloids include the 
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disruption of microtubules, inhibition of protein synthesis and nucleic acids, alteration of 
lipid metabolism and the lipid content of membranes, the elevation of cyclic adenosine 
monophosphate (cAMP), and the inhibition of calcium-calmodulin-regulated cAMP 
phosphodiesterase. It is the antineoplastic activity, or anti-tumor activity, of the bisindole 
alkaloids vinblastine (13) and vincristine (14) that has garnered value as clinical 
chemotherapies. The anti–tumor activity of the vinca alkaloids is generally attributed to 
the disruption of microtubule formation that ultimately results in the degradation of 
mitotic spindles and metaphase arrest in dividing cells.211, 212 The effects of the vinca 
alkaloids on the organization and function of microtubules has been heavily researched 
and it has been determined that each heterodimer of α,β-tubulin possesses a single high 
affinity and “vinca specific” binding site and several low affinity, nonspecific sites.213 On 
the basis of in vitro microtubule assembly experiments it is assumed that the vinca 
alkaloids operate by more than one biological mechanism.214, 215 At low concentrations 
vinblastine (13) inhibits the formation of microtubules by means of sub-
stoichiometrically binding to high affinity sites at the ends of microtubules. At higher 
concentrations microtubule disassembly results from vinblastine (13) binding to 
heterodimers located along the surface of the microtubule. The binding to the low affinity 
sites along the microtubule surface occur through stoichiometric interaction with vinca–
specific sites.  
 A well-described correlation between the cytotoxic actions of the vinca alkaloids 
and tumor cell resistance has been reported in the literature.216, 217 The accumulation and 
retention of vinblastine (13) in cultured tumor cells was reported as the primary 
mechanism of drug resistance, not necessarily because of alterations in tubulin binding 
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sites.218 The process of vinca alkaloid drug resistance is mediated by P-glycoprotein 
(Pgp). Similar to other known clinical anti–cancer drugs, Pgp binds vinca alkaloids and 
extrudes them from the tumor cell. As a result significant research has been formed at 
combination chemotherapy protocols in which Pgp modulators, or sacrificial substrates 
for Pgp, are used to increase plasma levels of the vinca alkaloid and increase their half-
life.219  
 More specifically, vinblastine (13) has been approved as a component of 
combination therapy for the use in treatment of Hodgkin’s lymphoma, non–Hodgkin’s 
lymphomas, advanced mycosis fungoids, advanced testicular carcinoma, Kaposi’s 
sarcoma and histiocytosis. Vincristine (14) has also been approved for the treatment of 
the same spectrum of Hodgkin’s and non–Hodgkin’s lymphomas, rhabdomyosarcoma, 
neuroblastoma, Wilms’ tumor, Ewing sarcoma, melanoma, and small–cell lung cancer.  
 
 2.4.3 Selected Syntheses and General Strategies  
 Of the numerous strategies that have been used in the synthesis of aspidosperma 
alkaloids, the classic approach that Stork used in his synthesis of rac–aspidospermine 
(277)6 became an approach used by several groups for the construction of the tricyclic 
terpenoid end of the molecule. Stork’s strategy is the basis of the work presented in this 
document, i.e. the formation of a tricyclic intermediate similar to 278, and, thus, the 
syntheses selected will also reflect the tricyclic intermediate–Fischer indolization 
approaches to aspidosperma alkaloids. 
 
81 
 
 
Stork (1963) 
 Stork’s seminal work in the field of aspidosperma synthesis was reported in 1963 
and stands as the first synthesis of aspidospermine (277), Scheme 15.6 The initial part of 
the sequence utilizes Stork’s enamine alkylation method220 in which the enamine of 
butyraldehyde 279 was used in the Michael addition with methyl acrylate and after acid 
hydrolysis yielded aldehyde 280. A second Michael addition of an enamine derived from 
280 with methyl vinyl ketone followed by hydrolysis and aldol reaction provided enone 
281. Amidation with ammonium hydroxide and subsequent cyclization formed lactam 
282 that was then subject to the classical Fischer indolization conditions yielding the 
undesired linear indole 283. According to the report the outcome was not unexpected and 
the means to circumvent the linear indolization was to construct a tricyclic system by re-
functionalizing ester 281. The primary amide 284 was prepared and cyclized to give 285. 
Acylation of 285 to 286 and substitution of the chloride with the enolate of 286 provided 
tricycle lactam 287. In this case, Fischer indolization of tricycle 287 provided the kinetic 
ene–hydrazine and led to indole 288 instead of the desired thermodynamic outcome. 
Stork speculated that by reducing the amide functionality in 287 and, thus, increasing the 
number of tetrahedral centers, would allow for a more favorable transition state leading to 
the thermodynamic ene–hydrazine and the ultimate cyclization. His rationale proved 
correct when 278 was subjected to indolization to form the indolenine which was reduced 
and acetylated to yield rac-aspidospermine (277).   
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 Several diastereomerics from Stork’s work were later deduced by Ban et al. on 
the basis of chemical properties comparison during his synthesis of aspidospermine.221 
 
Scheme 15. Stork's synthesis of rac-aspidospermine (1963). 
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Ban (1965) 
 The synthesis of aspidospermine (277) by Ban and co-workers shared a similar 
strategy to that of Stork’s6 but was significant in that a stereochemical divergence was 
identified by the comparison of synthetic intermediates.221 Ban’s synthesis began with the 
addition of pentanone 289 to two equivalents of acrylonitrile which, upon heating in 
concentrated sulfuric acid, cyclized to vinylogous amide 291, Scheme 16. The reduction 
of 291 with palladium/H2 in a basic medium afforded alcohol 292 of which the amide 
moiety was deoxygenated with LiAlH4 to 293. The oxidation of 293 to 294 using 
Oppenauer’s conditions222 intercepted an intermediate utilized in Stork’s synthesis, 
namely 285, and provided an opportunity to compare physical properties, Figure 47. 
Despite the evident difference in physical characteristics between Stork and Ban’s 
intermediates the synthesis was continued in the hope to validate the synthetic pathway 
from presumed (at the time) diastereomers. From the point of ketone 294 the synthesis 
mimics that of Stork’s by the formation of tricyclic lactam 296 and subsequent 
chemistries that lead to the Fischer indolization product deacetyl aspidospermine 297. 
Acylation of 297 yielded aspidospermine (277) whose spectral data matched those of the 
natural alkaloid.  
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Scheme 16. Ban's aspidospermine synthesis (1965). 
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Figure 47. Comparison of physical properties. 
 Regardless of which diastereomer is prepared, Stork’s 278 or Ban’s 299, the 
cyclization reaction that yields indolenine 300 and 301 is immediately followed by a 
retro-Mannich process6 that defines the stereochemistry of that ring system. This 
redundant process was originally proposed by Smith and Wróbel.223  The imminium 302 
ultimately equilibrates to the more stable pentacyclic core of aspidospermine (277) and 
substantiates Stork’s claim regarding the ambiguity of the chiral centers involved in the 
indolization process, namely during the formation of the ene-hydrazine, Figure 48. 
Stork’s statement regards the sole dependency of the quaternary center’s (C-22, 
aspidospermine numbering) stereochemistry on the outcome of the final product of the 
indolization. The retro-Mannich equilibration is favored at elevated temperatures and has 
been used in the syntheses of other aspidospermine and quebrachamine-like natural 
products. 
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Figure 48. Retro-Mannich equilibration of diastereomers to aspidospermine (277). 
 
Kuehne (1966) 
 Kuehne and Bayha proposed the synthesis of two additional diastereomers of the 
“Stork” tricyclic ketone in 1966.224 Although comprehensive investigation could not 
confirm the identity of the structural isomers 303 and 304, Scheme 17, spectroscopic 
comparison with 278 and 299 showed similarities and Kuehne claimed that the 
diastereomers could be paired based on trans or cis-fused six membered rings: trans-
fused 278/303 and cis-fused 299/304. The reaction scheme is shown with stereochemistry 
deduced from other isomers prepared (and validated). There is uncertainty because of the 
lack of physical characteristics and conflicting assignments with previous reports by 
Stork and Ban. 
 Kuehne and Bayha’s synthesis started with the alkylation of ethyl ester of proline 
305 with γ-bromo ethylbutyrate to give 306. Compound 306 underwent a Dieckmann 
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condensation followed by decarboxylation to yield bicycle 307.  Annulated product 307 
by  was subjected to Wittig olefination and reduced to yield 309. The tricyclic ketone 311 
was constructed via enamine condensation of 310 with methyl acrylate. This was the 
stepping off point for the preparation of diastereomers 303/304. Vinylogous amide 311 
was reduced over a platinum catalyst and re-oxidized to produce 303 while, alternatively, 
311 was treated with LiAlH4 to yield 304. 
 
Scheme 17. Kuehne’s synthesis of tricyclic ketone 303/304 (1966). 
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 R. V. Stevens’s formal synthesis of (±)-aspidospermine (277) provided yet 
another strategy to construct the tricyclic ketone intermediate utilized by Stork, Ban, and 
Kuehne.225 Stevens’s synthesis is highlighted by the thermal rearrangement of 
cyclopropyl imine 317 prepared from the condensation of cyano ester 312 with 1,3-diol 
313 followed by subsequent chemistry, Scheme 18. The formation of the pyrroline 318 
allowed for the formation of the annulation product 319 which, upon treatment with 
sodium methoxide/methanol, was transformed to a pair of separable tricyclic enol ethers 
320/321 (28:72). The major component 321 was reduced to 322 and hydrolyzed – 
dehydrated to enone 323. The formal synthesis of rac-aspidospermine (277) was 
completed upon hydrogenation over palladium and matching spectral data to authentic 
samples. 
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Scheme 18. Stevens' formal synthesis of aspidospermine (1971). 
Aube (2000 / 2005) 
 Although Aubé and co-workers’s efforts toward the synthesis of (+)–
aspidospermidine (325) were arduous in planning, lengthy (22 linear steps), and suffered 
from low overall yield (1.1 %) the technical display of chemistries used to construct the 
tricyclic ketone is noteworthy and represents a modern approach to the Stork’s classical 
intermediate 278.226, 227 The synthesis began with an asymmetric version of the Robinson 
annulation developed by d’Angelo.228 The enamine that resulted from the condensation of 
(S)-methylbenzylamine and 2-ethyl cyclopentanone 326 was used to alkylate Michael 
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acceptor 327, Scheme 19. Acid hydrolysis followed by cyclization with sodium 
methoxide/MeOH yielded bicyclic enone 328 in good enantiomeric excess (84 – 86%), to 
which was increased to enantiopurity downstream. The series of transformations that led 
to 328 established the only stereocenter (C-22, aspidospermine numbering) critical for the 
preparation of the natural product, Figure 48. The gamma position of the enone in 328 
required a higher oxidation state in order to establish a basis for the future Schmidt 
reaction. To this end 328 was treated with isopropenyl acetate to generate the dienol 
acetate 329 and subsequently oxidized with potassium peroxymonosulfate (Oxone) to 
yield γ-hydroxy enone 330. It was determined through other failed routes (not shown) 
that although the enone in 330 needed to be fully saturated in the α,β-position, the 
nucleophilicity that resulted from the enolate presented problems during attempts to 
install the azide moiety, e.g. competitive cyclopropanation. Instead, Aubé and co-workers 
performed a “redox ketalization” using bis(trimethylsilyl)neopentyl glycol and 
trimethylsilyl triflate (TMSOTf) to form ketone 332 (12:1 mixture of diastereomers) 
through enol 331, while at the same time protecting the side chain from epimerization. 
Functional group interconversion of the benzyl group in 332 to azide 333 was completed 
via hydrogenolysis and a subsequent Mitsunobu reaction with hydrazoic acid. The latent 
ketone in acetal 333 was liberated with lithium tetrafluoroborate (LiBF4) to yield the 
Schmidt intermediate 334 as a 10:1 mixture of diastereomers (major shown). The 
Schmidt reaction of azido diketone 334 assisted by titanium tetrachloride (TiCl4) proved 
to be regioselective and provided a single diastereomer of 335 (84% ee). A series of 
functional group manipulations led to the eventual synthesis of Stork’s tricyclic ketone 
278 and completed the formal synthesis of aspidospermine (277). To extrapolate from 
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tricycle 278 to (+)-aspidospermidine (325) Fischer indolization was performed at 
elevated temperatures with phenylhydrazine in acetic acid. The resulting indolenine was 
reduced to form (+)-aspidospermidine (325). 
 
Scheme 19. Aubé's formal synthesis of aspidospermidine (2005). 
 The classical synthetic routes described in this section are linear in the means at 
which the target alkaloids are constructed. The bond-by-bond construction strategy is still 
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commonly used in modern synthesis and those tactics will continue to be implemented 
when necessary. However, more efficient tandem processes are generally used in the 
strategic planning of the synthesis of complex natural products. Some examples of these 
practices will be outlined by the work of Fowler, Zard, and Marino in the coming 
chapters.     
  
93 
 
3 Results and Discussion 
3.1 Introduction 
 The following chapter summarizes the efforts made by this author to contribute 
examples of chemoenzymatic syntheses and showcases the versatility of (–)-3,5-
cyclohexadiene-1,2-diol-1-carboxylic acid 4, generated enzymatically from benzoic acid 
by the mutant organism Ralstonia eutropha B9. The chapter is divided into four main 
bodies of work and that include: 1) enzymatic dihydroxylation of benzoic acid by R. 
Eutropha B9, 2) the synthesis of (–)-idesolide, 3) the synthesis of an iminosugar, and 4) 
approaches toward the synthesis of Vinca alkaloids. 
3.2 Dihydroxylation of Benzoic Acid by Ralstonia eutropha B9 
 The use of the whole-cell fermentation technology to generate enantiomerically 
pure molecules and the utility of these compounds in enantioselective syntheses has 
proven to be a powerful and versatile combination.19, 74, 77 As a part of the sustained effort 
to demonstrate the benefits of a combined chemoenzymatic approach to organic 
synthesis, substrates for enzymatic oxidation are sought that would result in useful chiral 
molecules. To this end the mutant organism R. eutropha B9, discovered in 1971 by 
Reiner42, 229 and exploited by Myers in 2001,66  was utilized as the vehicle for benzoate 
dioxygenase (BZDO) for the accumulation of (–)-3,5-cyclohexadiene-1,2-diol-1-
carboxylic acid 4 in fermentations with benzoic acid. The research groups of 
Mihovilovic, Lewis, and Widdowson have also utilized the R. eutropha B9 cell lines 
toward chemoenzymatic synthesis.67-69, 72, 73, 77, 230  
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 The production of ipso diene diol 4 is fairly robust and specialized equipment is 
not required. Like all biotransformation processes that utilize aromatic compounds as 
substrates, the technique relies on a fed-batch feeding regime to prevent substrate 
inhibition. In doing so high cell densities can be achieved and metabolic efficiencies can 
be maximized. In 2001 Myers et al. depicted a rudimentary process consisting of a 55 
gallon drum (80 L working volume) that was capable of generating greater than 200 
grams of ipso diol 4. 
 In 2010 Mihovilovic and co-workers presented a significant improvement of the 
biooxidation process by establishing the correlation of oxygen consumption with 
substrate metabolism, a well-known phenomenon that occurs during enzymatic 
dihydroxylation.69 Fine tuning of the substrate and carbon source feed limits were 
established for the fed-batch process that consisted of small additions of both substrate 
and carbon source into the ferment broth over several days. The implementation of D-
fructose as a carbon source in place of succinate was also established and, in conjunction 
with a controlled substrate introduction, allowed for metabolite titers of up to 14.4 g/L on 
2 L scale. The single most valuable and practical information from the report was on the 
isolation of the labile ipso diol 4. Traditionally, and with most other metabolites derived 
from enzymatic dihydroxylation, cis-dihydro diene diols are isolated from basic ferment 
broth by exhaustive liquid-liquid extractions with an organic solvent. The tendency for 
cis diene diol metabolites to aromatize via dehydration is high unless careful measures 
are taken to limit exposure to acidic environments, either on macro- or micro-scale, even 
as far as to base-washed ethyl acetate (EtOAc) used in the extraction process. The 
dehydration of the cis-diene diols is self-propagating (autocatalytic) as a result of 
95 
 
accumulation of phenol of type 336, Figure 49. To circumvent the two re-aromatization 
pathways leading to the degradation of ipso diene diol 4 to phenol 338 and salicyclic acid 
(339), Figure 49, Mihovilovic concentrated the neutral aqueous ferment broth to less than 
1 L and precipitated the carboxylate of 4 with the addition of isopropanol (iPrOH). This 
method yielded a mixture of inorganic salts and the mixed potassium/sodium carboxylate 
337. The carboxylate salt 337 was found to be bench stable for more than six months 
without any observable degradation. This particular method of isolation proved to be 
irreproducible on larger scales (e.g. 8.5 L working volume) and it became more 
convenient to concentrate the ferment broth to dryness after centrifugation of cell matter. 
The composition of the mixture that contained diol carboxylate 337 was established 
quantitatively using the internal standard method by NMR and yields in the range of 18 – 
22 g/L were consistently observed.  
 
Figure 49. Chemical degradation of cis diene diols. 
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  If the protonated carboxylic acid was needed as an intermediate, an aqueous 
solution of 337 could be prepared, acidified at 0 ˚C, and quickly extracted with ethyl 
acetate without too much danger of re-aromatization.  
 
3.3 Chemoenzymatic Synthesis of (–)-Idesolide from Benzoic Acid 
 In 2010 back to back reports by Iwbuchi82 and Kuwahara83 were released on the 
synthesis of idesolide (5). The skeletal features, substitution pattern, and degree of 
oxygenation contained in idesolide (5) show an obvious resemblance to the ipso diene 
diol 4. Two possible routes were envisaged for the synthesis of the monomeric precursor 
8, a previously established synthetic intermediate for idesolide, and that would allow for 
an efficient synthesis. The most concise route consisted of a direct isomerization of diene 
diol ester 340 to α-hydroxy ketone 8, an overall neutral redox event, Figure 50. A second 
plan involved the selective reduction of the olefin distal to the ester group in diene ester 
340 followed by a subsequent oxidation step. 
 
Figure 50. Idesolide retrosynthesis. 
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 As a start to the synthesis of (-)-idesolide (5), carboxylic acid 4 and methyl ester 
340, derived by the treatment of 4 with diazomethane, were probed for selective 
reduction of the distal alkene with diimide. The Hudlicky group has used diimide, 
derived from the decarboxylation of potassium azodicarboxylate (PAD),231 to reduce 
olefins in other syntheses that used diene diol metabolites obtained from the fermentation 
of arenes.232 Diimide shows little electronic preference toward reactions with cis alkenes, 
as long as the alkene is not highly polarizable, and selectively is typically a result of the 
steric environment of the substrate. In the case of carboxylic acid diol 4 and methyl ester 
diol 340 the additional of steric bulk provided a slight increase in selectivity for the 
methyl ester 340. A 1:1 ratio of reduced products 341 and 342 were observed when 
carboxylic acid 4 was treated with diimide while a 2:1 ratio in favor of the desired 
distally reduced olefin 129 was observed, Scheme 20. Separation of the two alkene 
isomers was possible on silica gel and the result provided some precedence for the 
synthetic route. To further demonstration the influence of steric bulk on the diimide 
reduction the preparation of the tert-butyl ester of 4 was attempted. Attempts at the 
derivatization of the carboxylic acid 4 as the t-butyl ester 344 were not successful and the 
failure was attributed to the incompatibility of the known methodology used to generate 
isobutylene in situ, e.g. dehydration of tert-butanol (tBuOH) with catalytic or 
stoichiometric sulfuric acid (H2SO4).233, 234 
98 
 
 
Scheme 20. Reduction of distal olefin in ester 340. 
 With cis-diol 129 readily available the oxidation to yield monomer 8 was 
screened.  Snider, Iwabuchi, and Kuwahara approached the common monomeric 
intermediate 8 in slightly different ways in order to combat the problematic and 
sometimes labile nature of cis-1,2-diols toward oxidation. Snider utilized a completely 
different strategy in forming 8.  By means of dearomatization of SEM-protected methyl 
salicylate 112 via Birch reduction, Snider and co-works were able to generate SEM-enol 
ether 113.81 In doing so, 113 was unmasked as the α-hydroxy ketone 8 by a Lewis acid 
mediated desilylation – isomerization reaction, Scheme 21. Iwabuchi’s choice of oxidant 
came about serendipitously prior to the improvement of the reaction conditions with N-
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oxyl AZADO 115, Figure 31. N-Oxyl based-oxidants impart a mild oxidative 
environment and the bulky and rigid nature of the adamantane-like skeleton of 115 was 
able to provide advantage over any participation from the vicinal alcohol.82 Alternatively, 
Kuwahara and co-workers prepared a set of chromatographically separable epoxy 
alcohols 137α/137β (1:5) that were used to prepare trans-1,2-diol 139 (from 137β), 
Scheme 4.83 trans-Diol 139 underwent oxidation with Dess-Martin periodinane 
(buffered) in high yield (76% over two steps) without any interference from the 
neighboring trans alcohol . Comparatively, Kuwahra extrapolated the minor epoxy 
alcohol 137α to cis-diol 129 and subjected it to the same oxidative conditions as 139 for a 
significantly reduced product yield (25%).  
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Scheme 21. Comparison of yields for monomer 8. 
 Glycol cleavage is a well-known and often desired transformation in organic 
chemistry. Taking into consideration the required stereochemical relationship for 1,2-diol 
cleavage to occur, the comparative yields obtained by Kuwahara and co-workers for the 
oxidation of 129 versus 139, the somewhat exotic choice of the oxidant by Iwabuchi, and 
finally, the lack of other common oxidants that were not attempted and/or reported led to 
the speculation that the cis-diol moiety in 129 was prone to cleavage and over oxidation. 
Iwabuchi’s oxidation protocol using AZADO 115 in catalytic amount and polymer bound 
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bis(acetoxy)iodobenzene (BAIB) as the bulk oxidant proved unreliable and low yields of 
an equally low quality of 8 (85% pure by NMR analysis) were ever obtained. However, 
the reaction conditions did serve as a means to access a standard sample of 8 that could 
be used for further screening purposes. With a standard sample of 8 in hand a reagent 
screen was performed for the oxidation of cis-diol 129 to monomer 8 and is outlined 
below, Table 8. 
Table 8. Reagent screen – oxidation of 129. 
 
Entry Oxidant Result (% yield) 
1 Dess-Martin periodinane 
129 (30%)  
8 (5-10%)  
cleavage/over oxidation 
2 Collin’s reagent 
15% recovered 129 
cleavage/over oxidation 
3 AZADO (cat.), PS-BAIB82 8 (30%) 
4 Corey-Kim procedure235 complex mixture 
5 
oxoammonium TEMPO (1 
equiv)236 
129 
8 (trace) 
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complex mixture 
6 
Oppenauer oxidation (AlMe3, 
nitrobenzaldehyde, 
PhMe/CH2Cl2)237 
no reaction 
7 
CrO3/Ac2O, CH2Cl2 
(-40 ˚C, -20 ˚C, 0 ˚C) 
8 formed initially. Decomposition during 
workup, e.g. concentration, neutralization 
yields complex mixture and additional 
attempts to trap as the hydrazone failed. 
8 
IBX, EtOAc, 80 °C 
(heterogeneous mixture) 
8 (27%) 
IBX-3° alcohol adduct  
9 
Fetizon’s reagent 
(Ag2CO3/Celite)238 
cleavage, rearomatized products 
10 Dimethyldioxirane (DMDO) epoxidation 
11 
tetrapropylammonium 
perruthenate (TPAP)239 
8 (trace) 
12 BaMnO4 no reaction 
13 
2,3-dichloro-5,6-dicyano-1,4-
benzoquinone (DDQ) 
no reaction 
14 Swern oxidation240 
129 
8 (12%) 
15 Mukaiyama oxidation241 no reaction 
16 IBX, DMSO, rt 8 (40 – 60%) 
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 The oxidation of 129 was not trivial although several sets of conditions were 
successful in generating the α-hydroxy ketone 8. o-Iodoxybenzoic acid (IBX) was chosen 
as the oxidant for the transformation based on the reaction profile presented during the 
screening process and the known inhibition of the 1,2-diol cleavage pathway.242 
Heterogeneous conditions (IBX in EtOAc, 80 ˚C) provided the most convenient workup 
of simply filtering off residual IBX and the insoluble reduced by-product iodosobenzoic 
acid (345) (IBA). However, there was always an inseparable impurity in appreciable 
amounts that could not be purged. The assumption, based on NMR analysis and 
ultraviolet (UV) activity of crude mixtures, was that the impurity was some form of IBX 
adduct with the tertiary alcohol in 129/8. To this end, homogenous reaction conditions 
(IBX in DMSO, rt) were used for the oxidation and the reaction proceeded smoothly at 
ambient temperature. Dimethylsulfoxide (DMSO) presented other known challenges for 
workup, namely the high dielectric constant and high boiling point. The isolation of 8 
from IBA by chromatographic methods was not possible, nor was liquid-liquid 
partitioning with diethyl ether successful. Yields were in the range of 20 – 30% using this 
workup. In order to circumvent further diminishment of yield through repetitive 
purifications, the IBA was precipitated by the slow addition of the reaction mixture into a 
stirred volume of water (2.25 x volume of DMSO). The inverse addition was necessary to 
avoid gum formation and entrapment of 8. This improved workup procedure provided 
consistent yields in the 55-60% range with an improved quality of product 8. 
 The final step of the synthesis of (-)–idesolide (5) was the dimerization of 
monomer 8 and this was performed using Kuwahara’s reported conditions of dispersed 
sodium bicarbonate (NaHCO3, 2.0 equiv) in neat 8. The reaction was executed at room 
104 
 
temperature with a noticeable increase in viscosity over time. Idesolide (5) began to 
crystallize in the reaction mixture as the conversion of 8 to idesolide (5) proceeded. The 
reaction took anywhere from 12 – 48 hours to surpass the ratio of 1:1 8/(5), as monitored 
by NMR, and rarely did the conversion of 8 ever surpass 75%. The purification of the 
reaction mixture consisted of trituration with pentanes or hexanes. (-)–Idesolide (5) was 
the only compound in the reaction mixture soluble in the non-polar solvent and yields 
were observed in the range of 56 – 66% using this method of isolation. The mixtures that 
contained (-)-idesolide (5) were not able to be isolated by chromatographic purification 
and attempts were detrimental to product recovery, despite other reports of its isolation 
by these means. 
 Although Kuwahara’s conditions for the dimerization of 8 were consistent, a 
screen of solid support reagents was performed, Table 9. However, the conversion of 8 to 
(-)–idesolide (5) never exceeded 33% based on NMR analysis and a set of conditions 
superior to dispersed NaHCO3 (s) was never established. 
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Table 9. Reagent screen – dimerization of 8 to (-)-idesolide (5). 
 
Entry Solid Support Result 
1 Neutral alumina Idesolide (5) formed, low conversion by TLC 
2 
Basic alumina 
(Brockman Act I) 
Idesolide (5) formed, low conversion by TLC 
3 
Amberlyst A-21 
Ion exchange 
resin 
(weakly basic) 
Most promising by TLC; NMR conversion to idesolide (5) 
33% 
4 
Amberlyst A-27 
Ion exchange 
resin 
(strongly basic) 
Idesolide (5) formed, low conversion by TLC 
* 5 mg-scale of 8, 100 wt% solid support, no solvent 
 Having established the means to produce the monomeric unit 8 of idesolide (5) 
the direct isomerization of diene diol 340 to 8 was studied, Table 10. Several metal 
catalyst are known for the isomerization of simple allylic alcohols.243-247 Several sets of 
conditions were screened with diene diol 340 without successfully forming ketone 8. 
Several reactive pathways exist in using transition metals with 340: 1) a diene moiety, 2) 
doubly allylic alcohols, 3) vic diols, and 4) thermally labile substrate prone to re-
aromatization via dehydration. In the course of the reagent screen, complex mixtures of 
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products were commonly encountered; however, two reactions stand out as their products 
were stable and isolable, Scheme 22.  
Table 10. Reagent screen – attempts at the direct isomerization of 340 to 8. 
 
Entry Conditions Result 
1 
Crabtree catalyst 
[Ir(cod)(PCy3)(py)]PF6 (5 
mol%), DCM 
No reaction 
2 Fe2(CO)9, DCM, hυ Low conversion (4 spots) – 
346 (35%, Scheme 22)  
3 Fe3(CO)12, DCM, hυ Low conversion (5 spots) – 
no 8 
4 Fe2(CO)2, PhMe, 45 ˚C No reaction 
5 TPAP, octanol, PhF, Δ Complex mixture (5 spots) – 
no 8 
6 Grubbs I (5 mol%), toluene, Δ Complex mixture (7 spots) – 
347 (20%, Scheme 22) 
7 Fe(CO)5, DCM, hυ  Low conversion (3 spots) – 
no 8 
8 Ru3(CO)12, DCM, rt → 40 °C Low conversion – 
decomposition 
9 Ru2Cl2(CO)4, DCM, rt → 40 °C Low conversion (5 spots) – 
no 8 
10 
Ru3(CO)12, DCM, rt → 130 °C, 
several days 
Complex mixture (4 spots) – 
no 8 
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11 Pd/C, Et3N, toluene, 130 °C 
Complex mixture – no 8, 
rearomatization (+ FeCl3 
test) 
12 
RuCl3·H2O, MeOH 
(rt, 16 h; 45 ˚C → 65 ˚C) 
Non-polar spot (+ FeCl3 
test), low conversion, no 8 
13 
RuCl2(PPh3)3, MeOH 
(rt, 16 h; 45 ˚C → 65 ˚C) 
Several non-polar spots 
formed upon heating, no 8 
14 
RhCl3·3H2O, MeOH 
(rt, 16 h; 45 ˚C → 65 ˚C) 
Non-polar spot (+ FeCl3 
test), low conversion, no 8 
15 
[RhCl(C2H4)2]2, MeOH 
(rt, 16 h; 45 ˚C → 65 ˚C) No reaction 
 * 5 mg-scale 129 
 Although not known to our research group at the time the group of Simon Lewis 
had been experimenting with iron(0) carbonyl complexes of diene diol 340 and reported 
the formation of η4-cyclohexadiene complex 346.248 Lewis was able to form 346 in 55% 
yield over 15 days at room temperature using two equivalents of nonacarbonyldiiron 
[Fe(CO)9]. Lewis reported the complete facial selectivity as being mediated by the 
hydroxy groups in 340.249 X-Ray analysis confirmed the structure of 346 and it was not 
until several months later that we could validate our structural assignment from his 
elucidation of iron(0) carbonyl complex 346.  
 Allylic alcohol isomerizations using ruthenium catalysis have been documented, 
in particular TPAP244 and Grubbs’ catalyst246 mediated isomerizations. Upon treatment of 
diene diol 340 with Grubbs’ Generation I catalyst at elevated temperatures several 
reaction products formed. Non-polar material that tested positive with ferric chloride 
(FeCl3) test, i.e. re-aromatized phenol, was observed and was in competition with 340-
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catalyst interaction. However, conversion of 340 to any product required elevation of 
temperature and enone 347 was isolated. 
 
Scheme 22. Conversion of diene diol 340 to iron carbonyl complex 346 and enone 347. 
 Our inability to isomerize diene diol 340 was disappointing. However, the 
synthesis of (-)-idesolide (5) was concise in terms of step count. The overall yield of (-)-
idesolide (5) from diene diol carboxylic acid 4, in four chemical steps, ranged from 10 – 
19% based on sets of average yields obtained at each step, Scheme 23.70 
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Scheme 23. Chemoenzymatic synthesis of (-)-idesolide (5). 
 
3.4 Chemoenzymatic Synthesis of Polyhydroxylated Pyrrolidines 
from Benzoic Acid 
 Many of the diene diol metabolites, e.g. 2, derived from enzymatic 
dihydroxylation of aromatic compounds have been reported as part of the Hudlicky group 
biocatalysis program and have been used for the 
preparation of pseudo sugars,250, 251 inositols,252-
254 and iminosugars.255-257 The functional groups 
in 2 (1,3-diene, vic diol, vinyl halide, two 
different allylic alcohols) allow for many 
opportunities for redox transformations and  
different modes of oxygenation, Figure 51. 
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Reagents: (i) R. eutrophus B9 (18 - 22 g/L); (ii) diazomethane, THF, 0 °C (70-76%); (iii) PAD, HOAc
(glac), MeOH, 5 °C rt (64%); (iv) IBX, DMSO, rt (60%); (v) NaHCO3, neat, rt (66%).
i ii iii iv
v
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(3) 4 340 129 (-)-8
Figure 51. Functional handles in 
metabolite 2. 
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However, the ipso diene diol 4 has not been utilized to the same extent as other 
halobenzene derive cis-dihydrodiols of type 2. Recently, Parker73 and Lewis230 have 
prepared carbosugar derivative 94 and inositol-amino acid hybrids 348 – 350, 
respectively, from benzoic acid, Figure 52.  
 
Figure 52. Carbosugar and inositol–amino acid derivatives. 
 
3.4.1 Pyrrolidone Approach 
 In keeping with the theme of target oriented synthesis using ipso diene diol 4, 
pyrrolidine 6, an analogue of a recently reported iminosugar 151,119 was pursued on the 
basis of the highly oxygenated substitution pattern that contained a quaternary carbon 
center. Prior to the successful preparation of pyrrolidine 6 from diene diol 4 via a separate 
route and a set of intermediate compounds,71 the synthetic route to pyrrolidone 351 was 
envisioned and was inspired by Danishefsky’s vernolepin synthesis, Figure 53.258 The 
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key transformation of this route was to be the oxidative cleavage and concomitant loss of 
a carbon atom from keto diol 352 to form diester 353 using lead tetraacetate [Pb(OAc)4]. 
From intermediate 353 the deprotection of the t-butoxy carbonyl (Boc) group on the 
nitrogen would initiate the cyclization to the pyrrolidone skeleton of type 351. 
 
Figure 53. Retrosynthetic analysis of pyrrolidone 351. 
 To this end, the ipso carboxylate diol 337, isolated from the ferment broth as a 
mixture of sodium and potassium salts, was subjected to 2,2-dimethoxypropane (2,2-
DMP, 1.0 M) and trifluoroacetic acid (TFA, 1.5 equiv) as a heterogeneous mixture in 
acetone (4.9 M) at 0 ˚C.69 The formation of isopropylidene sodium carboxylate 354 was 
inconsistent, at best, in terms of impurity profile, conversion, and yield. A strong acid, 
TFA, was required to counteract the buffering effects of the inorganic phosphate salts 
carried over from the ferment broth. Protonation of the carboxylate 337 was required for 
acetalization to proceed. In using such a strong organic acid as TFA dehydration to 
salicyclic acid (339) was a major cause for impurities in the reaction mixture run-to-run. 
High pressure liquid chromatography (HPLC) was used to monitor the reaction and we 
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could easily separate carboxylate 337 from acetonide 354 and salicylic acid (339) by this 
method and provided relative percentages of each. The influence of TFA and 2,2-DMP 
on the reaction was evident from previous reactions where yields would vary from 30% – 
60%. Full conversion of 337 required the titration of additional TFA (> 4 equiv) over 24 
– 48 hours, and salicylic acid (339) was present in ranges of 20 – 30%. The inconsistency 
of reaction profiles and the low yields at the beginning stages of the material supply line 
prompted the statistical analysis of the formation of isopropylidene carboxylate 354 from 
carboxylate diol 337. A two-level, three-factor design of experiment (23 DoE)259 was 
performed using the mole ratio of TFA/337, concentration of 2,2-DMP, and 
concentration of acetone as the main effect variables along with interaction effects 
analyzed in the design (i.e. full factorial design), Table 11. 
Table 11. 23 Full factorial DoE for the acetalization of 337. 
 
 
Run 
TFA/337  
(mol/mol) 
2,2-DMP  
(mol/L) 
acetone 
(mol/L) 
337 
(%) 
354 
 (%) 
339  
(%) 
1 1.5 0.5 0 32.5 63.3 4.2 
2 1.5 0.5 6 25 70.2 4.8 
3 1.5 2 0 20.1 72.1 7.8 
4 1.5 2 6 21.8 73.7 4.5 
5 6 0.5 0 7.2 80.4 12.4 
6 6 0.5 6 7.4 79.4 13.2 
7 6 2 0 7.5 71.3 21.2 
8 6 2 6 5.7 74.0 20.3 
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   * 337 (purity of 76 wt% based on NMR internal standard method) 
   * Reactions performed in parallel, 100 mg-scale 
   * Percentages based on HPLC area under the curve (AUC), non-calibrated 
      response factors. 
 By utilizing the multivariate analysis software SAS JMP® 10.0.0, main effects and 
interaction effects were identified and modeled (see plot, Figure 54). The largest main 
variable effect was the mole ratio of TFA to 337, a 17-fold larger effect than the next 
largest main effect – the concentration of 2,2-DMP. A large interaction effect between 
TFA/337 mole ratio and the concentration 2,2-DMP exists for this reaction. Using the 
data generated from the DoE screen, the reaction was performed two additional times at 
increasingly larger scales. The reaction was performed on 4.5 g-scale (79% yield) and 
61.6 g-scale [90% yield, < 4% salicylic acid (339)] using 6.0 equivalents of TFA, 0.4 M 
2,2-DMP, and no acetone at 0 ˚C. These conditions represent the optimal reaction 
parameters for substrate 337 of that particular chemical composition, 79% purity that 
contained inorganic phosphate salts used as buffers in the fermentation of benzoic acid. 
The material from the fermentation, isolated in the same way as previously described, did 
not vary significantly in terms of purity and the optimized reaction conditions served well 
for diol 337 of similar weight-weight composition. The reaction was complete in 
approximately 12 hours and allowed for ample acetonide 354 (multiple 100 gram-scale 
batches) to be obtained for the subsequent synthetic work. 
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reaction mixture and an aqueous base wash (NaHCO3). The regioisomers were not 
separable by physical or chemical means and the ratio of isomers was determined by 
NMR. Treatment of 9/357 with molybdenum hexacarbonyl [Mo(CO)6] in aqueous 
acetonitrile (MeCN) caused the reduction of the nitrogen – oxygen bond to amino 
alcohols 358/359 (not shown).261 This mixture was further subjected to oxidation with 
Dess-Martin periodinane (DMP) to yield a separable mixture of enones 360 and 361.  
 
Scheme 24. Synthetic route to pyrrolidone 351. 
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 Standard Upjohn dihydroxylation conditions262 were problematic for the electron 
deficient enone 360 and yielded complex mixtures. A couple of different strategies were 
attempted with only marginal success, such as epoxidation (products such as 362 and 
363) and hydroxylation of 9 to give 364. Plietker and co-workers had developed a 
bimetallic RuCl3–Ce(IV)–periodate system, prepared by heating an aqueous mixture of 
cerium chloride heptahydrate (CeCl3·7H2O) and NaIO4 and mixing with ruthenium 
chloride (RuCl3), that was mild enough not to undergo glycol cleavage typical of 
periodate oxidations and diol 352 was formed, Scheme 24 and 25.  
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Scheme 25. Oxidation of enone 360. 
 The stability of 352 was suspect because it underwent elimination to form acetoxy 
enone 365 upon derivatization with Ac2O, Scheme 24. The conditions presented in the 
literature, and slight alterations thereof, were attempted on keto diol 352.258, 263 The 
combined lability of 352 and the aggressiveness of Pb(OAc)4 produced unidentifiable 
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mixtures immediately upon addition and indicated by a deep red color. No evidence of 
diester aldehyde 353 was ever obtained and no further extrapolation to pyrrolidone 351 
was pursued. At this point a secondary synthetic strategy was assessed. 
 3.4.2 Pyrrolidine Approach 
 Having met with failure with the synthesis of pyrrolidone 351 a secondary 
strategy was implemented that would provide pyrrolidines of type 6 via acetal 11, Figure 
55. 
 
Figure 55. Retrosynthetic analysis of pyrrolidine 6. 
 The synthesis was redisgned and initiated from isoxazolidines 9/357 and was 
subjected to ozonolysis in order to “unfold” the molecule via oxidative cleavage and add 
necessary oxygenation for subsequent functional maneuvers, i.e. the formation of acetal 
11 via cyclization, Scheme 26. The intermediate ozonide of 9/357 was reduced with 
NaBH4 at -55 ˚C with slow warming to room temperature over several hours (> 8 h) to 
yield an intermediate triol 366/367. This highly polar material, like several subsequent 
intermediates in this approach, was trapped as triacetate 368, which was isolated by 
column chromatography in yields ranging from 22 – 37% from the 6:1 mixture of 9/357. 
The primary function of the acetylation of triol 366/367, other than to cap the polar 
functional groups, was to separate the regioisomeric mixture of 368/369. Having isolated 
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368, the acetates were removed by methanolysis to give 366 and the nitrogen – oxygen 
bond was reduced using Mo(CO)6 to give tetrol 370 that contained a set of vicinal 1,2-
diol moieties. The N–O bond cleavage was a difficult reaction at first and alternative 
conditions, such as hydrogenolysis and mercury – aluminum amalgam, were inert toward 
substrate 366. A brief study of this reaction indicated that the purity of the Mo(CO)6 was 
of importance in achieving homogeneity of the reaction mixture. To this end Mo(CO)6 
was purified by sublimation. Another crucial observation that was made indicated that the 
formation of the active species Mo(CO)3(MeCN)3 that could be observed by TLC 
throughout the reaction.264, 265 Mo(CO)3(MeCN)3 was thus prepared, in an unknown 
purity, and was shown to reduce the N–O  bond in substrate 366 in MeOH at reflux in 
significantly less time, less than one hour compared to greater than ten hours at reflux in 
MeCN/H2O. However, there was some variation in subsequent reactions that was 
attributed to the purity and/or stability of the Mo(CO)3(MeCN)3 species. Last, and most 
significant, was the workup for the molybdenum reduction. Effective decomplexation of 
the product 370-molybdenum species was completed by the addition of sodium 
bicarbonate (either solid NaHCO3 or as a saturated solution) and vigorous stirring as to 
introduce air into the reaction mixture. This method of workup turned the black and 
viscous reaction mixture that contained 370 into a light brown heterogeneous mixture that 
contained finely dispersed precipitate in twelve hours. Yields up to 87% were achieved 
for this reaction with the improved workup procedure. Now, that the 1,2-diol moiety had 
been unmasked, all  that was left in order to access acetal 11, the precursor to pyrrolidine 
6, was to oxidatively cleave the glycolic bond in 370 to form aldehyde 371 and trap the 
resulting hemiacetal 372 as acetal 373. Initial conditions for the reaction of 370 to 372 
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included a biphasic system of aqueous alkaline solution of NaIO4 and methylene 
chloride. Hemiacetal 372 was difficult to capture in a pure state under these conditions 
and the aldehyde signals in NMR spectrum were typically observed in varying degrees. 
An excess of alkali was probably suppressing equilibria and so another method was 
sought. Silica gel–supported periodate266 provided a much cleaner reaction profile and 
workup consisted of the filtration of the reaction mixture that contained hemiacetal 372 
directly into another mixture of Ac2O/Et3N/DMAP/CH2Cl2. The telescoped reaction 
sequence provided acetal 373 in 41% yield from tetraacetate 368. All that was left for the 
final cyclization to the pyrrolidine core was the deprotection of the strategically placed 
protecting groups. Acid-mediated decomposition of the tert-butoxy carbonyl (Boc) group 
with strong organic acid (TFA) provided the amine TFA salt 11 which, upon treatment 
with basic methanol, unmasked the electrophilic hemiacetal and concomitantly cyclized, 
via neutralization of the amine salt 11, to generate azomethine 374. The hydrogenation of 
374 using palladium on charcoal (Pd/C) and subsequent hydrolysis of the isopropylidene 
yielded 375 and final iminosugar 6, respectively, and completed the synthesis of the 
highly oxygenated pyrrolidine ring system.  
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Scheme 26. Synthesis of pyrrolidine 6. 
 The inspiration for the synthesis of pyrrolidine 6 came from a report describing a 
series of iminosugars prepared by BioCryst in 2011 in their effort to identify a more 
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potent inhibitor of human purine nucleoside phosphorylase (PNP).119 In addition to 
forming five-membered heterocyclic compounds from ipso diol 4, a series of 
diastereomers, with respect to 151/209, that contained an additional oxygen atom was 
envisioned and included compounds 6 and 376, Figure 56.  
 
Figure 56. Pyrrolidine series. 
 Having prepared tetra hydroxylated pyrrolidine 6 we sought to reduce the 
hydroxy methylene attached to the quaternary center in 6. In doing so, the reduction of an 
early intermediate in the synthesis toward 376 was attempted, diene ester 355. Diene 
ester 355 was used to provide diene alcohol 377 via hydride reduction with lithium 
borohydride (LiBH4) and the different tactics used in the attempts to reduce the primary 
alcohol 377 to 378 are shown below, Scheme 27. 
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Scheme 27. Reduction of 377 attempts. 
 The displacement of iodide 381 was attempted using the conditions listed below, 
Table 11. The ring expansion of 381 was observed under radical conditions (entry 6) via 
cyclopropane; however, no reduction to 378 was observed. 
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Table 12. Reduction of iodide 381. 
 
Entry Conditions Result 
1 NaBH4, DMSO, 80 ˚C no reaction 
2 LiEt3BH, DMSO, RT → 80 ˚C 381 + trace polar material 
3 LiEt3BH, THF, reflux no reaction 
4 KH, 18-C-6, DME, reflux no reaction 
5 LiAlH4, THF, RT → reflux complex mixture 
6 nBu3SnH, AIBN, PhH, reflux complex mixture; trace 383 
 
 Further attempts at the displacement of tosylate 379 and mesylate 380 with 
hydride sources failed to provide 378, Table 13. 
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Table 13. Sulfonate 379/380 displacement attempts 
Entry Conditions Result 
1 379: LiAlH4, THF, -50 °C → 0 °C → RT no reaction, 379 (85%)
2 379: NaBH4, 15-Crown-5, DME, 0 °C → RT no reaction, 379 
3 379: LiBH4, 12-Crown-4, DME, 0 °C → RT no reaction, 379 
4 379: LiAlH4, THF, reflux no reaction, 379 
5 380: LiAlH4, THF, 0 °C → RT aromatization  
6 380: LiBH4, DME, 0 °C → RT, >48 h no reaction, 380 
 
 The lability of primary xanthates and their tendency to undergo a slow 
fragmentation step to an unstable primary radical during the Barton-McCombie 
deoxygenation reaction provides the opportunity for substrates to enter into competition 
with other reaction pathways, e.g. formation of thioformates, xanthate transfer reactions, 
etc.267 Xanthate 382 was prepared in good yield (82%) by using a non-traditional base, 
potassium hexamethyldisilazide (KHMDS), and low temperatures (-60 ˚C). The use of 
NaH at and above room temperature in the formation of xanthate 382 provided only 
traces of the desired product (3%). The treatment of 382 under thermally initiated radical 
conditions (nBu3SnH, AIBN) provided oxetane 384 as the only identifiable compound of 
a complex mixture, Scheme 28. Triethylborane/air/water was also used to no avail in the 
formation and subsequent trapping the primary radical with a hydrogen atom.268 The 
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deoxygenation of primary alcohol 377 was never realized with the methods and 
intermediates utilized by this practitioner. 
 
Scheme 28. Deoxygenation of 382 attempts. 
 The synthesis of pyrrolidine 6 and its precursors demonstrate the utility of ipso 
diol 4 as a useful raw material for a variety of reactive intermediates. The synthesis of 
iminosugar 6 was completed in 13 chemical steps that included a hetero Diels-Alder 
reaction, two oxidative scissions, numerous redox operations, two cyclizations, and 
provided an opportunity to orchestrate different modes of those cyclization based on 
orthogonal protecting group strategies (nitrogen vs. oxygen and 1˚ alcohols vs. 1,2-diol).  
 
3.5 Approaches to Synthesis of Vinca Alkaloids 
 This chapter will discuss the various approaches toward the tricyclic core of type 
15, the central core of aspidosperma alkaloids, and include a thermally induced 1-aza 
diene approach using 385, an amidyl radical cyclization approach using 386, 
miscellaneous cycloaddition and indolization approaches,  and a tandem conjugate 
addition approach using intermediates 387 and 388, Figure 57. 
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Figure 57. Overview of synthetic approaches towrd tricycle 15. 
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 3.5.1 Thermally Induced 1-Aza-1,3-Diene Diels-Alder Approach 
 1-Aza-butadienes have been used in the construction of six membered 
heterocycles since at least the early 1980’s when Ghosez269 and Fowler270 reported on the 
thermally induced cycloadditions of various pre–functionalized substrates.  
 The presence of a nitrogen atom in aza-butadienes effectively lowers the highest 
occupied molecular orbital (HOMO) energy in comparison to non-heteroatom containing 
butadienes. The energy difference between the lowest unoccupied molecular orbital 
(LUMO) of electron deficient dienophiles is increased by the presence of the nitrogen in 
the diene and makes the cycloaddition reaction more difficult to perform. Therefore, 1-
aza-butadienes have been utilized in inverse–demand Diels–Alder reactions where an 
electron rich dienophile is used to bridge the HOMO – LUMO energy gap, Figure 58.  
 
Figure 58. Azadiene HOMO-LUMO and reactivity map. 
 Conversely, many reports are available where electron deficient 1-aza-butadienes 
such as 2-cyano-1-aza-butadiene271-276 or N-sulfonyl-1-aza-butadiene277, 278 have been 
used to perform cycloaddition reactions with unactivated alkenes. Recently, catalytic 
versions of the [4+2]-cycloaddition reaction involving 1-aza-dienes have been developed 
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and offer good enantioselectivity.279 The main strategy in the development of the 
enantioselective variants has focused on the activation of 1-aza-dienes through lowering 
of the LUMO energy by Lewis acid metal complexes and organocatalysis. 
 Much of the work presented here is based on the early reports by Fowler where he 
constructed a series of bicyclic heterocycles from linear 1-aza-butadienes. The 1-aza-
butadienes, such as 387, were formed thermally and in the gas phase by loss of acetic 
acid from O-acetylhydroxamic acids of type 388 and yielded indolizidines such as 389, 
Scheme 29.270 Evidence of 1-aza-butadiene formation was provided from a methanol 
quench where a benzene-d6 solution of hydroxamic acid 390 was passed through a hot 
reaction tube with methanol placed in the receiving flask. In this fashion was the acyl 
imine 391 briefly formed and trapped as amide 392. When Fowler attempted to form 1-
azadiene of 388 in toluene at 180 ˚C for several hours the loss of acetic acid was 
observed but only amide 393 was obtained from the reaction. 
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Scheme 29. Pyrolysis of O-acetylhydroxamic acids to form 1-aza-butadienes. 
 Intrigued by Fowler’s work and the desire to efficiently construct the tricyclic ring 
system of type 394, we focused on obtaining intermediate 385 on the assumption of 
gaining entropic advantage for the cyclization through the loss of acetic acid. The path to 
the key hydroxamic intermediate 385 is outlined below and proceeds through the epoxy 
ester 395 and eventually to coupling partners 396 and carboxylic acid 397, Figure 59. 
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Figure 59. Synthetic analysis for tricycle 394. 
 The ipso-diol carboxylate 337 was protected as acetonide sodium carboxylate 
354. An alkaline solution of 354 was treated with a solution of bromine in methylene 
chloride at 0 ˚C to afford bromo lactone 397 as a single regioisomer, Scheme 30.66, 280 
The treatment of bromo lactone 397 with anhydrous sodium methoxide (NaOMe) gave a 
mixture of epoxy ester 395 and allylic bromide 398 in approximately 1:1 ratio. Isolation 
of 398 and resubjection to NaOMe would produce another mixture that contained more 
of epoxide 395. In this fashion the epoxy ester 395 could be produced. 
 
Scheme 30. Synthesis of epoxy ester 395. 
 The selective opening of the epoxide ring in the epoxy ester 395 with a two-
carbon nucleophile was attempted. However, despite the reaction conditions and 
additives that were used the electrophilicity of the ester in 395 outweighed that of the 
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Reagents: (i) 2,2-DMP, TFA, 0 °C rt (94%); (ii) Br2, NaHCO3 (aq), CH2Cl2, 0 °C rt (30%); (iii)
NaOMe, MeOH, 0 °C (58%).
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epoxide. No two-carbon nucleophiles could be added to the epoxide in the presence of 
the ester, Scheme 31. Creger’s dianion of acetic acid,281 used by Danishefsky in his 
synthesis of vernolepin,258 was unsuccessful and produced 1,3-dicarbonyl 399, despite 
successful epoxide openings on model systems 400 and 401, Scheme 32. Organo-
aluminum compounds did not show any preference in delivering the anionic ligand and 
404 and chloride 405 were formed from epoxide 395. Sodium borohydride readily 
reduced the methyl ester to provide 406 and only upon heating the reaction mixture above 
room temperature did the epoxide in 406 open to furnish diol 407. Lewis acid-mediated 
epoxide opening using the anion of acetonitrile also failed in the presence of the methyl 
ester of 395.  
133 
 
 
Scheme 31. Epoxide opening attempts of epoxy ester 395. 
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Scheme 32. Creger's acetic acid dianion opening of model epoxides 400 and 401. 
 The electrophilic sink in epoxy ester 395 was removed by reduction to the 
primary alcohol 406. The alcohol 406 was temporarily protected as the silyl ether 408 
and the epoxide was readily opened with the anion of acetonitrile to yield cyano alcohol 
409, Scheme 33. Deprotection of 409 with fluoride gave diol 410 that was subsequently 
re-protected as the acetonide 411. Saponification of cyano 411 gave carboxylic acid 412 
after neutralization. The coupling of carboxylic acid 412 with N-allyl hydroxylamine 413, 
prepared from hydroxylamine hydrochloride (414), Scheme 34)270, 282, 283 yielded 
hydroxamic acid 385 after acylation with acetic anhydride. 
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Scheme 33. Synthesis of hydroxamic acid 385. 
 
Scheme 34. Synthesis of N-allyl hydroxyl amine 413. 
 Initially, O-acyl hydroxamic acid 385 was investigated in attempts to trap the 
acylimine (1-azadiene) with MeOH upon treatment with potassium t-butoxide 
(tBuOK).284 Unsurprisingly, methanolysis to give 419 was the outcome, Scheme 35. 
Condensed state experiments with 385 were performed in dilute solutions and at elevated 
temperatures (> 170 ˚C) for several days with no conversion of 385 observed. Flow 
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pyrolysis was utilized with a glass–packed reaction tube so as to ensure a high surface 
area for a reaction center. A solution of 385 in methylene chloride was injected into the 
argon-filled reaction tube with a steady flow of argon gas. Two receiving flasks in 
tandem were used to collect material and were cooled in liquid nitrogen. Multiple 
experiments were performed in this manner and the only material obtained was 385 in 
ranges of 75 – 85%. 
 
Scheme 35. Solvolysis of hydroxamic acid 385. 
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 3.5.2 6-endo-trig Cyclization via Amidyl  Radical Approach 
 Zard has dedicated most of his professional career to the development of radical–
based methodology and the synthesis of complex natural products by using radically 
themed techniques.8, 267, 285-290 Zard first extended his methodology on the homolysis of 
the nitrogen – oxygen bond by stannane mediated reactions with O-benzoyl hydroxamic 
derivatives such as 420 and 421 in 1994, Scheme 36.285 In 1998 Newcomb published the 
most comprehensive source to date for amidyl radical kinetic information.291 The rate 
constants of the reactions involving intramolecular cyclizations of amidyl radicals and the 
corresponding hydrogen radical transfers have been tabulated. These kinetic 
considerations were used by Zard in his syntheses of (±)-13-deoxyserratine (424)288 and 
(±)-aspidospermidine (325),8 Scheme 36. The tandem and regioselective strategy for the 
5-exo/6-endo-trig cyclizations included the use of a vinyl chloride and two equivalents of 
stannane in order to affect the cyclization and subsequent dehalogenation. 
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Scheme 36. Zard 5-exo/6-endo-trig tandem cyclization strategy. 
 Zard’s tandem cyclization strategy for the synthesis of aspidospermidine (325) 
was the inspiration for our amidyl radical-based approach to the vinca alkaloid series 
,Figure 60. Our approach to radical precursor 429 is divergent from intermediate 
carboxylic acid 397 that was used for the thermal approach, Figure 60.  
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Figure 60. Synthetic analysis for radical precursor 429. 
 
 The preparation of N-(2-chloroallyl)hydroxylamine 430 was prepared via 
Finkelstein reaction with 2,3-dichloropropene 431 and sodium bromide.292 3-Bromo-2-
chloropropene 432 underwent substitution with N,O-diacetyl hydroxylamine 415 to yield 
433. N-Acetoxy acetamide 433 was hydrolyzed to give N-alkylated hydroxylamine 430 
which was subsequently coupled with carboxylic acid 397 to give 434 and then 
benzoylated to yield 429, Scheme 38. 
 
Scheme 37. Synthesis of hydroxyl amine 430 and radical precursor 429. 
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 A concern with this radical based approach was addressed by Zard confronted in 
his report on the synthesis of aspidospermidine (325), namely the kinetics of allylic 
hydrogen transfer versus the cyclization via nitrogen centered radical.8 The proton 
transfer from tin hydride at the allylic carbon of Zard’s intermediate 435 proved to 
outcompete the rate of cyclization and yielded aromatic ester 436, Scheme 38. 
Newcomb’s empirically determined rate of cyclization versus rate of proton transfer are 
generalized below, 437 – 442, Scheme 39. 
 
Scheme 38. Hydrogen abstraction from allylic ester 435. 
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Scheme 39. Rate constant approximations for cyclization (kc) vs. hydrogen transfer 
(kH).291 
 The concern with the kinetic pathway for intermediate 429 is not unfounded for 
compounds 440 and 441, Scheme 39, and in view of consideration Zard’s outcome for 
435, Scheme 38. The hydrogen transfer rate constant for amidyl radical 440 is 100 times 
that  of the rate constant for the corresponding cyclization. The allylic atom hydrogen 
transfer is overwhelmingly favored for 441, as reported by Zard.290 Unfortunately, the 
outcome of treating 429 with stannane and radical initiator substantiated reports and the 
tandem 5-exo-trig/6-endo-trig cyclization could not be executed as desired, Scheme 40. 
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The reaction profile was variable for the cyclization attempts of 429. Special care was 
taken to degas reagents and reaction mixtures, dilute reaction conditions were used (≥ 
0.02 M), and addition times spanned several hours. The only material isolated, other than 
recovered 429, was amide 443 as a result of the substantially faster reaction rate of the 
hydrogen extraction from the reagent (tin hydride) or transfer from one of the two allylic 
positions where C-centered radical may also extract a hydrogen atom from the reagent. 
 
Scheme 40. Amidyl radical generation of 429. 
 
 3.5.3 Miscellaneous Indolization, Claisen Rearrangement, and 
Diels-Alder Approaches 
Construction of Indoline Core 
 The construction of the indoline core prior to the functionalization of the 
carbocycle was explored with intermediate 444 in a Fischer indolization to generate 445, 
as shown in, Figure 61. 
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Figure 61. Synthetic rationale for indoline 446. 
 The synthesis of alcohol 409 was previously demonstrated, Scheme 33, and the 
oxidation to provide 444 could be executed in good yield (81%) by using Dess-Martin 
periodinane, Table 14.  
Table 14. Oxidation of 409. 
Entry Conditions Results 
1 
IBX (2.0 equiv), EtOAc, rt → 50 
°C, sealed tube, overnight – non-
aqueous workup 
Slow and incomplete 
conversion to 444 
2 CrO3/Ac2O, DCM, rt (titration) 444 (28%) 
3 
CrO3/Ac2O, DCM, 0 °C  
(titration) 
444 (54%) 
4 
IBX (2.0 equiv), EtOAc, 30 °C, 
3 days – aqueous workup 
Slow conversion to 444, 
appearance of byproduct 
after workup procedure 
5 
Dess-Martin periodinane (2.5 
equiv), DCM 
444 (81%) 
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 When the β,γ–unsaturated ketone 444 was subjected to classical Fischer 
indolization conditions isomerization occurred to form α,β-unsaturated phenyl hydrazone 
447. Enone 444 was, in fact, sensitive to acidic conditions and upon treatment with acetic 
acid at room temperature isomerized to 448. Pyridinium p-toluenesulfonate (PPTS) was 
used as a weak acid catalyst and zinc chloride (ZnCl2) as a Lewis acid without any 
evidence of indolization, Table 15. 
Table 15. Fischer indolization attempts on 444. 
 
Entry Conditions Result 
1 Phenylhydrazine, HOAc (glac), 95 °C 447 (62%) and 448 (17%)
2 Phenylhydrazine, PPTS, toluene, 111 °C complex mixture 
3 Phenylhydrazine, EtOH/H2O, RT complex mixture 
4 Phenylhydrazine, ZnCl2, MeOH, RT 448  
5 HOAc (aq), EtOH 448 
 In order to circumvent the isomerization from 444 to 448 and thus construct the 
indoline skeleton 449, via 450, Figure 62, the deprotection of 444 was attempted, Table 
16. Protecting group incompatibility prevented any selectivity for diol 451 and mixtures 
of products were obtained that contained the isomerized protolysis products 452 – 454. 
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Figure 62. Indolization of ene-dione 450. 
 
Table 16. Deprotection of 444. 
 
Entry Conditions Result 
1 HCl, EtOH, rt 452 
2 HCl, THF, rt 448 (50%) 
3 TFA, THF/H2O, 0 °C → rt complex mixture 
4 Amberlyst 15 (H+), dioxane/H2O, RT → 55 °C 452 and 453 
5 HOAc(aq), 55 °C 452 and 453 
6 Kim’s reagent (FeCl3·SiO2), CHCl3293 444, 453 (trace), 454 (trace) 
7 CeCl3·7H2O, (CO2H)2, CH3CN294 complex mixture, 452 (28%)
8 HOAc(aq), ethylene glycol, 50 °C 453, degradation 
9 
BF3·OEt2, 1,3-dithiolpropane, CH2Cl2,  
0 °C295 
448 (75%) 
 Unable to generate intermediate 450 to explore indolizations of ene-1,5-diones, 
Fischer indole synthesis was pursued with model enones based on the work of Sapi.296 
Sapi prepared indoles of type 455 and 456 from the corresponding 1,3-dione 456, 
Scheme 41. Sapi’s reaction conditions were applied to both 1,3-dione 457 and to keto-
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enol 458 to form indole 459. The tautomeric phenyl hydrazones (460 – 463) provided the 
electronic “assistance” to generate the required ene-hydrazine 464 crucial for the [3, 3]-
sigmatropic rearrangement in forming the indole nucleus.  
 
Scheme 41. Fischer indolization of 1,3-diketones. 
 Any extension of the reaction conditions demonstrated with 1,3-diones  toward 
the indolization of α,β-unsaturated phenyl hydrazone 447 or enone 448 failed, even when 
a good Michael donor (triphenyl phosphine, Ph3P) was provided in an attempt to form a 
tautomeric species, such as in the case of  460 - 463.  
 Model enones 465 and 466 were prepared from 467 and 468, respectively, along 
with the trisubstituted cyclohexanone 469, to be subjected to various indolization 
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conditions, Scheme 42.297, 298 The alkylation of diketone 468 generated a mixture of keto 
enol-ethers 470 and 471 and the minor component 470 was reduced to enone 466. 
 
Scheme 42. Preparation of model enones 465 and 466. 
 Conditions were applied to these model compounds with the hope to apply similar 
conditions eventually to ketone 444. Limited success was achieved in finding general 
conditions for the electronically and sterically similar models, Scheme 43. The treatment 
of enone 466 with phenylhydrazine hydrochloride provided α,β-unsaturated 
phenylhydrazone 472 in low yield and as a component of a complex mixture. 
Alternatively, the formation of the typically more stable 2,4-dinitrophenylhydrazone 473 
was facile and high yielding. However, the electronic effects of the nitro groups in 473 
and 474 favored a dissociative pathway and only 2,4-dinitro aniline 475 was isolated.299 
 With no success in finding conditions to transform substrate 444/447/448  into 
the corresponding indoline compound, the saturated carbocyclic intermediate 476 was 
prepared, Scheme 44. 
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Scheme 43. Fischer indolization of enones - model compounds. 
When ketone 444 was subjected to hydrogenation conditions (Pd/C) the isomerized 
products 448 and 477 were formed in a 2:1 ratio, likely because of isomerization 
tendency to form the more stable, or highly substituted, olefin commonly seen when 
using Pd/C as a catalyst. No hydrogenated product 476 was obtained even with increased 
hydrogen pressure and time. To this end, alcohol 409 was hydrogenated under the same 
conditions and afforded 478 in 90% yield. The saturated alcohol 478 was oxidized with 
Dess-Martin periodinane to provide 476. Ketone 475 was subjected to acid catalyzed 
indolization conditions and afforded protolysis product 479 and several polar impurities. 
Phenylhydrazone 480 was formed when 476 was treated with phenylhydrazine 
hydrochloride in pyridine but conversion to 480 was low and no indoline product was 
afforded, despite the successful cyclization of a model compound 469 to imine 481 and 
subsequently reducing to indoline 482.300 The bulkiness of the TBS-silyl either in 476 
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was suspected to be a disabling factor in terms of adequate orbital overlap of the phenyl 
group of the phenylhydrazone 480 to undergo the sigmatropic rearrangement. The 
hypothesis was never empirically substantiated. 
 
Scheme 44. Indolization attempts with ketone 476. 
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Claisen Approach 
 An approach based on Johnson – Claisen 
rearrangement was envisioned that would provide 
intermediate 483, diastereomeric at the allylic 
position, from an allylic alcohol such as 484, 
Figure 63. The route incorporated the Kornblum – 
DeLaMare rearrangement301 of endoperoxide 485, 
recently reported by Lewis, Scheme 45.302 Alcohol 377 was protected as the silyl ether 
486 and then subjected to photolysis in the presence of sensitizer (tetraphenylporphyrin, 
TPP) to generate endoperoxide 485. The regioselectivity reported by Lewis indicated that 
the intramolecularly initiated Kornblum–DeLaMare rearrangement via primary alkoxide 
was entirely selective for 487. When endoperoxide 485 was treated with 
tetrabutylammonium floride (TBAF) a ratio of 1:1.2 of 487/488 was observed in 78% 
yield. Dilution factors and reaction conditions could not affect a better distribution of 
487/488. The mixture of enones 487/488 were labile and only small amounts of acetate 
489 were obtained. The poor regioselectivity of the Kornblum–DeLaMare rearrangement 
deemed this route a dead end.  
Figure 63. Johnson-Claisen 
intermediate. 
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Scheme 45. Johnson–Claisen approach. 
 The Kornblum–DeLaMare rearrangement of methyl ester 355 gave equally 
complex mixtures and isolation of useful intermediates was futile, Scheme 46. 
Degradation of endoperoxide 490 with Hunig’s base yielded a mixture of enones 491/492 
(1.4:1) and upon acylation isomerization products 493 and 494 were isolated in low 
yields. 
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Scheme 46. Kornblum–DeLaMare rearrangement of 355. 
Imidate Cycloaddition Model 
 A model imidate system was prepared in order to test the feasibility of a 
cycloaddition approach from 495, Scheme 47. Cyclohexenone 496 was reduced under 
Luche conditions to afford allylic alcohol 497. Johnson–Claisen rearrangement was 
performed on 497 and the resulting ester 498 subjected to saponification to yield 
carboxylic acid 499.303 The acid chloride derived from 499 was prepared and treated with 
liquid ammonia to provide primary amide 500. Treatment of amide 500 with n-butyl 
lithium and quenching the resulting anion with acryloyl chloride 501, prepared in three 
steps from diethyl 2-ethylmalonate 502,304 provided imide 495. 
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Scheme 47. Synthesis of model imide 495. 
  A series of alkylations were attempted on the stabilized functional group without 
the successful formation of an imidate, Table 17.  
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Table 17. O-alkylation attempts on imidate 495. 
Entry Conditions Result 
1 nBuLi, TMSCl, THF, -65 ˚C → RT 495 
2 NaH, TMSCl, THF, 0 ˚C→ RT 495 
3 Meerwein reagent (trimethyloxonium tetrafluoroborate), 
DCM, 0 ˚C → RT 495 
4 Bis(TMS)trifluoroacetamide, MeCN, RT → 110 ˚C 495 
5 MeI, NaH, THF, 0 ˚C 495 + trace polar 
material 
 
 3.5.4 Conjugate Addition – Alkylation Approach 
 In 2002 Marino and co-workers reported on the total synthesis of (+)-
aspidospermidine (325) in 18 steps from Boc-protected aniline 506.9  A key step in his 
synthesis was a tandem conjugate addition–enolate alkylation of enone 507 to form the 
tricyclic intermediate 508, Scheme 48.  
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Scheme 48. Marino's (+)-aspidospermidine synthesis – formation of tricycle 508. 
 The preparation of an intermediate enone, such as 387, Figure 64, was pursued in 
order to implement a tandem process similar to that Marino et al. 
published. To initiate the approach toward enone 387 the secondary 
alcohol of 409 needed to be masked. The benzyl (Bn) group 
provided compatibility with the other protecting groups and would 
allow for maneuvering during the course of re-functionalizing the 
carbocycle. However, the protection did not turn out to be trivial 
and several products were isolated, including unreacted 409 and 
509 – 511, Scheme 49. The addition of tetrabutylammonium iodide to the reaction 
provided the kinetic advantage, because of the increased reactivity of benzyl iodide, to 
suppress formation of side products.  
Figure 64. Enone 
387. 
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Scheme 49. Benzylation of 409. 
 The benzyl nitrile derivative 509 was treated with lithium aluminum hydride in 
diethyl ether to afford amine 512, Scheme 50. The reduction was followed with acylation 
and subsequent deprotection to triol 514. The allylic alcohol was selectively oxidized 
with manganese dioxide (MnO2, 100% conversion) to 515 as evidenced by TLC analysis. 
However, yields in the range of 35 – 40% were typical, presumably because of adsorption 
of the polar substrate to the surface of the reagent. Isopropylidine 387 was prepared under 
standard conditions by treatment with dimethoxypropane and p-toluenesulfonic acid. 
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Scheme 50. Synthesis of enone 387. 
 Having already prepared one of the precursors for the cyclization, namely 387, an 
alternative enone amide 388 was also prepared, Figure 65. The 
preparation began from the base hydrolysis of benzyl silyl ether 
510. Hydrolysis stopped at amide 516 with concomitant removal 
of the TBS-group, Scheme 51. The carboxylic acid could not be 
prepared in any appreciable amounts using these conditions. 
Acylation of the primary alcohol in 516 with acetic anhydride gave 
517, which upon N-alkylation with 1-bromo-3-chloropropane gave alcohol 516.  
Figure 65. Enone 
388. 
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Scheme 51. Synthesis of amide 519. 
 The silyl ether in 510 was removed with fluoride to give 518, which was in turn 
alkylated with benzyl chloride to give 519, Scheme 52. Hydrolysis of 519 gave amide 
520 which was alkylated with 1-bromo-3-chloropropane to give 521. Several hydrolytic 
conditions were used in order to attempt the removal of the acetonide in 521. 
Hydrochloric acid in methanol led to the transesterification of the amide, aqueous acetic 
acid did not provide 521, and hydrochloric acid in isopropanol gave a 1:1 ratio of 
521/522. Iron(III) chloride adsorbed onto silica gel gave the best results but with large 
variation in yield (30% - quantitative), regardless of the quality of the reagent. The 
selective oxidation of 522 with manganese dioxide gave the cyclization precursor 388 in 
moderate yield. 
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Scheme 52. Synthesis of precursor 388. 
 With cyclization precursors 387 and 388 in hand, the effort toward their 
cyclization was made. The initial intramolecular Michael addition of 387 to 523/524 was 
facile and could be induced under several conditions, Table 18. The acrylamide 524, 
however, was resilient to further enolate addition. The treatment of 524 with Meerwein’s 
reagent (triethyl and trimethyloxonium tetrafluoroborate) yielded material 
indistinguishable from a carbocyclic skeleton.305 A report recently published by Qiu and 
Jin,306 Table 18 (Entry 9), describes the Michael addition of an acrylamide to and α, β-
unsaturated aldehyde followed by the subsequent enolate addition to the acrylamide, a 
tandem Michael addition. When Qiu and Jin’s conditions were applied to enone 387 only 
the first Michael addition to the enone was successful and the second conjugate addition 
to the acrylamide failed and yielded 524. 
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Table 18. Cyclization conditions for enone 387. 
 
Entry Conditions Result 
1 NaH (1.0 equiv), DMF, 5 ˚C → rt decomposition 
2 NaH (1.0 equiv), THF, 5 ˚C, 1.5 h 524 (quant) 
3 NaH (1.0 equiv), THF, 5 ˚C, 1 h 523 (62%) + 524 (18%)
4 PhMe (0.004 M), 180 ˚C, 4 days no conversion, 387 
5 PPTS, PhMe, 50 ˚C 523 + 524 (< 2%) 
6 DBU (2.0 equiv), THF, rt 524 
7 nBuLi, THF, -80 ˚C → -20 ˚C 523 + 524 (trace) 
8 nBuLi, (-)-sparteine, THF, -80 ˚C → -20 ˚C 523 
9 K2CO3, MeCN, 80 ˚C, 8 h 524 
 To prevent the tendency of the halide to eliminate and form a conjugated species, 
such as acrylamide 524 (from 387), enone 388 was prepared with the carbonyl functional 
group placed on the other side of the nitrogen. 
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 A solution of enone 388 was treated with sodium hydride (2 equivalents) at 0 ˚C. 
These conditions were previously used with enone 387 and afforded Michael addition 
product 523 in good yield. However, no conversion of enone 388 was observed under this 
reaction conditions and starting material was recovered. When 388 was treated with 
pyridinium p-toluenesulfonate in methylene chloride no reaction occurred and starting 
material was also recovered. However, upon treatment of 388 with sodium hydride (2 
equivalents) in DMF cyclization occurred, initially forming lactam 525, and was 
followed by transesterification (lactonization) of the lactam with the tertiary alkoxide in 
525 to generate 526, Scheme 53. The proximity of the tertiary alkoxide in 525 to the 
lactam moiety and the conformational stability of product 526 (bicyclo[3.3.1]nonane-like 
skeleton) combine to overcome the thermodynamic stability of amide 525 and result in 
the trans lactonization to afford 526. Further effort to manipulate the chemoselectivity of 
intermediate 388 toward intramolecular cyclizations, such as masking the tertiary alcohol 
or heating mixtures that contained 526, would be worthwhile.   
 
Scheme 53. Cyclization of enone 388. 
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4.0 Conclusions and Future Work 
 Microbial metabolites derived from whole-cell biotransformations have proven to 
be useful enantiomerically enriched raw materials. Chemoenzymatic syntheses can 
provide a significant advantage over traditional chemical methods. It is hoped that the 
body of the work presented here helps to emphasize the versatility of metabolites such as 
(–)-3,5-cyclohexadiene-1,2-diol-1-carboxylic acid (4) that was generated from benzoic 
acid (3) via Ralstonia eutrophus B9 cell line. In doing so the chemoenzymatic synthesis 
of the natural product (–)-idesolide (5) was prepared in four chemical steps, the 
polyhydroxylate pyrrolidine 6 was synthesized in 13 chemical steps, and several 
approaches toward the total synthesis of vindoline (7) have been presented.  
 Future effort for the synthesis of vinca alkaloids could utilize intermediates as 
shown in Scheme 54. The propensity of the tertiary alcohol in enone 528 to undergo 
transesterification to 529, as demonstrated with 388 → 526, could lead to a 
thermodynamically favored cyclization that would yield a tricyclic amide such as 530. 
An alternative synthetic route would first build up the indoline skeleton from ketone 531 
by means of Fischer indolization followed by cyclopropanation to afford 532. 
Degradation of the cyclopropane ring at C-2 (indole numbering) of indoline 532 would 
unmask the two-carbon electrophilic handle in 533 and allow another opportunity for an 
alkylation-lactonization-cyclization sequence with intermediates 534/535. A brief outline 
of this future work is shown below. 
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Scheme 54. Future work for synthesis of vinca alkaloids. 
 
 
 
 
 
164 
 
5.0 Experimental Section 
5.1 General Experimental Details 
All non-hydrolytic reactions were carried out under an argon atmosphere. Glassware used 
for moisture-sensitive reactions was flame-dried under vacuum and subsequently purged 
with argon. THF was distilled from potassium/benzophenone. Methylene chloride and 
acetonitrile were distilled from calcium hydride. Flash column chromatography was 
performed using Silicycle SiliaFlash P60 silica gel (40–66 μm).. Analytical thin-layer 
chromatography was performed using silica gel 60-F254 plates.  Melting points were 
measured on a Thomas-Hoover melting point apparatus and are reported uncorrected. IR 
spectra were obtained on a Perkin-Elmer FT-IR 1600 Series Spectrum One instrument 
and were recorded as neat samples. 1H and 13C NMR spectra were obtained on either a 
300 MHz (75 MHz) or 600 MHz (150 MHz) Bruker spectrometer.  Data are reported as 
(s = singlet, d = doublet, t = triplet, q = quartet, quin = quintet,  m = multiplet, br = broad; 
coupling constants(s) in Hz, integration).  Specific rotation measurements are given in 
deg cm3
 
g-1
 
dm-1 and were recorded on a Perkin-Elmer 341 Polarimeter. Ultraviolet 
spectroscopy was performed using a Perkin-Elmer 8452 A diode array 
spectrophotometer. Large-scale fermentation was performed in a 15-L B. Braun Biostat 
C-15 fermenter. Combustion analyses were performed by Atlantic Microlabs, Norcross, 
Georgia, USA. 
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General procedure for the biotransformation of benzoic acid (3)  
 
(1S,2R)-1,2-dihydroxycyclohexa-3,5-diene-1-carboxylic acid (4).  
The whole-cell biotransformation of benzoic acid was performed based on a modified 
procedure established by Mihovilovic and co-workers.69Error! Bookmark not defined. LB(II) 
medium (100 mL) was inoculated with a single colony of Ralstonia eutrophus B9 that 
was grown on LB(II) agar plates at 30 ˚C for two days. The inoculated medium was 
incubated at 30 ˚C on an orbital shaker at 185 RPM until OD600 = 4.8 (1:10 dilution; ~ 24 
h). At this point the cellular suspension (80 mL) was used as a preculture and added to a 
15 L Sartorius Biostat C bioreactor that contained HMB medium (8.4 L) at pH = 7.4, 
aerated with sterile air at 3 L/min, agitation speed of 300 RPM, and D-fructose (50 mL of 
a 1.5 m aq. solution) concentration of 0.009 m. The culture was grown until an OD600 = 
2.8 (1:10 dilution) was achieved (~ 20 h) and then induced with sodium benzoate (12 mL 
of a 1.5 m aq. solution; 18 mmol) and D-fructose (53 mL of a 1.5 m aq. solution; 80 
mmol). After 6 h consumption of benzoate was observed by UV analysis (265 nm) and a 
repetitive feeding program was initiated at which 15 min feeding of an aq. solution of 
sodium benzoate (22 mL, 1.5 m; 1.5 mL/min feed rate) and aq. D-fructose (22 mL, 1.5 m; 
1.5 mL/min feed rate) was performed every 3 hours over the course of 4 days; a total of 
approximately 170 g of sodium benzoate was fed. After the feeding regime was 
completed the broth was drained and separated from cell matter by centrifugation at 5 ˚C 
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(10,000 RPM). The dark brown ferment broth was concentrated in vacuo at 35 ˚C to 
dryness to obtain several lots of ipso diene diol carboxylate as the mixed 
potassium/sodium salts, contaminated with other inorganic salts. NMR spectroscopy 
assay was used to establish a weight-weight percentage of the crude material with an 
internal standard (potassium benzoate). A total mass of 261.5 g of crude material was 
obtained and corresponded to 177 g of the salt of ipso diol 337 that could be stored at 
room temperature without any observable degradation (several months). 
 
337: 1H NMR (600 MHz, D2O) δ 6.03 (dd, J = 9.5, 5.2 Hz, 1H), 5.93 – 5.81 (m, 1H), 
5.71 – 5.64 (m, 2H), 4.77 (s, 1H).  
The free acid 4 was obtained by the acidification of a cold aqueous solution of the salts 
with 6 M HCl and extraction with EtOAc. Compound 4 spectral and physical data match 
those reported in the literature.66, 69 
4: mp = 94 – 96 (CH2Cl2); [α]D20 = 64.9 (c = 1.0, CHCl3); 1H NMR (300 MHz, D2O) δ 
6.12 (dd, J = 9.3, 5.1 Hz, 1H), 6.05 – 5.90 (m, 1H), 5.77 (d, J = 9.6 Hz, 2H), 4.86 (s, 
1H).66 
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5.2 Detailed Experimental Procedures 
 
(1S,2R)-methyl-1,6-dihydroxycylohexa-2,4,-dienecarboxylate (340). To a pre-chilled 
solution of ipso diene diol carboxylic acid 4 (4.0 g, 25.6 mmol) in THF (distilled, 32 mL, 
0.8 M) at ~5 °C (ice-bath) was added a preformed solution of diazomethane (excess) in 
Et2O dropwise over 30 minutes. The addition of the ethereal solution of diazomethane 
was continued until consumption of starting material was observed by TLC analysis (1:1 
hexanes/EtOAc, CAM). The reaction mixture turned from a slight yellow to a full yellow 
color over the course of diazomethane addition. The reaction mixture was removed from 
the ice-bath and allowed to warm to room temperature with stirring. After warming to 
ambient temperature the reaction mixture was concentrated in vacuo to provide orange oil 
(quantitative by mass). The crude material was chromatographed on silica gel (1:1 
hexanes/EtOAc) to yield 3.39 g (78% yield) of diene ipso diol methylester  340 as white 
needle-like crystals after crystallization from Et2O. 
340: Rf = 0.23 (1:1 hexane/EtOAc); mp = 59 – 60 °C (Et2O); [α]D20 = -96.7 (c 1.0, 
CHCl3); FT-IR (film) ν 3412, 1736, 1641, 1564, 1439, 1407, 1265, 1085, 1044, 945, 854, 
816 cm-1; 1H NMR (CDCl3, 300 MHz) δ 6.17 (q, J = 5.1 Hz, 1), 5.98 (d, J = 1.3, 9.5 Hz, 
1), 5.85 (td, J = 1.0, 9.7, 1), 4.87 (s, 1), 3.90 (s, 1), 2.89 (s, 2); 13C (CDCl3, 75 MHz) δ 
175.6, 132.0, 126.8, 124.7, 122.7, 73.9, 70.9, 53.7; MS (EI+) m/z 170; HRMS cald. for 
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C8H10O4: 170.05852; Found: 170.05791. Anal calcd.: C 56.47, H 5.92, O 37.61. Found: 
C 56.44, H 5.87.  
 
(1S,6R)-Methyl 1,6-dihydroxycyclohex-2-enecarboxylate (129).  
To a stirred, chilled (ice-bath) solution of ester diol 340 (399 mg, 2.34 mmol) in 
anhydrous MeOH (5.8 mL) was added potassium azodicarboxylate (PAD) (1.35 g, 7.03 
mmol) in portions over 5 minutes. This yellow slurry was allowed to stir at slightly lower 
temperature (~ 5 °C) for 15 minutes prior to a portionwise addition of a solution of acetic 
acid (glacial, 11.7 mmol) in MeOH (2 mL) over ~1.5 hours. The rate of addition of 
HOAc/MeOH was dictated by the rate of N2(g) evolution (bubbler) observed from the 
reaction mixture. The reaction was monitored by evolution of nitrogen gas and by TLC 
(2:1 EtOAc/hexanes) – Note: 129 co-elutes with starting material 340 and can be 
differentiated by the fact that only 340 is UV active. After the addition was complete the 
reaction mixture was allowed to stir at ~5 °C for additional 20 minutes prior to slowly 
warming to room temperature. Once at ambient temperature the reaction mixture was 
concentrated to dryness and reconstituted in EtOAc (15 mL) to produce a white slurry. 
The slurry was filtered and the filtrate concentrated to provide a colorless oil (576 mg). 
The crude oil was chromatographed on silica gel (3:1 → 1:1 hexanes/EtOAc) to yield 155 
mg (40%) single isomer 129 as a white crystalline solid; 81% overall yield, combined 
isomers 129 and 343. 
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129: Rf = 0.50 (2:1 EtOAc/hexanes); mp = 68 – 71 °C (EtOAc); [α]D20 = -36.1 (c 1.0, 
CHCl3); FT-IR (film) ν 3441, 2953, 1735, 1436, 1262, 772 cm-1; 1H NMR (CDCl3, 300 
MHz)  1.68 - 1.85 (m, 1 H) 1.86 - 1.97 (m, 1 H) 2.21 - 2.32 (m, 2 H) 3.86 (s, 3 H) 4.04 
(dd, J=11.7, 3.8 Hz, 1 H) 5.62 (dt, J=9.8, 2.1 Hz, 1 H) 6.05 (ddd, J=9.7, 4.2, 3.0 Hz, 1 H); 
13C NMR (CDCl3, 75 MHz) δ 175.8, 132.9, 125.4, 73.8, 70.9, 53.4, 26.5, 24.9;  MS (EI+) 
m/z 172; HRMS calcd. for C8H12O4: 172.07, Found: 172.07388. Anal calcd.: C 55.81, H 
7.02, O 37.17. Found: C 55.68, H 7.15.  
343: light brown oil. Rf = 0.39 (2:1 EtOAc/hexanes); [α]D20 = -21.9 (c 1.0, CHCl3); 1H 
NMR (CDCl3, 300 MHz) δ 5.85 (md, J=1.5, 8.6 Hz, 1 H), 5.58 (qd, J=2.0, 10.2 Hz, 1 H), 
4.50 (m, 1 H), 2.32 (m, 1 H), 2.08 (m, 1 H), 2.05 – 1.65 (m, 4 H), 1.50 – 1.35 (m, 1 H). 
13C NMR (CDCl3, 75 MHz) δ 176.3, 129.0, 127.9, 74.5, 72.3, 69.0, 53.2, 34.4, 30.3, 24.1, 
21.2, 19.9; MS (EI+) m/z 172; HRMS calcd. for C8H12O4: 172.07, Found: 172.07356. 
Anal calcd.: C 55.81, H 7.02, O 37.13. Found: C 53.89, H 7.49. 
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(S)-methyl 1-hydroxy-6-oxocyclohex-2-enecarboxylate (8).  
To a solution of diol 129 (409 mg, 2.37 mmol)  in dimethyl sulfoxide (7.9 mL) was added 
2-iodoxybenzoic acid (1.99 g, 7.12 mmol) in portions over 1 minute. The white slurry 
turned to a light yellow and clear mixture over several minutes. The reaction was 
monitored by TLC analysis (1:1 hexanes/EtOAc, CAM) and stirred at room temperature 
for 15.5 hours prior to workup. The reaction mixture appeared as a slightly yellow-white 
slurry and was filtered. The filtrate was dropped into a stirring volume of water (18 mL) 
and produced a white precipitate that was stirred at room temperature for 0.5 h prior to 
filtration. The mother liquor was extracted with Et2O (10 x 8 mL, 7 x 7 mL, 6 x 4 mL) 
and ethyl acetate (2 x 6 mL). The organic layers were combined and dried over MgSO4, 
filtered, and concentrated provide an orange oil (585 mg crude). The crude material was 
subjected to silica gel chromatography (2:1 hexanes/EtOAc) and provided 240 mg (59% 
yield) of the α-hydroxy ketone 8  as a colorless oil that was stored for short periods of 
time in the freezer (< 0 ˚C). 
8: Rf = 0.58 (1:1 hexanes/EtOAc); [α]D20 = -239.7 (c 1.0, CHCl3); FT-IR (film) ν 3468, 
2957, 1744, 1725, 1438, 1259, 1138, 1040, 996, 875, 813 cm-1; 1H NMR (CDCl3, 300 
MHz) δ 2.46 – 2.71 (m, 3 H), 2.88 – 2.95 (m, 1 H), 3.72 (s, 3 H), 4.33 (s, 1H, OH), 5.72 
(dt, J=1.7, 9.7, 1H), 6.06 (dt, J=3.8, 9.7, 1H); 13C NMR (CDCl3, 75 MHz) δ 205.8, 170.4, 
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131.9, 127.6, 78.0, 53.5, 35.1, 26.9; MS (EI+) m/z 170; HRMS calcd. for C8H10O4: 
170.0600, Found: 170.0579. 
 
(1’R, 2’S, 3aR, 7aS)-Dimethyl 2’,3a-dihydroxy-3a,4,5,7a-
tetrahydrospiro[benzo[d][1,3]dioxole-2,1’-cyclohex[3]ene]-2’7a-dicarboxylate [(-)-
Idesolide (5)]. To a solution of α-hydroxy ketone 8 (45 mg, 0.261 mmol) in chloroform 
was added anhydrous sodium bicarbonate (44 mg, 0.522 mmol) and the heterogeneous 
mixture, including stir bar, was concentrated on a rotoevaporator with slow rotation in 
attempts to concentrate the oil at the bottom of the round bottom flask and evenly 
distribute the sodium bicarbonate. The resulting colorless oil, spiked with sodium 
bicarbonate, was subjected to slow stirring under argon atmosphere. After several hours 
the stirring was inhibited by the viscosity of the crude reaction mixture. The reaction 
mixture was allowed to stand at room temperature under argon atmosphere. NMR 
analysis after 43 hours indicated a 1:0.6 ratio of idesolide (5) to monomer 8. The reaction 
was allowed to proceed for an additional 5.5 hours before the mixture was diluted with 
CHCl3 and filtered. The filtrate was concentrated in vacuo to provide 54 mg of a colorless 
oil that was stored at -78 °C overnight. Oily white crystals were observed and the crude 
material was triturated with pentanes (4 x 0.2 mL) and hexanes (6 x 0.2 mL) to provide 
25 mg of (-)-idesolide (5) (57% yield) as white crystalline solid.  
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5: Rf = 0.48 (1:1 hexanes/EtOAc); mp = 136-139 °C; [α]D20 = -242.5 (c 1.0, CHCl3); FT-
IR (film) ν 3365, 3030, 2955, 2848, 1755, 1738, 1439, 1350, 1259, 1124, 975, 802, 751 
cm-1; 1H NMR (CDCl3, 600 MHz) δ 6.01 (m, 2H), 5.61 (dd, J = 1.8, 10.0 Hz, 1H), 5.49 
(dd, J = 2.5, 10.1 Hz, 1H), 3.93 (s, 3H), 3.79 (s, 3H), 2.41 (m, 2H), 2.27 (m, 4H), 2.15 
(m, 1H), 1.85 (m, 1H); 13C NMR (CDCl3, 150 MHz) δ 173.2, 169.1, 132.5, 130.7, 126.5, 
126.2, 111.0, 102.2, 86.4, 76.7, 54.3, 52.8, 31.1, 29.7, 24.4, 22.4; MS (EI+) m/z 340; 
HRMS calcd. for C16H20O8: 340.1200, Found: 340.1150. Anal calcd.: C 56.47, H 5.92. 
Found: C 55.27, H 5.84. 
 
(S)-Methyl 1-hydroxy-2-oxocyclohex-3-enecarboxylate (347).  
To a solution of diene 340 (65 mg, 0.381 mmol) in distilled toluene (1.5 mL) was added 
Grubbs First Generation catalyst (15 mg, 0.019 mmol) under argon and with stirring. The 
lightly colored brown/yellow solution quickly turned purple upon addition of catalyst. 
The reaction was heated to 111 °C and turned to a clear brown color over several 
minutes. The reaction was monitored by TLC analysis and deemed complete after 
approximately 17 h. The reaction mixture was concentrated to dryness and the crude 
black oil (70 mg) was chromatographed on silica gel (2:1 hexanes/EtOAc → 1:1 
hexanes/EtOAc) to yield 28 mg (43% yield) of enone 347 as a light brown/red oil.  
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347: Rf = 0.52 (1:1 hexanes/EtOAc); FT-IR (film) ν 3460,  2955, 2938, 1741, 1681, 
1436, 1389, 1259, 1220, 1198, 1139, 1114, 1070 cm-1; 1H NMR (CDCl3, 600 MHz) δ 
7.09 (m, 1H), 6.17 (d, J = 10.2 Hz, 1 H), 4.24 (OH, s, 1H), 3.79 (s, 3H), 2.62 (m, 3H), 
2.10 (m, 1H); 13C NMR (CDCl3, 75 MHz) δ 194.8, 170.7, 152.7, 126.6, 53.0, 32.1, 24.2; 
MS (EI+) m/z 170; HRMS calcd. for C8H10O4: 170.0579, Found: 170.0579.  
 
(3aS,7aR)-Methyl 2,2-dimethyl-3a,7a-dihydrobenzo[d][1,3]dioxole-3a-carboxylate, 
sodium salt (354).  
To a slurry of mixed sodium/potassium carboxylate of 337 [61.6 g (81.1 g at 76 wt% 
purity), 317 mmol] in 2,2-dimethoxypropane (790 mL, 0.4 M) at 0 ˚C with vigorous 
stirring was added trifluoroacetic acid (146 mL, 1.90 mol, 6.0 equiv) dropwise over 6 
minutes while the internal temperature was monitored; no significant exotherm observed. 
The reaction mixture was warmed up to room temperature and stirred until the 
consumption of 337 was observed by TLC (4:1 EtOAc/MeOH) and/or HPLC analysis 
(254 nm) at approximately 6 h. The reaction mixture was filtered through a pad of Celite 
and the filtrate concentrated in vacuo to a dark brown/black oil. The crude oily mixture 
was dissolved in H2O (100 mL) and extracted twice with CH2Cl2 . The organic phase was 
then extracted with an aqueous NaHCO3 solution (sat’d, 3 x 100 mL) and concentrated to 
dryness in vacuo to provide the sodium salt of 354 as a solid, contaminated with other 
inorganic salts. The crude product was then dissolved in MeOH and the heterogeneous 
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mixture containing undissolved inorganic salts was filtered. The filtrate was concentrated 
in vacuo to yield 62.1 g (90%) of sodium salt acetonide 354 as a slightly off-white solid. 
The storage of the sodium carboxylate was convenient in that its shelf life at room 
temperature exceeded several months with no loss in purity as indicated by NMR 
analysis. 
354:  1H NMR (300 MHz, D2O) δ 6.13 (dd, J = 5.6, 9.5 Hz, 1H), 6.06 (dd, J = 5.5, 9.6 
Hz, 1H), 5.92 (dd, J = 4.3, 9.5 Hz, 1H), 5.71 (dd, J = 9.9, 4.5 Hz, 1H), 4.80 (d, J = 4.2 
Hz, 1H), 1.33 (s, 3H), 1.33 (s, 3H).  
 
The corresponding free acid was obtained by the acidification of a cold aqueous solution 
of the salts with 6 M HCl and extraction with EtOAc. Spectral data matches that reported 
in the literature.66, 69  
(3aS,7aR)-2,2-Dimethyl-3a,7a-dihydrobenzo[d][1,3]dioxole-3a-carboxylic acid (356):   
[α]D20 = -33.9 (c = 0.9, CHCl3); 1H NMR (300 MHz, CDCl3) δ 10.23 (bs, 1H), 6.16 
(m, J = 3.6 Hz, 1H), 6.04 (dd, J = 4.7, 9.6 Hz, 1H), 5.77 (q, J = 3.2 Hz, 1H), 4.93 (d, J = 
4.2 Hz, 1H), 1.49 (s, 3H), 1.44 (s, 3H).66  
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(3aS,7aR)-Methyl 2,2-dimethyl-3a,7a-dihydrobenzo[d][1,3]dioxole-3a-carboxylate 
(355).  
To a clear light brown solution of freshly extracted 356 (67 g, 341 mmol) in methylene 
chloride (1.7 L, 0.2 M) at 10 ˚C was added MeOH (34 mL, 853 mmol, 2.5 equiv), 
dimethylaminopyridine (4.2 g, 34.1 mmol, 0.1 equiv), and N,N’-
dicyclohexylcarbodiimide (77.4 g, 375 mmol, 1.1 equiv) under an  atmosphere of argon 
and with vigorous stirring; almost immediately a white slurry was generated and the 
reaction was stirred to room temperature and monitored by TLC analysis (5:1 
hexanes/EtOAc). After 12 h the reaction mixture was filtered and the filter cake rinsed 
with methylene chloride (2x). The filtrate was slightly concentrated, which allowed for 
additional precipitation of dicyclohexylurea and the material was filtered again. The 
filtrate was concentrated to dryness in vacuo and provided crude material (71.92 g) as a 
brown oil that was contaminated by dicyclohexylurea. The crude material was subjected 
to silica gel chromatography (5:1 → 4:1 hexanes/EtOAc) and yielded 42.2 g (67%) of 
known methyl ester 355 as a yellow oil that solidified to a low-melting, white crystalline 
solid at low temperature (5 ˚C).  
355: Rf = 0.51 (hexanes/EtOAc 5:1); IR (film) ν 3043, 2989, 2934, 2846, 1753, 1735, 
1454, 1434, 1380, 1371, 1254, 1209, 1168, 1036, 885, 710 cm-1; 1H NMR (300 MHz, 
CDCl3) δ 6.12 (m, 2H), 6.04 (m, 1H), 5.84 (m, 1H), 4.99 (d, J = 4.1 Hz, 1H), 3.81 (s, 
3H), 1.46 (s, 3H), 1.44 (s, 3H); 13C (CDCl3, 75 MHz) δ 172.2, 124.8, 124.5, 124.1, 124.0, 
106.8, 79.4, 72.7, 53.0, 26.9, 25.2.Error! Bookmark not defined.66 
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8-tert-butyl 3a-methyl (3aR,4R,7S,7aR)-2,2-dimethyl-7,7a-dihydro-4,7-(epoxyimino)-
1,3-benzodioxole-3a,8(4H)-dicarboxylate (9/357).  
To a solution of diene ester 355 (2.72 g, 12.9 mmol) in a mixture of MeOH/H2O (4:1 v/v, 
65 mL, 0.2 m) at 0 ˚C was added sodium periodate (3.60 g, 16.8 mmol, 1.3 equiv) as a 
single portion. To this mixture was added a solution of t-butyl hydroxycarbamate (2.24 g, 
16.8 mmol, 1.3 equiv) in MeOH/H2O (4:1 v/v, 10 mL, 1.7 M) dropwise over several 
minutes. The reaction mixture became a thick slurry upon addition of the hydroxy 
carbamate and the progress of the reaction was monitored by TLC analysis (4:1 
hexanes/EtOAc, CAM). Upon consumption of 355 (approximately 2.5 h) the reaction 
mixture was diluted with EtOAc and the thick slurry was filtered. The filter cake was 
rinsed with EtOAc and the filtrate was collected and washed with aqueous NaHCO3 
(saturated, 1x), H2O (1x), and then brine (1x). The organic phase was dried over Na2SO4, 
filtered and concentrated in vacuo to yield an orange oil. The crude material was 
chromatographed on silica gel (2:1 hexanes/EtOAc) to yield a mixture regioisomers 9 and 
357 (4.32 g, 96%; 3:1 9/357 ratio determined by NMR). The purity of the crude material 
was sufficient enough to use without further purification.  
9/357: Rf = 0.34 (4:1 hexanes/EtOAc); IR (film, cm-1) ν 2984, 2954, 2940, 2253, 1745, 
1709, 1458, 1437, 1382, 1372, 1263, 1213, 1160, 1110, 1088, 1061, 1017, 877, 732; 1H 
NMR (600 MHz, CDCl3) δ 6.53 (m, J = 4.9 Hz, 1H), 6.49 (dd, J = 2.0, 8.0 Hz, 1H), 5.17 
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(d, J = 4.4 Hz, 1H), 5.14 (dd, J = 1.4, 5.9 Hz, 1H), 5.09 (m, J = 2.9 Hz, 1H), 3.89 (s, 1H), 
1.48 (s, 1H), 1.34 (s, 1H), 1.31 (s, 1H); 13C NMR (75 MHz, CDCl3) δ 170.9, 157.0, 
131.0, 129.9, 128.7, 112.7, 82.7, 82.3, 74.4, 72.7, 53.5, 53.1, 28.1, 26.2, 26.1; MS (EI+) 
m/z (%) 341 (0.4), 159 (12), 158 (35), 151 (7), 143 (21), 124 (8), 109 (7), 105 (13), 93 
(13), 83 (22), 73 (21), 65 (12), 61 (15), 59 (42), 58 (16), 57 (100), 56 (26), 55 (16), 45 
(20), 44 (34), 43 (96), 42 (17), 41 (65); HRMS (+EI) calcd for C12H23N1O7: 341.1475. 
Found: 341.1475.  
 
(3aR,7S,7aR)-Methyl-7-(tert-butoxycarbonylamino)-2,2-dimethyl-4-oxo-3a,4,7,7a-
tetrahydrobenzo[d][1,3]dioxole-3a-carboxylate (360).  
To a solution of isoxazolidines 9/357 (773 mg, 2.26 mmol) in MeCN/H2O (16 mL, 0.15 
M, 15:1 v/v) at 80 ˚C was added molybdenum hexacarbonyl (897 mg, 3.39 mmol, 1.5 
equiv) with stirring. The reaction was monitored by TLC analysis (CHCl3/MeOH 95:5) 
and deemed complete after 24 hours. The reaction mixture was filtered through a plug of 
Celite and the filtrate concentrated to dryness in vacuo. The crude mixture of amino 
alcohol regioisomers (3:1 ratio established by NMR analysis) was subjected to oxidative 
conditions by dissolution in methylene chloride (23 mL, 0.1 m), chilling the solution to 0 
˚C, and a single portion addition of Dess-Martin periodinane (1.44 g, 3.39 mmol, 1.5 
equiv) with stirring. The reaction mixture was allowed to slowly warm to ambient 
O
O
O
NHBoc
CO2Me
360
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temperature and was monitored by TLC analysis (hexanes/EtOAc 1:1). After 23 h the 
reaction was quenched with aq. Na2S2O3 (sat’d, 2 mL) and diluted with methylene 
chloride (25 mL). Precipitation occurred and the solid was filtered. The organic filtrate 
was washed with aq. NaHCO3 (sat’d, 1 x 6 mL), brine (1 x 8 mL), and then dried over 
MgSO4 and filtered. The crude organic solution was concentrated in vacuo to a solid 
crude material (1.34 g) that was chromatographed on silica gel (two chromatographic 
processes) (CHCl3/MeOH/hexanes 78:4:1) to yield 360 (246 mg, 32% from 9/357) as a 
yellow-orange oil and 361 (30 mg, 4% from 9/357) as a yellow oil. 
360:  Rf = 0.60 (hexanes/EtOAc 1:1); [α]D20 = 64.9 (c = 1.0, CHCl3); IR (film) ν 3029, 
2986, 1710, 1692, 1496, 1299, 1226, 1162, 1101, 770 cm-1; 1H NMR (300 MHz, CDCl3) 
δ 6.87 (ddd, J = 1.6, 5.0, 9.9 Hz, 1H), 6.86 (d, J = 1.7 Hz, 1H), 6.16 (d, J = 10.2 Hz, 1H), 
5.41 (d, J = 9.3 Hz, 1H), 4.84 (dd, J = 5.0, 7.4 Hz, 1H), 4.43 (s, 1H), 3.83 (s, 1H), 1.44 (s, 
1H), 1.34 (s, 1H); 13C NMR (75 MHz, CDCl3) δ 191.3, 168.6, 154.7, 145.8, 127.5, 111.2, 
82.0, 80.6, 79.4, 77.3, 53.6, 45.4, 28.3, 27.1, 25.6; MS (+EI) m/z (%) 285 (2), 270 (4), 
248 (7), 228 (9), 159 (55), 143 (7), 127 (41), 96 (9), 83 (37), 73 (21), 59 (15), 57 (100), 
43 (18), 41 (18); HRMS (+EI) calcd for C16H23O7N: 341.1475. Found: 341.1481. 
 
(3aR,7S,7aR)-Methyl-7-(tert-butoxycarbonylamino)-5,6-dihydroxy-2,2-dimethyl-4-
oxohexahydrobe-nzo[d][1,3]dioxole-3a-carboxylate (365). 
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Step 1. To a solution of sodium periodate (904 mg, 4.22 mmol, 1.5 equiv.) in H2O (0.85 
mL, 3.3 M) at room temperature was added cerium (III) chloride heptahydrate (104 mg, 
0.281 mmol, 10 mol%) and the white slurry was gently heated so that it became yellow in 
color. The yellow slurry was cooled in an ice-bath and a mixture of ethyl 
acetate/acetonitrile (1.2:1 v/v) was added. To this chilled mixture was added ruthenium 
(III) chloride hydrate (RuCl3·xH2O, 0.25 mol%) and the reaction mixture immediately 
turned to a dark brown color. A solution of enone 360 (962 mg, 2.81 mmol, 1.0 equiv.) in 
ethyl acetate (6.5 mL, 0.43 M) was added to the reaction mixture and the reaction mixture 
was stirred for approximately 23 hours with gradual warming to room temperature over 
the first 1.5 hours. The reaction was monitored by TLC analysis (ethyl acetate/hexanes 
2:1). Once the reaction was deemed complete by TLC small portions of sodium sulfite 
were added until no more active oxidant was detectable by KI/starch paper. The reaction 
mixture was filtered and the filtered solid washed with small portions of ethyl acetate. 
The filtrate was concentrated to yield 1.00 g of crude material as a light yellow foam-like 
solid. Silica gel chromatography (ethyl acetate/hexanes 2:1) provided 647 mg of 352 
(quant.).  
Step 2. To a solution of reasonably pure 352 (26 mg, 0.081 mmol, 1.0 equiv.) in 
methylene chloride (0.8 mL, 0.1 M) at room temperature was added acetic anhydride (30 
µL, 0.327 mmol, 4.0 equiv.), triethylamine (45 µL, 0.327 mmol, 4.0 equiv.), and 
dimethylaminopyridine (DMAP, cat.) in succession. Upon addition of triethylamine the 
clear and colorless mixture became clear and yellow and following the addition of 
DMAP the mixture lightened in color. The reaction was monitored by TLC analysis 
(hexanes/ethyl acetate 1:1) and starting material was consumed after 10 minutes. The 
180 
 
reaction was quenched with an aqueous solution of ammonium chloride (sat’d, 0.2 mL) 
and followed by the addition of H2O (0.4 mL). The phases were separated and the 
organic phase was washed with H2O (2x), brine (1x), and then dried over MgSO4. The 
organic phase was concentrated in vacuo to yield 28 mg of crude material as a white 
foam-like solid. The crude material was subjected to chromatography on silica gel 
(hexanes/ethyl acetate 2:1) to yield 18 mg (52%) of acetate 365 as a white solid. 
365: mp 103 – 105 ˚C (pentane); Rf = 0.54 (hexane/EtOAc 2:1); [α]D20 = +64.9 (c = 0.9, 
CHCl3); IR (film) ν 3393, 2984, 1773, 1703, 1498, 1369, 1303, 1193, 1165, 1094, 1014, 
875, 755 cm-1; 1H NMR (300 MHz, CDCl3) δ 6.55 (d, J = 5.6 Hz, 1H), 5.48 (d, J = 9.6 
Hz, 1H), 5.03 (dd, J = 9.1, 6.0 Hz, 1H), 4.46 (s, 1H), 3.89 (s, 3H), 2.25 (s, 3H), 1.53 – 
1.46 (m, 12H), 1.45 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 185.2, 168.1, 154.6, 143.9, 
131.5, 111.9, 83.4, 80.7, 79.5, 77.4, 77.0, 76.6, 53.8, 44.9, 28.3, 27.0, 25.6, 22.3, 20.2, 
14.0; HRMS (EI+ TOF) calcd for C18H25NO9: 399.1529. Found: 399.1539. 
 
[(3aR,4R,7S,7aR)-2,2-Dimethyldihydro-4H-[1,3]dioxolo[4,5-d][1,2]oxazine-3a,4,7- 
triyl]tri(methylene) triacetate  (368). 
To a clear and colorless solution of isoxazolidine 9/357 (104 mg, 0.295 mmol, ~3:1 
mixture of regioisomers) in methylene chloride (6 mL) at -70 °C was bubbled ozone until 
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a blue color persisted (ca. 35 minutes) which corresponded to the consumption of 9/357 
by TLC analysis (hexanes/EtOAc 2:1). Oxygen was used to purge the reaction mixture 
and make it devoid of excess ozone and its blue color. Sodium borohydride (21 mg) was 
added directly to the reaction mixture at -54 °C and the reaction was slowly warmed to 
room temperature and allowed to stir for a total of 23 h at room temperature. To the hazy, 
off-white reaction mixture was added H2O (3 drops) and stirring was allowed for several 
minutes prior to concentration in vacuo. The crude mixture was then reconstituted in 
methylene chloride (3 mL) and acetic anhydride (140 μL, 1.47 mmol), triethylamine (205 
μL, 1.47 mmol), and 4-dimethylaminopyridine (DMAP, cat.) was added in sequence and 
allowed to stir overnight at room temperature. After 17 hours the reaction was quenched 
with aq. NH4Cl (sat’d, 1 mL) and the phases were separated. The organic phase was 
washed with H2O (2 x 1 mL) and brine (1 x 1 mL), dried over anhydrous MgSO4, and 
concentrated in vacuo to provide an orange oil (119 mg). The crude material was 
chromatographed on silica gel (hexanes/EtOAc 2:1) to yield 368 (31 mg, 22%) as a 
colorless oil.  
368: Rf = 0.41 (hexanes/EtOAc 2:1); [α]D20 = +37.5° (c 0.7, CHCl3); IR (film) υ 2984, 
2936, 1746, 1706, 1456, 1370, 1337, 1233, 1165, 1132, 1043, 930, 885, 854, 759 cm-1; 
1H NMR (300 MHz, DMSO) δ 4.55 (d, J = 4.0 Hz, 1H), 4.38 – 4.23 (m, 3H), 4.20 (s, 
2H), 4.14 (dd, J = 8.9, 6.6 Hz, 1H), 4.01 (dd, J = 13.0, 8.4 Hz, 1H), 3.81 (dd, J = 8.3, 2.1 
Hz, 1H), 2.04 (s, 3H), 2.03 (s, 3H), 2.02 (s, 3H), 1.45 (s, 9H), 1.40 (s, 3H), 1.35 (s, 3H). ; 
13C NMR (75 MHz, DMSO) δ 170.7, 170.5, 170.1, 155.9, 109.6, 81.9, 81.8, 78.3, 73.5, 
64.8, 62.2, 62.0, 52.8, 28.3, 27.2, 26.0, 21.2, 21.1, 20.9; MS (+EI) m/z (%) 283 (M+-CH3, 
1), 375 (11), 223 (21), 167 (20), 149 (100), 101 (15), 57 (87); HRMS (+EI) calcd for 
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C21H33O11N: 475.2054. Found 475.2054. Anal. Calcd for C21H33O11N: C, 53.05; H, 7.00. 
Found C, 52.84; H, 6.87. 
 
 
(3aR,4R,7S,7aR)-tert-Butyl3a,4,7-tris(hydroxymethyl)-2,2-dimethyldihydro-3aH-
[1,3]dioxolo[4,5-d][1,2]oxazine-6(4H)-carboxylate (366). 
To a solution of protected isoxazolidine 368 (39 mg, 0.082 mmol) in MeOH (2 mL) at 
room temperature was added an aqueous solution of potassium carbonate (10%, 1.3 mL) 
with stirring. The consumption of 368 was observed by TLC analysis (EtOAc) after 1.2 
hours and the reaction mixture was neutralized with aqueous HCl (1 M). The mixture was 
extracted with EtOAc (3 x 1.5 mL), the combined organic phases were dried over 
anhydrous sodium sulfate and concentrated in vacuo to yield 366 (31 mg, quant.) as a 
colorless oil. An analytical sample was obtained by silica gel chromatography (EtOAc).  
366: Rf = 0.37 (EtOAc); [α]D20 = +56.7° (c = 0.7, CHCl3); IR (film, cm-1) υ 3379, 2983, 
2935, 1700, 1456, 1393, 1370, 1337, 1251, 1217, 1150, 1117, 1050, 1010, 904, 866, 844, 
826, 756; 1H NMR (600 MHz, DMSO) δ 5.18 (t, J = 5.2 Hz, 1H), 4.85 (t, J = 5.5 Hz, 
1H), 4.52 (d, J = 3.6 Hz, 1H), 4.48 (t, J = 5.7 Hz, 1H), 3.79 (dt, J = 9.8, 4.2 Hz, 1H), 3.68 
– 3.63 (m, J = 9.5, 4.7 Hz, 1H), 3.63 – 3.53 (m, 4H), 3.45 – 3.38 (m, 2H), 1.42 (s, 9H), 
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1.34 (s, 3H), 1.29 (s, 3H); 13C NMR (150 MHz, DMSO) δ 157.4, 108.3, 85.1, 81.1, 80.1, 
74.5, 63.8, 60.4, 59.1, 57.5, 28.4, 27.5, 26.6; MS (FAB+) m/z (%) 350 (3), 294 (13), 250 
(10), 192 (14), 136 (12), 109 (11), 107 (12), 97 (14), 95 (17), 57 (100), 43 (58), 41 (50), 
39 (18), 29 (23); HRMS (FAB+) calcd for C15H28O8N: 350.1815 [M++1]. Found 
350.1791. Anal. Calcd for C15H27O8N: C, 51.57; H, 7.79. Found C, 51.33; H, 7.63. 
 
tert-Butyl (S)-1-((4R,5S)-5-((R)-1,2-dihydroxyethyl)-5-(hydroxymethyl)-2,2-
dimethyl-1,3-dioxolan-4-yl)-2-hydroxyethylcarbamate (370). 
To a clear, light yellow and degassed solution of isoxazolidine 366 (152 mg, 0.435 mmol, 
1.0 equiv) in MeCN/H2O (4.4 mL, 0.1 M, 15:1 v/v) at room temperature was added 
molybdenum hexacarbonyl (sublimed, 252 mg, 0.957 mmol, 2.2 equiv.) with stirring and 
under a blanket of argon. The reaction mixture slowly changed from a light yellow 
heterogeneous mixture of Mo(CO)6 crystals and dissolved substrate to a darker 
homogeneous mixture and an eventual black mixture upon heating to reflux. The reaction 
was monitored by TLC analysis (4:1 EtOAc/MeOH, CAM) and stirred for ca. 20 h prior 
to cooling to room temperature and spiking the reaction mixture with solid NaHCO3 (two 
small spatula tips) and several drops of an aqueous NaHCO3 (sat’d) solution and 
exposing to air for > 8 h. Celite (small scoop) was added to the reaction mixture with 
stirring and then passed over a short pad of Celite/SiO2 (1:1 w/w) and eluted with EtOAc. 
BocHN O
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Three fractions were collected and the main fraction that contained 370 was concentrated 
in vacuo to yield 133 mg (87%) of 370 as a slightly pink crude material that was used 
without further purification.  
370: mp 61 – 63 ˚C (EtOAc); Rf = 0.58 (EtOAc/MeOH 4:1); [α]D20 = +2.1 (c = 1.5, 
CHCl3); IR (film, cm-1) ν 3418, 2982, 2936, 1691, 1507, 1456, 1384, 1252, 1218, 1168, 
1053, 894, 865, 615; 1H NMR (300 MHz, MeOD) δ 4.38 (d, J = 4.6 Hz, 1H), 4.11 (dd, J 
= 11.0, 5.3 Hz, 1H), 3.88 (dd, J = 7.3, 3.5 Hz, 1H), 3.81 – 3.72 (m, 1H), 3.72 – 3.57 (m, 
5H), 1.51 (s, 3H), 1.47 (s, 8H), 1.40 (s, 3H); 13C NMR (75 MHz, MeOD) δ 156.7, 107.5, 
84.2, 79.0, 78.4, 71.6, 63.6, 62.3, 62.2, 51.0, 27.3, 25.8, 25.1; MS (FAB+) m/z (%) 353 
(12), 352 (67.5), 296 (17), 253 (12), 252 (99), 238 (15), 214 (21), 194 (33), 176 (10), 149 
(29), 113 (12), 57 (100),  55 (13), 43 (28), 41 (24), 29 (12); HRMS (FAB+) calcd for 
C15H30NO8: 352.1971 [M+1]. Found 352.1976; Anal. Calcd for C15H29O8N: C, 51.27; H, 
8.32. Found C, 51.37; H, 8.16.  
 
((4S,5R)-5-((S)-2-Acetoxy-1-(tert-butoxycarbonylamino)ethyl)-4-((R)-2-acetoxy-1-
hydroxyethyl)-2,2-dimethyl-1,3-dioxolan-4-yl)methyl acetate (370a). 
To a clear and colorless solution of isoxazolidine triol 366 (52 mg, 0.148 mmol) in a 
mixture of acetonitrile/H2O (1.5 mL, 15:1 v/v) at room temperature was added 
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molybdenum hexacarbonyl (58 mg, 0.223 mmol) with stirring. The reaction mixture was 
heated to reflux for ca. 24 hours prior to an additional portion of molybdenum 
hexacarbonyl (39 mg, 0.148 mmol) was added. The reaction mixture was stirred at reflux 
for another 12 hours prior to cooling to room temperature and filtration through a pad of 
Celite. The filtrate was concentrated in vacuo to yield a crude black mass that was 
dissolved in DCM (2.5 mL) and acetic anhydride (140 μL, 1.48 mmol), Et3N (206 μL, 
1.48 mmol), and 4-dimethylaminopyridine (cat.) was added sequentially at room 
temperature and with stirring. The reaction mixture was stirred for 20 h and quenched 
with aq. NH4Cl (sat’d, 0.5 mL). The phases were separated and the organic phase was 
washed with H2O (2x) and brine (1x). The organic phase was dried over MgSO4 and 
concentrated to provide crude material (25 mg) that was chromatographed on silica gel 
(hexanes/EtOAc 1:1) to yield 370a (6 mg, 8%) as a white foam.  
370a: Rf = 0.53 (hexanes/EtOAc 1:1); IR (film) υ 3368, 2981, 2930, 1747, 1715, 1497, 
1454, 1369, 1226, 1165, 1046, 870, 603 cm-1; 1H NMR (300 MHz, CDCl3) δ 5.39 (dd, J 
= 7.2, 3.4 Hz, 1H), 4.96 (d, J = 9.0 Hz, 1H), 4.34 – 4.23 (m, 2H), 4.21 (d, J = 4.2 Hz, 
2H), 4.18 – 4.05 (m, 3H), 2.13 (s, 3H), 2.09 (s, 3H), 2.05 (s, 3H), 1.99 (s, 3H), 1.50 (s, 
3H), 1.46 (s, 8H), 1.36 (s, 3H); MS (EI+) m/z (%) 448 (2), 404 (3), 346 (10), 287 (14), 
259 (15), 149 (11), 102 (36), 57 (64), 43 (100); HRMS (EI+) calcd for C22H34O12N: 
504.2081 [M+-CH3]. Found 504.2084. Anal. Calcd for C23H37O12N: C, 53.17; H, 7.18. 
Found C, 54.20; H, 6.69. 
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 ((3aR,7S,7aR)-4-Acetoxy-7-(tert-butoxycarbonylamino)-2,2-dimethyltetrahydro-
3aH-[1,3]dioxolo[4,5-c]pyran-3a-yl)methyl acetate (373). 
To a clear and red solution of tetrol 370 (2.37 g, 6.74 mmol; 3.70 g 370 with 64.1% w/w 
purity) in methylene chloride (70 mL, 0.1 M) at 0 ˚C was added a freshly prepared 
quantity of silica gel support NaIO4 (15% w/w; 13.5 g, 9.43 mmol, 1.4 equiv)1 over 2 
minutes; the color of the slurry immediately changed from red to light yellow and a small 
exotherm was detected. The reaction was monitored by TLC analysis (EtOAc, CAM) and 
370 was consumed after 0.5 h. The reaction mixture was filtered and the solid support 
was rinsed thoroughly with methylene chloride and ethyl acetate until no chemical 
species was detectable by TLC [Rf = 0.61 (EtOAc)]. The clear and yellow filtrate was 
dried over Na2SO4 and quickly concentrated in vacuo prior to reconstitution in methylene 
chloride (70 mL, 0.1 M) and addition of acetic anhydride (4.5 mL, 47.1 mmol, 7 equiv), 
triethylamine (6.6 mL, 47.1 mmol, 7 equiv), and a catalytic amount of dimethylamino 
pyridine with stirring. The acylation was monitored by TLC analysis (EtOAc, CAM) and 
the intermediate lactol 372 (Rf = 0.61) was consumed within 1 h. An aqueous solution of 
NH4Cl (half sat’d, 25 mL) was added to the chilled (ice bath) reaction mixture. After 
warming to ambient temperature the phases were separated and the organic phase was 
washed with H2O (1x), brine (1x), dried over Na2SO4, filtered and then concentrated in 
vacuo to an orange oil (4.03 g). The crude material was chromatographed on silica gel 
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(3:1 → 2:1 hexanes/EtOAc) to yield 1.53 g (56%) of acetal 373 as a hygroscopic white 
foam.  
373: mp 53 – 56 ˚C (pentane); Rf = 0.39 (2:1 hexanes/EtOAc); IR (film) υ 3362, 2983, 
2934, 1764, 1747, 1711, 1511, 1454, 1382, 1366, 1305, 1240, 1218, 1171, 1097, 1053, 
1006, 899, 872, 757, 735 cm-1; 1H NMR (300 MHz, CDCl3) δ 5.69 (s, 1H), 5.27 (d, J = 
7.8 Hz, 1H), 4.48 – 4.31 (m, J = 4.0, 2.0 Hz, 3H), 4.09 (d, J = 12.1 Hz, 1H), 4.03 (s, 1H), 
3.86 (d, J = 12.2 Hz, 1H), 2.15 (s, 3H), 2.13 (s, 3H), 1.53 (s, 3H), 1.46 (s, 8H), 1.41 (s, 
3H); 13C NMR (75 MHz, CDCl3) δ 170.1, 169.0, 154.9, 109.7, 95.5, 80.1, 66.6, 61.5, 
46.8, 28.3, 27.8, 26.3, 20.9, 20.8; MS (EI+) m/z (%) 403 (< 1), 272 (19), 227 (20), 184 
(18), 113 (45), 101 (12), 88 (29), 57 (76), 43 (100); HRMS (EI+) calcd for C18H29O9N: 
403.1842 [M+]. Found 403.1842. Anal. Calcd for C18H29O9N: C, 53.59; H, 7.25. Found 
C, 53.68; H, 7.26. 
 
((3aR,7S,7aR)-4-Acetoxy-7-amino-2,2-dimethyltetrahydro-3aH-[1,3]dioxolo[4,5-
c]pyran-3a-yl)methyl acetate (11). 
To a flamed dried flask a solution of acetal 373 (33 mg, 0.081 mmol) in methylene 
chloride (2 mL) at 0 ˚C was added trifluoroacetic acid (0.5 mL) as a single portion with 
stirring and under a blanket of argon. The reaction mixture was allowed to warm to room 
temperature and monitored by TLC analysis (EtOAc/MeOH 4:1 (or) hexanes/EtOAc 
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2:1). The reaction was deemed complete after 50 minutes and concentrated in vacuo to 
provide crude material (31 mg) that was passed through a plug of deactivated (20% wt/wt 
H2O) silica gel and eluted with ethyl acetate. The mother liquor was concentrated to yield 
15 mg (62%) of amine salt 11 as a white crystalline solid.  
11: mp 163 – 165 ˚C (Et2O); Rf = 0.13 (ethyl acetate); [α]D20 = -17.9 (c = 0.6, CHCl3); IR 
(KBr, cm-1) ν 3369, 2991, 2939, 1769, 1746, 1678, 1376, 1212, 1137, 1063, 907, 836, 
799, 721, 665; 1H NMR (300 MHz, CDCl3) δ 5.85 (bs, 2H), 5.68 (s, 1H), 4.68 (d, J = 
12.8 Hz, 1H), 4.44 (s, 1H), 4.36 (d, J = 12.8 Hz, 1H), 4.20 – 3.90 (m, 2H), 3.60 (s, 1H), 
2.15 (s, 2H), 2.14 (s, 2H), 1.54 (s, 3H), 1.42 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 171.2, 
168.9, 110.1, 95.5, 77.8, 77.4, 77.0, 76.6, 75.6, 65.6, 60.8, 47.6, 27.8, 26.1, 20.8, 20.7; 
HRMS (EI+) calcd for C13H21NO7: 303.1318. Found: 303.1339 Anal. Calcd for 
C15H22F3NO9: C, 43.17; H, 5.31. Found C, 42.92; H, 5.34. 
 
((3aR,6S,6aR)-2,2-Dimethyl-6,6a-dihydro-3aH-[1,3]dioxolo[4,5-c]pyrrole-3a,6-
diyl)dimethanol (374). 
To a flamed dried vessel that contained vacuum dried solid K2CO3 (31 mg, 0.229 mmol, 
4.0 equiv) was added a solution of trifluoroacetate salt 11 (23 mg, 0.057 mmol, 1.0 equiv) 
in anhydrous MeOH-d4 (0.50 mL, 0.11 M) with stirring. The reaction mixture was stirred 
for 5.5 h at room temperature and the reaction was monitored by 1H NMR [Note: Rf is 
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identical to that of starting material 11, Rf = 0.52 (4:1 EtOAc/MeOH)]. The reaction was 
filtered through a pad of Celite and washed with small volumes of MeOH (2 x 0.5 mL). 
The filtrate was concentrated in vacuo to provide an oily white crystalline material (32 
mg) that was contaminated with KOAc and CF3CO2K. The crude material could be 
purified by trituration with acetone several times to yield 9 mg of 374 (81%) as a 
colorless oil.  
374: Rf = 0.52 (4:1 EtOAc/MeOH); [α]20D = -24.4 (c = 0.45, MeOH); IR (KBr) ν 3306, 
2987, 2930, 2846, 1626, 1572, 1454, 1373, 1240, 1215, 1182, 1090, 1049, 900, 863 cm-1; 
1H NMR (600 MHz, MeOH-d4) δ 4.62 (d, J = 4.1 Hz, 1H), 4.07 – 3.99 (m, 1H), 3.93 – 
3.84 (m, 2H), 3.84 – 3.77 (m, 2H), 1.39 (s, 3H), 1.35 (s, 3H); 13C NMR (MeOH-d4, 150 
MHz) δ 169.2, 111.9, 97.7, 80.0, 75.6, 61.4, 59.9, 26.2, 25.5; HRMS (EI+) calcd for 
C9H16NO4 (M+H): 202.1079. Found: 202.1071. 
 
((3aR,6S,6aR)-2,2-Dimethyltetrahydro-3aH-[1,3]dioxolo[4,5-c]pyrrole-3a,6-
diyl)dimethanol (375).  
To a round bottom flask that contained crude pyrroline 374 (22 mg, 0.109 mmol, 1.0 
equiv; contaminated with KOAc/CF3CO2K) was added HOAc (1.0 mL; aqueous, 3 m) 
followed by 10% Pd/C (2 mg, 10 wt%) and the reaction vessel was purged with H2 (3x) 
and the reaction mixture set to stir at room temperature for approximately 15 h under 1 
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atmosphere of hydrogen. The reaction mixture was filtered over a pad of Celite and 
rinsed with small amounts of H2O. The filtrate was concentrated in vacuo to yield crude 
material that was crystalline in nature and was triturated with acetone (precipitating any 
KOAc/CF3CO2K). The mother liquor was concentrated in vacuo to yield a sticky white 
foam, 8 mg, 375 (quantative over 2 steps from TFA salt 11).  
375: Rf = 0.30 (4:1 EtOAc/MeOH); [α]20D = +17.3 (c = 0.40, MeOH); IR (KBr) ν 3416, 
2937, 1681, 1563, 1414, 1384, 1206, 1139, 1051, 803, 723 cm-1; 1H NMR (600 MHz, 
MeOH-d4) δ 4.60 (d, J = 3.0 Hz, 1H), 3.92 (dd, J = 11.4, 5.7 Hz, 1H), 3.80 (dd, J = 11.4, 
7.6 Hz, 1H), 3.77 – 3.72 (m, 2H), 3.15 (dd, J = 12.8 Hz, 2H), 1.52 (s, 3H), 1.39 (s, 3H), 
signal (1H) under solvent peak; 13C NMR (151 MHz, MeOH-d4) δ 111.8, 91.4, 81.8, 
65.0, 63.5, 58.3, 53.3, 48.0, 47.9, 47.7, 47.6, 47.5, 47.3, 47.2, 25.8, 24.8; HRMS (ESI) 
calcd for C9H17NO4 (M+H): 204.1228. Found: 204.1236. 
 
(2S,3R,4R)-3,4-Dihydroxy-2,4-bis(hydroxymethyl)pyrrolidinium chloride (6). 
To a light yellow solution of protected pyrrolidine 375 (165 mg, 0.811 mmol) in MeOH 
(4 mL, 0.2 M) at room temperature was added conc. HCl (0.7 mL) with stirring and under 
a blanket of argon. The reaction mixture was heated to 40 ˚C and monitored by NMR. 
Starting acetonide 375 was consumed after approximately 5 h and the reaction mixture 
was concentrated in vacuo to dryness. The reaction mixture was reconstituted in a 
H2N
OH
OH
OH
HO
6
Cl
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minimal amount of MeOH and precipitated with the addition of Et2O while stirring. The 
slightly off-white precipitate was dried under high vacuum to yield 121 mg (75%) of 
pyrrolidine tetrol 6 as the hydrochloride salt. An analytical sample was obtained by 
recrystallization from boiling MeOH to give white crystalline solid.  
6: Rf = 0.0 (EtOAc/MeOH 4:1); mp 141 – 143 ˚C (MeOH); [α]D20 = -29.9 (c = 0.95, 
MeOH); IR (film) ν 3214, 1607, 1415, 1322, 1251, 1196, 1119, 1031, 696, 636, 524 cm-1; 
1H NMR (600 MHz, MeOD) δ 4.26 (d, J = 6.7 Hz, 1H), 3.97 – 3.87 (m, 2H), 3.81 (dd, J 
= 12.7, 6.6 Hz, 1H), 3.61 (d, J = 11.6 Hz, 1H), 3.59 (d, J = 12.6 Hz, 1H); 13C NMR (150 
MHz, MeOD) δ 78.9, 70.7, 63.4, 63.3, 58.2, 49.9; MS (FAB+) m/z (%) 223 (18), 164 
(56), 131 (100), 75 (11), 61 (14), 57 (23), 43 (12), 39 (45), 29 (13); HRMS (FAB+) calcd 
for C12H14O4N: 164.0917. Found: 164.0930. Anal. Calcd for C6H15NO4.5Cl: C, 34.54; H, 
7.27. Found C, 34.48; H, 6.89. 
 
(3aR,7aR)-2,2-Dimethyl-3a,7a-dihydrobenzo[d][1,3]dioxol-3a-yl)methanol (377). 
To a chilled solution of diene ester 355 (2.30 g, 9.65 mmol) in THF (65 mL) was added 
LiBH4 (252 mg, 11.5 mmol, 1.2 equiv) as a single portion and with stirring. The reaction 
mixture was allowed to warm to room temperature and was monitored by TLC analysis 
(hexanes/EtOAc 1:1). Upon consumption of 355 the reaction mixture was cooled to 0 ˚C 
and quenched with H2O (10 mL) over 2 mintues. The quenched mixture was filtered and 
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the filtrate concentrated in vacuo to remove THF. The aqueous mixture was extracted 
with EtOAc (2x) and the organic phases were then washed with H2O (1x), brine (1x), and 
then dried over Na2SO4. The organic phase was concentrated in vacuo to a clear and 
colorless oil that crystallized on standing at room temperature. The oily crystals were 
triturated with pentanes, the mother liquor decanted, and the crystalline 377 dried under 
vacuum to yield 1.46 g (83%) of white crystalline solid that required no further 
purification.69 
377: Rf = 0.39 (hexanes/EtOAc 1:1); mp 38 – 40 °C (hexanes/EtOAc); IR (film) 3462, 
3043, 2987, 2934, 2868, 1456, 1414, 1380, 1370, 1243, 1213, 1168, 1145, 1119, 1034, 
909, 864, 711 cm-1; 1H NMR (CDCl3, 300 MHz) δ 6.15-6.10 (m, 1H), 6.07-6.02 (m, 2H), 
5.71 (d, J = 9.60 Hz, 1H), 4.52 (d, J = 4.47 Hz, 1H), 3.61 (dd, J = 4.48, 11.65 Hz, 1H), 
3.38 (dd, J = 9.03, 11.68 Hz, 1H), 1.89 (dd, J = 4.56, 9.00 Hz, 1H), 1.48 (s, 3H), 1.40 (s, 
3H); 13C NMR (CDCl3, 75 MHz) δ 128.9, 125.3, 124.4, 123.5, 106.4, 80.5, 70.9, 64.2, 
27.1, 26.7; MS (+EI) m/z (%) 183 (3), 169 (5), 151 (27), 135 (9), 97 (9), 95 (21), 94 (21), 
93 (34), 77 (13), 69 (12), 66 (11), 65 (27), 60 (40), 57 (12), 55 (18), 45 (54), 44 (96), 43 
(100).  
 
O-((3aR,7aR)-2,2-Dimethyl-3a,7a-dihydrobenzo[d][1,3]dioxol-3a-yl)methyl S-methyl 
carbonodithioate (382). 
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To a clear and colorless solution of alchol 377 (52 mg, 0.285 mmol) in THF (3 mL, 0.1 
M) at -62 ˚C was added carbon disulfide (68 µL, 1.14 mmol, 4.0 equiv) with stirring. To 
this chilled mixture was added a solution of 0.5 M potassium hexamethyldisilazane in 
toluene (1.2 mL, 0.570 mmol, 2.0 equiv) over 1 minute; the reaction mixture turned from 
clear/colorless to clear/dark yellow-orange and was stirred at decreased temperature (< -
52 ˚C) for 27 minutes before adding methyl iodide (141 µL, 2.28 mmol, 8.0 equiv) over 
40 seconds. The reaction mixture slowly turned bright yellow and hazy and starting 
material was consumed after 20 minutes based on TLC analysis (hexanes/EtOAc 4:1, 
CAM); reaction mixture at -42 ˚C. The reaction was quenched with aqueous ammonium 
chloride (sat’d, 3 mL) at -32 ˚C and was allowed to stir to room temperature. The phases 
were separated and the aqueous phase extracted with EtOAc (3x). The organic phase was 
then washed with a small amount of H2O (1x), brine (1x), was dried over Na2SO4, filtered 
and concentrated in vacuo to an orange oil, 74 mg. The crude material was 
chromatographed on silica gel (hexanes/EtOAc 8:1 → 4:1) to yield xanthate 382 (63 mg, 
82%) as an orange oil.  
382: Rf = 0.65 (hexanes/EtOAc 4:1); [α]D20 = -296.1 (c = 1.1, CHCl3); IR (film) ν 2986, 
2932, 1413, 1370, 1230, 1213, 1072 cm-1; 1H NMR (600 MHz, CDCl3) δ 6.16 (dd, J = 
5.6, 9.4 Hz, 1H), 6.07 (m, 2H), 5.77 (d, J = 9.5 Hz, 1H), 4.62 (d, J = 11.3 Hz, 1H), 4.52 
(d, J = 11.3 Hz, 2H), 4.52 (d, J = 4.6 Hz, 2H), 2.58 (s, 3H), 1.49 (s, 3H), 1.41 (s, 3H); 13C 
NMR (75 MHz, CDCl3) δ 215.7, 127.7, 125.3, 124.4, 123.5, 106.8, 78.2, 74.5, 71.9, 27.1, 
26.4, 19.1;MS (+EI) m/z (%) 272 (5), 164 (23), 151 (13), 149 (20), 121 (10), 108 (13), 
107 (100), 106 (30), 94 (19), 93 (32), 91 (49), 79 (39), 78 (33), 77 (35), 65 (17), 60 (47), 
58 (20), 48 (23), 47 (34), 45 (20), 43 (81); HRMS (+EI) calcd for C12H16O3S2: 272.0541. 
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Found: 272.0535; Anal. Calcd for C12H16O3S2: C, 52.91; H, 5.92. Found C, 52.98; H, 
5.88. 
 
Methyl (1S,4R,7S,8R)-10,10-dimethyl-3.9.11-trioxatricyclo[6.3.0.0]undec-5-ene-7-
carbodithioate (384). 
To a clear and orange, degassed solution of xanthate 382 (59 mg, 0.215 mmol) in 
benzene (1 mL) was added tributyltin hydride (145 µL, 0.539 mmol, 2.5 equiv) and the 
reaction mixture was warmed. AIBN (2 mg) was added and the reaction mixture was 
heated to reflux with stirring. The reaction was monitored by TLC analysis 
(hexanes/EtOAc 4:1) until consumption of 382 was observed (ca. 6 h). The reaction was 
cooled to room temperature and the yellow-white slurry was adsorbed onto Celite and the 
solvent was removed in vacuo. The mixture was purified by silica gel chromatography 
(hexanes/EtOAc 7:1 → 4:1) and 3 mg of 384 (5%) was obtained as a light yellow oil.  
384: Rf = 0.3 (hexanes/EtOAc 4:1); 1H NMR (300 MHz, CDCl3) δ 6.13 (dd, J = 5.0, 9.8 
Hz, 1H), 6.03 (dd, J = 5.3, 9.8 Hz, 1H), 5.78 (d, J = 9.6 Hz, 1H), 5.32 (s, 1H), 4.47 (d, J = 
4.6 Hz, 1H), 3.35 (d, J = 10.5 Hz, 1H), 3.18 (d, J = 10.4 Hz, 1H), 1.54 (s, 1H), 1.35 (s, 
1H); 13C (150 MHz, acetone-d6) δ 133.3, 126.3, 109.6, 103.1, 86.1, 85.8, 72.1, 49.7, 38.7, 
31.4, 25.8, 25.7, 22.4, 12.0; MS (+EI) m/z (%) 272 (30), 164 (31), 151 (14), 150 (10), 149 
(36), 143 (20), 139 (11), 137 (11), 135 (11),  133 (9), 123 (9), 122 (8), 121 (15), 118 (11), 
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113 (17), 111 (15), 110 (13), 109 (18), 108 (12), 107 (78), 106 (32), 105 (22), 97 (40), 94 
(11), 93 (22), 91 (32), 89 (9), 85 (11), 84 (14), 79 (40), 78 (28), 77 (48), 76 (11), 75 (35), 
71 (11), 69 (12), 65 (18), 61 (11), 59 (11), 58 (22), 57 (12), 55 (12), 53 (10), 51 (14), 48 
(15), 47 (26), 45 (34), 43 (100), 41 (19). 
 
Methyl (3aR,5aR,6aR,6bR)-2,2-dimethyl-5a,6a-dihydrooxireno[e][1,3]benzodioxole-
6b(3aH)-carboxylate (395). 
To a solution of bromo lactone 397 (1.01 g, 3.67 mmol) in anhydrous MeOH (36 mL, 0.1 
M) at room temperature was added a solution of NaOMe (198 mg, 3.67 mmol) in 
anhydrous MeOH (4 mL, 0.92 M) over 5 minutes.  The reaction was monitored by TLC 
analysis (hexane/EtOAc 4:1, CAM) until consumption of starting material was observed 
(15 minutes). The reaction mixture turned from an initial clear and colorless solution to a 
clear and gold color after addition of NaOMe. The reaction mixture was concentrated to 
dryness and reconstituted in EtOAc. The crude organic mixture was washed with small 
portions of H2O (2 x 5 mL) and the organic phase was subsequently dried over anhydrous 
Na2SO4, filtered, and concentrated to dryness to give 761 mg of crude product as a gold 
oil. The crude material was chromatographed on silica gel (5:1 → 4:1 hexanes/EtOAc) to 
yield 483 mg (58% yield) of epoxy methyl ester 395 as a soft white solid.  
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395: Rf = 0.37 (4:1 hexanes/EtOAc); mp = 65 - 66 °C (CHCl3); [α]D20 = -130.2 (c 1.0, 
CHCl3); FT-IR (film) ν 2992, 2950, 1742, 1435, 1371, 1253, 1209, 1097, 1061, 1042, 
858, 776 cm-1; 1H NMR (CDCl3, 300 MHz) δ 6.16 (ddd, J = 1.71, 0.01, 10.15 Hz, 1 H), 
5.97 (ddd, J = 1.13, 2.59, 10.15 Hz, 1H), 5.01 (t, J = 2.15 Hz, 1H), 3.91 (s, 3H), 3.71 (d, J 
= 3.78  Hz, 1H), 3.45 (dt, J = 1.07, 1.88 Hz, 1H), 1.43 (s, 3H), 1.41 (s, 3H). 13C NMR 
(CDCl3, 75 MHz) δ 171.7, 132.9, 123.5, 113.00, 80.4, 72.3, 53.2, 51.5, 47.1, 28.2, 27.2; 
MS (EI+) m/z (%) 211(36), 169 (9), 167 (100), 137 (24), 109 (64), 81 (75), 59 (17), 53 
(33), 43 (87), 41 (8); HRMS calcd. for C11H14O5: 226.0841; Found: 227.0919 (M+1). 
Anal calcd.: C 58.40, H 6.24. Found: C 58.14, H 6.22.  
 
[(3aR,5aR,6aR,6bR)-2,2-Dimethyl-5a,6a-dihydrooxireno[e][1,3]benzodioxol-
6b(3aH)-yl]methanol (406). 
To a chilled solution (ice-bath) of epoxy ester 395 (634 mg, 2.80 mmol) in anhydrous 
MeOH (14 mL) was added NaBH4 (1.06 g, 28.0 mmol) with stirring. The reaction was 
kept at ~5 °C (ice-bath) and monitored by TLC analysis for 2 hours prior to quenching 
with NH4Cl (saturated solution, 2.5 mL) at 0 °C. The quenched reaction mixture was 
allowed to warm to room temperature with stirring and the resultant white slurry was 
filtered and washed with EtOAc. The filtrate was concentrated in vacuo and extracted 
with EtOAc (5 x 4mL), the organic phases were combined, dried over anhydrous Na2SO4, 
filtered and concentrated to yield a light brown oil with a mass of 503 mg. The crude 
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material was subjected to silica gel chromatography (1:1 hexanes/EtOAc) to yield 360 
mg (65%) of alcohol 406 as a white solid.  
406: Rf = 0.45 (hexanes/EtOAc 1:1, CAM); mp = 61 – 63 °C (CHCl3); [α]D20 = 69.6 (c 
0.95, CHCl3); FT-IR (film) ν 3480, 2991, 2928, 1370, 1240, 1217, 1160, 1055, 998, 896, 
836 cm-1; 1H NMR (CDCl3, 300 MHz) δ 6.19 (ddd, J = 1.45, 3.79, 10.09 Hz, 1H), 6.00 
(ddd, J = 1.03, 3.02, 10.11 Hz, 1H), 4.24 (dd, J = 1.44, 3.03 Hz, 1H), 3.84 (m, 2H), 3.62 
(d, J = 3.75 Hz, 1H), 3.45 (td, J = 0.93, 3.75 Hz, 1H), 2.12 (dd, J = 4.65, 8.55 Hz, 1H); 
13C NMR (CDCl3,  75 MHz) δ 132.8, 124.8, 111.7, 79.5, 72.6, 66.6, 51.9, 47.4,  28.7, 
28.5; MS (EI+) m/z (%) 199 (12), 183 (11), 167 (19), 165 (14), 155 (33), 153 (15), 152 
(21), 149 (10), 141 (39), 139 (18), 138 (41), 137 (28), 135 (14), 129 (10), 128 (10), 127 
(11), 125 (14), 124 (19), 123 (39), 121 (22), 120 (25), 119 (12), 115 (16), 113 (15), 111 
(40), 110 (11), 109 (36), 108 (19), 107 (61), 106 (15), 105 (32), 97 (21), 95 (46), 93 (22), 
90 (40), 89 (63), 81 (46), 79 (26), 71 (30), 69 (66), 65 (28), 59 (42), 55 (67), 43 (100), 41 
(51), 39 (36), 29 (19); HRMS calcd. for C9H11O4 (M-CH3): 183.0657, Found : 183.0657; 
Anal cald.: C 60.59, H 7.12. Found: C 60.38, H 7.17. 
 
tert-Butyl (((3aR,5aR,6aR,6bR)-2,2-dimethyl-5a,6a-
dihydrooxireno[2’,3’:3,4]benzo[1,2-d][1,3]dioxol-6b(3aH) yl)methoxy)dimethylsilane 
(408). 
198 
 
To a solution of alcohol 406 (700 mg, 3.53 mmol) in anhydrous DMF (6.6 mL) was 
added imidazole (312 mg, 4.59 mmol) with stirring. To this mixture was added t-
butyldimethylsilyl chloride (691 mg, 4.59 mmol) and the reaction was monitored by TLC 
analysis (hexanes/EtOAc 1:1, CAM) and deemed complete after 45 minutes. The reaction 
mixture was diluted with water (30 mL) and allowed to stir for several minutes. The 
aqueous phase was extracted with Et2O (4 x 7 mL), the organic phases were combined, 
dried over MgSO4, filtered and concentrated to yield 1.05 g (95%) of TBS-protected 
epoxide 408 as a colorless oil that needed no further purification. An analytical sample 
was prepared by passing through a plug of silica gel. 
408: Rf = 0.87 (hexanes/EtOAc 1:1);  [α]D20 = -54.9 (c 0.95, CHCl3); FT-IR (film) 3685, 
3020, 2400, 2253, 1794, 1523, 1474, 1425, 1382, 1212, 1097, 907, 780 cm-1; 1H NMR 
(CDCl3, 300 MHz) δ 6.16 (ddd, J = 1.47, 3.81, 10.08 Hz, 1H), 5.94 (ddd, J = 1.10, 2.94, 
10.08 Hz, 1H), 4.20 (dd, J = 1.50, 2.88 Hz, 1H), 3.84 (dd, J = 10.52, 23.88 Hz, 2H), 3.58 
(d, J = 3.78 Hz, 1H), 3.40 (dt, J = 0.98, 1.89 Hz, 1H), 1.48 (s, 3H), 1.38 (s, 3H), 0.95 (s, 
9H), 0.13 (s, 6H); 13C (CDCl3, 75 MHz) δ 132.9, 124.7, 111.6, 80.3, 77.2, 77.0, 76.8, 
72.5, 66.9, 51.7, 47.1, 28.8, 28.7, 25.9, 18.5, -5.3, -5.4; MS (FAB) m/z (%) 313 (7), 297 
(10), 255 (38), 239 (11) 209 (24), 198 (13), 197 (60), 181 (12), 179 (11), 169 (55), 167 
(83), 151 (54), 139 (20), 129 (20), 123 (68), 115 (43), 109 (24), 89 (70), 81 (70), 73 
(100), 59 (68), 43 (60), 29 (20); HRMS calcd. for C16H28O4Si: 312.1757, Found: 
313.1835; Anal calcd.: C 61.50, H 9.03. Found: C 61.48, H 8.99.  
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2-((3aS,4R,5S,7aR)-3a-((tert-Butyldimethylsilyoxy)methyl)-4-hydroxy-2,2-dimethyl-
3a,4,5,7a-tetrahydrobenzo[d][1,3]dioxol-5-yl)acetonitrile (409). 
To a solution of nBuLi (2.3 M in hexanes) in THF (11 mL) at -72 °C (external 
temperature) was added anhydrous acetonitrile (0.93 mL) over 1 minute with vigorous 
stirring; the clear and colorless mixture slowly turned to a slightly off-white (yellow) 
slurry within a minute of addition of acetonitrile. The reaction mixture was allowed to stir 
at < -65 °C for 35 minutes prior to cooling the mixture to -83 °C and performing the 
addition of epoxide 408 (930 mg, 2.97 mmol) in anhydrous THF (10 mL) over 10 
minutes (temperature after addition was -75 °C). The reaction was allowed to warm to -
55 °C at which point the reaction mixture became homogeneous and orange in color. The 
reaction vessel was moved to an ice-bath and the reaction was monitored by TLC 
analysis (hexanes/EtOAc 5:1, CAM). Starting material 408 was consumed approximately 
20 minutes after warming to 0 °C. The reaction mixture was quenched with NH4Cl (sat’d 
aqueous solution, 1.5 mL) at 0 °C at which point the mixture turned from dark orange to 
light yellow color. Water (6 mL) was added and the aqueous mixture was stirred at 0 °C 
for several minutes, warming to room temperature. The phases were allowed to separate 
and the aqueous layer (pH 8) extracted with EtOAc (3x). The organic phases were 
combined, dried over Na2SO4, filtered and concentrated to yield 1.37 g of an orange oil. 
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The crude mixture was purified by silica gel chromatography (hexanes/EtOAc 5:1 → 3:1) 
and provided 840 mg (80%) alcohol 409 as a very viscous, colorless oil.  
409: Rf = 0.31 (3:1 hexanes/EtOAc); [α]D20 = -54.9 (c 1, CHCl3); FT-IR (film) ν 3437, 
2930, 2857, 2246, 1471, 1381, 1253, 1216, 1158, 1095, 1055, 839 cm-1; 1H NMR 
(CDCl3, 300 MHz) δ 5.99 (ddd, J = 2.52, 3.95, 9.96 Hz, 1H), 5.89 (d, J = 10.17 Hz, 1H), 
4.51 (d, J = 3.87 Hz, 1H), 3.85 (dd, J = 10.97, 16.22 Hz, 2H), 3.63 (dd, J = 4.38, 10.11 
Hz, 1H), 3.08 (d, J = 4.53 Hz, 1H), 2.87 (dd, J = 4.11, 16.57 Hz, 1H), 2.64 (m, J = 3.40 
Hz, 1H), 2.41 (dd, J = 9.00, 16.57 Hz, 1H), 1.52 (s, 3H), 1.44 (s, 3H), 0.90 (s, 9H), 0.10 
(s, 3H), 0.09 (s, 3H); 13C NMR (CDCl3, 75 MHz) δ 131.3, 125.5, 118.2, 110.1, 82.5, 
75.1, 74.3, 62.8, 38.7, 28.7, 26.5, 25.8, 20.0, 18.2, -5.6, -5.7; MS (EI+) m/z (%) 338 (6), 
238 (24), 220 (16), 209 (13), 208 (73), 191 (11), 190 (61), 167 (18), 105 (16), 89 (21), 75 
(100), 73 (46), 59 (42), 43 (27), 41 (10); HRMS calcd. for C17H28O4NSi (M-CH3): 
338.1788, Found: 338.17796; Anal calcd.: C 61.15, H 8.84. Found C 61.26, H 8.82. 
 
2-((3aR,5S,7aR)-3a-((tert-Butyldimethysilyloxy)methyl)-2,2-dimethyl-4-oxo-
3a,4,5,7a-tetrahydrobenzo[d][1,3]dioxol-5-yl)acetonitrile (444). 
A solution of alcohol 409 (12 mg, 0.033 mmol) in methylene chloride (0.5 mL) was 
chilled in an ice-bath and DMP (28 mg, 0.067 mmol) was added as one portion. The 
reaction mixture was removed from the ice-bath after 15 minutes and allowed to warm to 
room temperature. The reaction was monitored by TLC analysis (hexanes/EtOAc 3:1, 
O
O
OTBS
O
CN
444
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CAM) and starting material was consumed after an additional portion of DMP (7 mg, 
0.015 mmol) was added and stirred overnight. The reaction mixture appeared as a white 
slurry and diluted with Et2O (1 mL), filtered, and the filtered solid washed with Et2O (1 x 
1 mL, 1 x 0.5 mL). The filtrate was washed with NaHCO3 (10% aqueous solution, 2 x 0.2 
mL), water (1 x 0.2 mL), and brine (1 x 0.2 mL). The organics were dried over MgSO4, 
filtered, and concentrated to provide 9 mg (81%) of a white crystalline solid, identified as 
ketone 444. 
444: Rf = 0.44 (hexanes/EtOAc 3:1); [α]D20 = -63.5 (c 0.3, CHCl3); IR (film) ν 2930, 
2857, 2247, 1734, 1470, 1380, 1254, 1218, 1097, 838, 780 cm-1; 1H NMR (300 MHz, 
CDCl3) δ 6.14 (td, J = 3.5, 10.0 Hz, 1H), 5.99 (dd, J = 2.1, 10.0 Hz, 1H), 4.82 (dd, J = 
1.3, 3.8 Hz, 1H), 3.89 (d, J = 10.5 Hz, 1H), 3.80 (d, J = 10.2 Hz, 1H), 3.56 (m, J = 3.1 
Hz, 1H), 2.90 (dd, J = 5.2, 17.3 Hz, 1H), 2.53 (dd, J = 8.9, 17.1 Hz, 1H), 1.40 (s, 6H), 
0.87 (s, 9H), 0.08 (s, 3H), 0.06 (s, 3H); 13C NMR (CDCl3, 75 MHz) δ 204.1, 129.2, 
127.3, 117.8, 110.9, 85.9, 78.9, 66.4, 44.8, 27.4, 26.5, 25.7, 18.1, 17.4, -5.6; MS (+EI) 
m/z (%) 336 (4), 248 (15), 236 (51), 208 (38), 207 (18), 206 (100), 204 (11), 190 (15), 
179 (24), 178 (29), 167 (14), 166 (38), 151 (18), 120 (54), 115 (11), 89 (36), 77 (11), 75 
(85), 73 (71), 65 (10), 59 (23), 58 (18), 57 (17), 45 (15), 43 (64), 41 (19); HRMS (+EI) 
calcd for C18H29NO4Si: 336.1625. Found 336.1631. 
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2-((3aS,4R,5S,7aR)-4-Hydroxy-3a-(hydroxymethyl)-2,2-dimethyl-3a,4,5,7a-
tetrahydrobenzo[d][1,3]dioxol-5-yl)acetonitrile (410). 
To a solution of TBS-protected alcohol 409 (466 mg, 1.31 mmol) in THF (13 mL) at 
room temperature was added a 1.0 M solution of tetrabutylammonium fluoride in THF 
(3.95 mL, 3.95 mmol) with stirring. The clear and colorless mixture turned to a clear and 
light brown color upon addition of TBAF and the reaction was monitored by TLC 
analysis (EtOAc). After 30 minutes the reaction mixture was quenched at room 
temperature with a saturated solution of NH4Cl (1 mL) and concentrated in vacuo. The 
concentrated reaction mixture was diluted with H2O and extracted with EtOAc (3x). The 
organic phases were combined, concentrated, passed through a plug of silica gel and 
eluted with EtOAc. The organic phase was dried over MgSO4 and concentrated to yield 
226 mg (72%) of diol 410 as a low melting white solid that required no further 
purification.  
410: Rf = 0.43 (EtOAc); [α]D20 = -27.9 (c 1.0, CHCl3); FT-IR (film) ν 3343, 3219, 2983, 
2890, 2236, 1426, 1366, 1220, 1164, 1072, 1047, 1034, 913, 866, 768, 744, 663 cm-1; 1H 
NMR (600 MHz, CDCl3) δ 6.02 (ddd, J = 2.4, 4.2, 10.0 Hz, 1H), 5.92 (d, J = 10.0 Hz, 
1H), 4.54 (d, J = 4.2 Hz, 1H), 4.06 (dd, J = 3.2, 12.1 Hz, 1H), 3.74 (dd, J = 3.8, 9.9 Hz, 
1H), 3.56 (dd, J = 9.0, 12.0 Hz, 1H), 2.87 (dd, J = 3.4, 15.9 Hz, 1H), 2.68 (d, J = 4.4 Hz, 
1H), 2.49 (m, J = 9.6 Hz, 2H), 2.03 (dd, J = 3.6, 9.1 Hz, 1H), 1.56 (s, 3H), 1.48 (s, 3H) ; 
13C NMR (CDCl3, 150 MHz) δ 131.3, 125.2, 110.4, 83.0, 74.4, 73.7, 60.1, 41.5, 38.2, 
28.9, 26.6, 20.0; MS (+EI) m/z (%) 338 (9), 323 (18), 238 (27), 221 (10), 209 (20), 208 
(85), 193 (16), 169 (22), 105 (13), 89 (34), 75 (100), 73 (55), 59 (48), 41 (10); HRMS 
calcd for C11H14O4N (M-CH3) 224.0923, Found: 224.0964. 
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2-((4aR7aR,10S,10aR)-2,2,6,6-Tetramethyl-10,10a-dihydro-4H,7aH-
[1,3]dioxolo[4’5’:2,3]benzo[1,2-d][1,3]dioxin-10-yl)acetonitrile (411). 
To a mixture of diol 410 (220 mg, 0.835 mmol) and 2,2-dimethoxypropane (1.02 mL, 
8.35 mmol) in acetone (8.3 mL) at room temperature was added a catalytic amount of p-
toluenesulfonic acid monohydrate (15 mg) with stirring. The reaction was monitored by 
TLC analysis (hexanes/EtOAc 1:1) and 410 was observed to be consumed after 95 
minutes. The reaction mixture was quenched with a 10% aqueous solution of NaHCO3 (2 
mL), concentrated and subsequently re-diluted with EtOAc and H2O. The phases were 
separated and the aqueous phase extracted with EtOAc (2x). The combined organic 
phases were dried over MgSO4 and concentrated to provide 229 mg (98%) of a light 
brown oil as bisacetonide 411 that was used without further purification and prolonged 
storage. 
411:  Rf = 0.73 (hexanes/EtOAc 1:1); [α]D18 = 18.0 (c 2.4, CHCl3); FT-IR (film) ν 2993, 
2938, 2878, 2248, 1595, 1383, 1371, 1236, 1076, 1043, 857, 665 cm-1; 1H NMR (600 
MHz, CDCl3) δ 5.92 (d, J = 10.0 Hz, 1H), 5.83 (dd, J = 4.4, 10.3 Hz, 1H), 4.80 (s, 1H), 
4.23 (s, 1H), 3.82 (d, J = 11.2 Hz, 1H), 3.75 (d, J = 11.3 Hz, 1H), 2.76 (dd, J = 8.7, 16.6 
Hz, 1H), 2.63 (dd, J = 7.8, 16.5 Hz, 1H), 2.55 (q, J = 6.6 Hz, 1H), 1.56 (s, 3H), 1.40 (s, 
3H), 1.39 (s, 3H), 1.38 (s, 3H); 13C NMR (150 MHz, CDCl3) δ 128.3, 126.2, 118.3, 
110.7, 99.0, 75.2, 73.5, 69.5, 65.7, 37.0, 30.3, 29.1, 28.5, 21.0, 18.5. 
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2-((4aR7aR,10S,10aR)-2,2,6,6-Tetramethyl-10,10a-dihydro-4H,7aH-
[1,3]dioxolo[4’5’:2,3]benzo[1,2-d][1,3]dioxin-10-yl)acetic acid (412). 
A white slurry of crude nitrile 411 (191 mg, 0.683 mmol) in a mixture of aqueous NaOH 
(15% w/w, 4.5 mL) and MeOH (2.7 mL) was heated to reflux for 40 minutes while 
monitored by TLC analysis (hexanes/EtOAc 1:1). Upon consumption of 411 the reaction 
was cooled to 0 °C in an ice-bath and neutralized with 6 M HCl. The neutral mixture was 
extracted with DCM (4x) and EtOAc (2x), the combined organic phases dried over 
Na2SO4 and concentrated to yield 197 mg (97%) of an off-white, foam-like solid 412. 
The material required no further purification. An analytical sample was acquired by silica 
gel chromatography (EtOAc) as a sticky (hygroscopic) white solid. 
412: Rf = 0.61 (streak, EtOAc); [α]D20 = -92.0 (c 1, CHCl3); IR (film)  ν 3192, 2993, 
2938, 1733, 1709, 1382, 1289, 1236, 1160, 1076, 920, 858, 734, 519 cm-1; 1H NMR 
(CDCl3, 300 MHz) δ 10.85 (s, 1H), 5.78 (m, 2H), 4.76 (s, 1H), 4.19 (s, 1H), 3.78 (d, J = 
11.16 Hz, 1H), 3.71 (d, J = 11.19 Hz, 1H) 2.80 (dd, J = 7.59, 15.76 Hz, 1H), 2.62 – 2.68 
(m, 1H), 2.56 (dd, J = 6.62, 15.71 Hz, 1H) 1.51 (s, 3H), 1.40 (s, 3H), 1.37 (s, 3H), 1.35 
(s, 3H); 13C NMR (CDCl3, 75 MHz) δ 177.8, 128.3, 126.4, 110.5, 98.8, 75.4, 73.6, 70.2, 
65.8, 36.8, 36.3, 30.3, 29.0, 28.4, 18.6; MS (+EI) m/z (%) 283 (36), 282 (26), 225 (19), 
223 (11), 182 (26), 181 (20), 169 (23), 168 (12), 165 (52), 164 (79), 163 (13), 152 (100), 
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151 (27), 137 (25), 123 (26), 120 (21), 108 (84), 107 (69), 95 (28), 91 (32), 83 (17), 81 
(22), 79 (46), 77 (37), 65 (15), 55 (12), 53 (13), 43 (97); HRMS (+EI) calcd for 
C14H19O6: 283.1176. Found 283.1181. 
 
N-Acetoxy-N-allylacetamide (416). 
To a solution of 415 (2.0 g, 17.0 mmol) in anhydrous DMF (80 mL) at room temperature 
was added K2CO3 (2.1 g, 15.4 mmol, 1.1 equiv) with stirring. To this mixture was added 
allyl bromide (2.2 mL, 25.5 mmol, 1.5 equiv) as a single portion and the reaction was 
monitored by TLC analysis (hexanes/EtOAc 1:1). Upon consumption of 415 the reaction 
mixture was filtered and the  DMF was distilled under reduced pressure. The crude 
material was purified by silica gel chromatography (hexanes/EtOAc 1:1) and yielded 1.20 
g (46%) of 416 as a light brown, non-viscous oil whose spectral data matched literature 
values.270, 282 
416: 1H NMR (300 MHz, CDCl3) δ 5.90 – 5.77 (m, 1H), 5.30 – 5.22 (m, 2H), 4.32 (d, J = 
6.1 Hz, 2H), 2.20 (s, 3H), 2.06 (s, 3H).270, 282 
 
N-allylhydroxylamine (413). A solution of 416 (2.26 g, 14.3 mmol) in 3 M aqueous HCl 
(32 mL) was heated to reflux and monitored by TLC analysis (hexanes/EtOAc 1:1) until 
the consumption of 416 was observed (ca 1.5 h). The reaction mixture (clear and 
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colorless) was made alkaline with 6 M aqueous NaOH and extracted with Et2O (5x). The 
organic phase was dried over MgSO4, filtered and concentrated to yield 0.64 g (61%) of 
413 as colorless needle-like crystals.282 
413: 1H NMR (300 MHz, CDCl3) δ 5.94 (tdd, J = 6.4, 10.4 Hz, 17.2, 1H), 5.91 (td, J = 
6.4, 10.2 Hz, 1H), 5.32 – 5.20 (m, 2H), 3.59 (t, J = 1.1 Hz, 1H), 3.57 (t, J = 1.3 Hz, 1H); 
13C NMR (75 MHz, CDCl3) δ 133.8, 118.5, 56.6.282 
 
3-bromo-2-chloroprop-1-ene (432). 
To a slurry of NaBr (11.6 g, 112 mmol) in anhydrous DMF (100 mL) at room 
temperature was added 2,3-dichloropropene (4.1 mL, 45 mmol) with stirring. The 
reaction mixture was heated to 90 ˚C at which point the reaction mixture turned into a 
thick white slurry. After stirring at 90 ˚C for 16 h the reaction mixture was quenched with 
H2O (50 mL). The aqueous phase was extracted with pentanes (3 x 100 mL) and the 
organic phases were collected ad concentrated under reduced pressure at 0 – 5 ˚C. The 
crude material was distilled under reduced pressure to obtain 1.02 g (15%) of 432 as a 
colorless liquid that was used without further purification.  
432: 1H NMR (300 MHz, CDCl3) δ 5.61 (s, 1H), 5.42 (d, J = 1.9 Hz, 1H), 4.11 (s, 2H). 
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N-Acetoxy-N-(2-chloroallyl)acetamide (433). 
To a reaction slurry that contained K2CO3 (0.91 g, 6.62 mmol), N,O-bisacetate 415 (0.62 
g, 5.30 mmol), and DMF (10 mL) was added the freshly prepared vinyl chloride 432 
(0.99 g, 6.36 mmol) with stirring and at room temperature. Upon consumption of 415, as 
indicated by TLC (hexanes/EtOAc 1:1), the reaction mixture was filtered the DMF was 
distilled under reduced pressure. The remaining mother liquor was chromatographed on 
silica gel (hexanes/EtOAc 1:1) and afforded 0.42 g (35%) of 433 as a colorless oil that 
corresponded with the values reported in the literature. The remaining material was 
present as contaminated material in other chromatography fractions.8 
433: 1H NMR (300 MHz, CDCl3) δ 5.42 (d, J = 2.7 Hz, 2H), 4.48 (bs, 2H), 2.22 (s, 3H), 
2.09 (s, 3H); 13C NMR (150 MHz, CDCl3) δ 168.2, 135.4, 118.2, 115.7, 115.6, 20.1, 
18.3.8 
 
N-Allyl-N-hydroxy-2-((4aR,7aR,10S,10aR)-2,2,6,6-tetramethyl-10,10a-dihydro-
4H,7aH-[1,3]dioxolo[4’,5’:2,3]benzo[1,2-d][1,3]dioxin-10yl)acetamide (419). 
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To a chilled solution of carboxylic acid 412 (254 mg, 0.851 mmol) in THF (8.5 mL) was 
added triethylamine (130 μL, 0.936 mmol) followed by isobutyl chloroformate (122 μL, 
0.936 mmol). The clear and colorless solution immediately turned to a white slurry upon 
addition of isobutyl chloroformate. The reaction mixture was stirred at 0 °C until 
consumption of 412 was observed by TLC (hexanes/EtOAc 1:1) (10 minutes). A solution 
of N-allylhydroxylamine 413 (62 mg, 0.851) in THF (0.5 mL) was added to the cooled 
reaction mixture and the reaction was monitored by TLC (hexanes/EtOAc 1:1). After 5 
minutes the reaction mixture was filtered and the filtered solid was washed with EtOAc. 
The filtrate was concentrated in vacuo to provide the crude material as a colorless oil 
(350 mg). The crude material was chromatographed on silica gel (hexanes/EtOAc 1:1) to 
yield 419 (170 mg, 56%) as a colorless oil.  
419: Rf = 0.34 (hexanes/EtOAc 1:1); [α]D20 = +25.3 (c 0.45, CHCl3); IR (film) υ 3685, 
3020, 2430, 2400, 1602, 1521, 1476, 1423, 1384, 1208, 1075, 1015, 928, 850, 731, 669 
cm-1; 1H NMR (600 MHz, DMSO) δ 9.71 (s, 1H), 5.84 – 5.74 (m, 1H), 5.72 (dd, J = 4.5, 
10.3 Hz, 1H), 5.66 (dd, J = 1.7, 10.3 Hz, 1H), 5.23 – 5.13 (m, 1H), 4.59 – 4.55 (m, 1H), 
4.19 – 4.06 (m, 2H), 3.63 (s, 1H), 2.77 (dd, J = 7.6, 16.7 Hz, 1H), 2.62 (dd, J = 7.0, 16.5 
Hz, 1H), 2.56 – 2.52 (m, 1H), 1.43 (s, 3H), 1.34 (s, 3H), 1.30 (s, 3H), 1.24 (s, 3H); 13C 
NMR (150 MHz, DMSO) δ 171.9, 133.4, 130.4, 125.7, 117.8, 110.1, 98.5, 79.7, 75.6, 
73.5, 70.6, 65.8, 50.8, 36.2, 35.1, 30.6, 29.4, 28.8, 19.1; MS (+EI) m/z (%) 352 (1), 338 
(15), 322 (22), 295 (18), 220 (41), 204 (28), 164 (28), 147 (66), 135 (28), 107 (59), 56 
(48), 43 (97), 41 (100); HRMS (+EI) calcd for C17H24O6N: 338.1598. Found 338.1604. 
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N-Acetoxy-N-allyl-2-((4aR,7aR,10S,10aR)-2,2,6,6-tetramethyl-10,10a-dihydro-
4H,7aH-[1,3]dioxolo[4’,5’:2,3]benzo[1,2-d][1,3]dioxin-10yl)acetamide (385). 
To a chilled (ice-bath) solution of carboxylic acid 397 (27 mg, 0.090 mmol) in THF (0.9 
mL) was added Et3N (12 μL, 0.090 mmol) with stirring. The mixture was allowed to stir 
for 10 minutes prior to addition of isobutyl chloroformate (13 μL, 0.099 mmol); the 
reaction mixture turned from clear and colorless to a hazy-white slurry. After 15 minutes 
another portion of Et3N (24 μL, 0.180 mmol) was added followed by freshly prepared N-
allyl-O-acetyl hydroxylamine 417 (exess) in THF (0.2 mL) dropwise over 1 minute. The 
evolution of gas (CO2, isobutylene) was observed and the reaction mixture remained as a 
white slurry. The reaction was monitored by TLC analysis (hexanes/EtOAc 3:1) and was 
allowed to warm to room temperature over several hours while stirred in an ice-bath. 
After 18.5 hours the reaction mixture (white slurry) was filtered and the filtered solid was 
washed with Et2O. The filtrate was concentrated to dryness and the crude material was 
chromatographed as a complex mixture on silica gel (hexanes/EtOAc 2:1) to yield 2 mg 
(6%) of analytically pure 385 (more material available as impure fractions). 
385: Rf = 0.27 (hexanes/EtOAc 3:1); [α]D20 = +49.3 (c 0.3, CHCl3); IR (film) ν 2992, 
2934, 2873, 1795, 1676, 1432, 1382, 1366, 1236, 1177, 1075 cm-1; 1H NMR (CDCl3, 600 
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MHz) δ 5.87-5.78 (m, 3H), 5.28-5.24 (m, 2H), 4.78 (s, 1H), 4.38-4.41 (m, 1H rotameric), 
4.25-4.31 (m, 1H, rotameric), 4.16 (s, 1H), 3.78 (d, J = 11.25 Hz, 1H), 3.71 (d, J = 11.25 
Hz, 1H), 2.80-2.77 (m, 2H), 2.40 (bs, 1H), 2.18 (s, 3H), 1.54 (s, 3H), 1.39 (s, 6H), 1.37 
(s, 3H); 13C NMR (CDCl3, 150 MHz) δ 171.6, 167.2, 131.3, 129.2, 126.2, 110.2, 98.8, 
75.6, 73.7, 70.1, 65.9, 34.9, 30.4, 29.1, 28.5, 18.6, 18.4; MS (+EI) m/z (%) 380 (13), 261 
(14), 223 (14), 165 (12), 164 (14), 147 (38), 137 (12), 136 (10), 135 (14), 134 (16), 120 
(16), 119 (22), 113 (13), 108 (14), 107 (33), 95 (12), 91 (23), 85 (14), 81 (18), 77 (18), 71 
(16), 69 (13), 59 (22), 56 (29), 55 (26), 43 (100), 42 (18), 41 (64); HRMS (+EI) calcd for 
C20H29NO7: 395.1938. Found 395.1944. 
 
N-(2-Chloroallyl)-N-hydroxy-2-((4aR,7aR,10S,10aR)-2,2,6,6-tetramethyl-10,10a-
dihydro-4H,7aH-[1,3]dioxolo[4’,5’:2,3]benzo[1,2-d][1,3]dioxin-10-yl)acetamide 
(434). 
To a clear and colorless solution of carboxylic acid 412 (1.42 g, 4.75 mmol) in THF (30 
mL) at 0 °C was added Et3N (729 μL, 5.23 mmol) followed by isobutyl chloroformate 
(684 μL, 5.23 mmol); upon addition of isobutyl chloroformate the reaction mixture 
became a white slurry. The reaction was monitored by TLC (hexanes/EtOAc 1:1) and the 
consumption of 412 was observed after 10 minutes. The reaction mixture was maintained 
434
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at 0 °C and N-(2-chloroallyl)hydroxylamine 430 (904 mg, 5.94 mmol) in THF (17 mL) 
was added over the course of 3 minutes; no appearance change or exotherm was 
observable. The reaction was monitored by TLC (hexanes/EtOAC 1:1) and filtered after 
45 minutes at 0 °C. The filtered solid was washed with EtOAc and the filtrate was 
concentrated in vacuo to provide an orange oil (2.74 g) that was chromatographed on 
silica gel (hexanes/EtOAc 1:1) to yield 434 (1.41 g, 69%) as a slightly off-white, 
hygroscopic foam after trituration with pentanes. The material decomposed upon 
standing and was used quickly after its preparation. 
434: Rf = 0.34 (hexanes/EtOAc 1:1); mp = 49 °C (pentanes); [α]D20 = +25.3 (c 0.45, 
CHCl3); IR (film) υ 3192, 2993, 2938, 1733, 1709, 1382, 1289, 1236, 1160, 1076, 920, 
858, 734, 519 cm-1; 1H NMR (300 MHz, CDCl3) δ 9.88 (s, 1H), 5.74 (dd, J = 4.2, 10.4 
Hz, 1H), 5.66 (dd, J = 2.3, 10.5 Hz, 1H), 5.44 (d, J = 14.8 Hz, 1H), 4.57 (bs, 1H), 4.38 
(d, J = 16.1 Hz, 1H), 4.29 (d, J = 16.0 Hz, 1H), 4.13 (s, 1H), 3.63 (s, 2H), 2.82 (dd, J= 
7.7, 16.4 Hz, 1H), 2.66 (dd, J = 7.2, 16.4 Hz, 1H), 2.56 (t, J = 5.5 Hz, 1H), 1.43 (s, 3H), 
1.34 (s, 3H), 1.30 (s, 3H), 1.24 (s, 3H); 13C NMR (75 MHz, DMSO) δ 170.7, 170.5, 
170.1, 155.9, 109.6, 81.9, 81.8, 78.3, 73.5, 64.8, 62.2, 62.0, 52.8, 28.3, 27.2, 26.0, 21.2, 
21.1, 20.9. 
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N-(Benzoyloxy)-N-(2-chloroallyl)-2-((4aR,7aR,10S,10aR)-2,2,6,6-tetramethyl-10,10a-
dihydro-4H,7aH-[1,3]dioxolo[4’,5’:2,3]benzo[1,2-d][1,3]dioxin-10-yl)acetamide 
(429).  
A solution of freshly prepared hydroxamic acid 434 (131 mg, 0.337 mmol) in methylene 
chloride (3.4 mL, 0.1 M) at 0 ˚C was added Et3N (140 µL, 1.01 mmol, 3.0 equiv) 
followed by BzCl (117 µL, 1.01 mmol, 3.0 equiv) with stirring. The reaction was 
monitored by TLC analysis (hexanes/EtOAc 3:1) and 434 was consumed after 10 
minutes. The reaction mixture was quenched with an aqueous NH4Cl solution (sat’d, 0.3 
mL) and H2O (1 mL) at 0 ˚C. The phases were separated and the organic phase washed 
with H2O (1x), brine (1x) and then dried over Na2SO4 prior to filtration and concentration 
in vacuo to yield 236 mg of crude material as an oily white preciptate. The material was 
chromatographed on silica gel (hexanes/EtOAc 3:1) and afforded 142 mg (86%) of 429 
as a white foam-like solid (hygroscopic) after trituration with pentanes.  
429: Rf = 0.40 (hexanes/EtOAc 3:1); [α]D20 = +18.1 (c 0.40, CHCl3); IR (liquid) ν 2994, 
2939, 1633, 1456, 1412, 1423, 1384, 1288, 1234, 1161, 1075, 1049, 918, 850, 763, 739 
cm-1; 1H NMR (300 MHz, DMSO) δ 8.07 – 7.87 (m, 1H), 7.67 (t, J = 7.5 Hz, 1H), 7.51 
(t, J = 7.7 Hz, 1H), 5.65 (dd, J = 4.4, 10.3 Hz, 1H), 5.56 (dd, J = 1.8, 10.4 Hz, 1H), 5.51 
(s, 1H), 5.37 (d, J = 1.8 Hz, 1H), 4.60 (d, J = 16.4 Hz, 1H), 4.53 (d, J = 16.4 Hz, 1H), 
4.46 (bs, 1H), 4.03 (s, 1H), 3.53 (s, 2H), 2.91 (s, 1H), 2.78 (dd, J = 8.1, 15.9 Hz, 1H), 
2.40 (dd, J = 6.4, 15.8, 1H), 1.36 (s, 3H), 1.16 (s, 3H), 1.05 (s, 3H), 0.98 (s, 3H); 13C 
NMR (75 MHz, DMSO) δ 164.3, 135.8, 135.03, 130.0, 129.5, 127.1, 126.3, 117.0, 110.0, 
98.7, 75.9, 73.6, 70.3, 66.1, 54.4, 36.7, 35.1, 30.2, 29.2, 28.4, 19.4; Anal calcd for 
C25H30NO7Cl: C, 61.03; H, 6.15. Found: C, 60.94; H, 6.21. 
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2-((3aR,7aR,E)-3a-((tert-Butyldimethylsilyloxy)methyl)-2,2-dimethyl-4-(2-
phenylhydrazono)-3a,4,7,7a-tetrahydrobenzo[d][1,3]dioxol-5-yl)acetonitrile (477). 
To a solution of 444 (30 mg, 0.085 mmol) in glacial HOAc (0.5 mL) was added 
phenylhydrazine (21 µL, 0.213 mmol, 2.5 equiv) at room temperature and with stirring. 
The reaction was heated to 95 ˚C and monitored by TLC analysis (hexanes/EtOAc 3:1). 
Ketone 444 was consumed after 2.5 h and the reaction was neutralized with a 1 M 
aqueous solution of NaOH. The aqueous mixture was extracted with methylene chloride 
(3 x 1 mL) and the combined organic phases were dried over Na2SO4, filtered and 
concentrated to yield 59 mg of crude material. Silica gel chromatography 
(hexanes/EtOAc 3:1) provided 23 mg (62%) of hydrazone 477 as an orange oil and 5 mg 
(17%) of enone 448 as a colorless oil. 
 
2-((3aR,7aR)-3a-((tert-Butyldimethylsilyloxy)methyl)-2,2-dimethyl-4-oxo-3a,4,7,7a-
tetrahydrobenzo[d][1,3]dioxol-5-yl)acetonitrile (448): Rf = 0.24 (hexanes/EtOAc 3:1); 
FT-IR (film) ν 2987, 2954, 2929, 2857, 2250, 1734, 1679, 1471, 1383, 1373, 1253, 1093, 
O
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1006, 991, 840, 779 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.07 (m, 1H), 4.57 (m, 1H), 
4.10 (d, J = 9.4 Hz, 1H), 3.68 (d, J = 9.4 Hz, 1H), 3.37 (m, 2H), 2.95 (m, 2H), 1.40 (s, 
3H), 1.31 (s, 3H), 0.83 (s, 9H), 0.04 (s, 3H), -0.02 (s, 3H). 
477: Rf = 0.57 (hexanes/EtOAc 3:1); FT-IR (film) ν 3318, 2928, 2850, 2247, 1737, 1603, 
1563, 1505, 1471, 1372, 1258, 1237, 1093, 840, 752 cm-1; 1H NMR (300 MHz, CDCl3) δ 
9.61 (s, 1H), 7.32 (d, J = 7.6 Hz, 2H), 7.10 (d, J = 7.4 Hz, 2H), 6.92 (t, J = 7.2 Hz, 1H), 
6.05 (m, J = 4.1 Hz, 1H), 4.44 (m, 1H), 4.04 (d, J = 10.7 Hz, 1H), 3.85 (d, J = 10.7 Hz, 
1H), 3.52 (bs, 2H), 2.76 (m, 2H), 1.48 (s, 3H), 1.36 (s, 3H), 0.87 (s, 9H), 0.05 (s, 3H), 
0.02 (s, 3H); MS (+EI) m/z (%) 443 (5), 442 (18), 441 (55), 326 (17), 238 (41), 234 (12), 
207 (16), 150 (19), 117 (11), 115 (15), 105 (13), 89 (48), 77 (45), 73 (100), 71 (17), 65 
(17), 59 (20), 57 (26), 43 (61), 41 (28); HRMS (+EI) calcd for C24H35N3O3Si: 441.2440. 
Found 441.2447. 
 
2-((3aS,4R,5R,7aR)-3a-((tert-Butyldimethylsilyloxy)methyl)-4-hydroxy-2,2-
dimethylhexahydrobenzo[d][1,3]dioxol-5-yl)acetonitrile (478). 
To a clear and colorless solution of alkene 409 (229 mg, 0.647 mmol) in absolute EtOH 
(6.5 mL, 0.1 M) at room temperature was added Pd/C (20 mg of a 10 wt% mixture, 10 
w/w%) and the reaction vessel was purged with H2 (1 atm). The reaction was monitored 
by TLC analysis (hexanes/EtOAc 3:1, CAM) and alkene 409 was consumed after 6 hours 
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and confirmed by crude NMR analysis. The reaction mixture was filtered through a pad 
of Celite and the filtrate concentrated in vacuo to yield a colorless oil, 213 mg (93%) 478, 
that required no further purification. An analytical sample was obtained by silica gel 
chromatography (hexanes/EtOAc 3:1; 90% recovery).  
478: Rf = 0.40 (hexanes/EtOAc 3:1, CAM); [α]D18 = +89.5 (c = 1.0, CHCl3); IR (film) ν 
3436, 2931, 2858, 1463, 1382, 1252, 1219, 1106, 1039, 839, 777, 665 cm-1; 1H NMR 
(600 MHz, CDCl3) δ 4.30 (bs, 1H), 3.95 (d, J = 10.8 Hz, 1H), 3.74 (d, J = 10.8 Hz, 1H), 
3.64 (d, J = 11.3 Hz, 1H), 2.69 (dd, J = 3.7, 16.8 Hz, 1H), 2.63 (bs, 1H), 2.40 (dd, J = 8.0, 
16.7 Hz, 1H), 2.18 – 2. 16 (m, 1H), 2.02 – 2.00 (m, 1H), 1.82 – 1.76 (m, 2H), 1.67 – 1.63 
(m, 1H), 1.53 (s, 3H), 1.39 (s, 3H), 0.92 (s, 9H), 0.11 (s, 3H), 0.10 (s, 3H); 13C NMR 
(150 MHz, CDCl3) δ 118.6, 108.4, 83.3, 77.9, 63.1, 37.4, 28.5, 26.6, 25.9, 25.6, 25.1, 
20.5, 18.3, -5.5, -5.6;MS (+EI) m/z (%) 340 (5), 241 (11), 240 (61), 222 (29), 211 (12), 
210 (61), 192 (11), 182 (15), 181 (14), 117 (12), 105 (16), 75 (100), 73 (41), 59 (40), 43 
(25), 41 (17); HRMS (+EI) calcd for C17H30O4NSi: 340.1944. Found: 340.1935; Anal. 
Calcd for C18H33O4NSi: C, 60.81; H, 9.36. Found C, 60.68; H, 9.41. 
 
2-((3aR,5R,7aR)-3a-((tert-Butyldimethylsilyloxy)methyl)-2,2-dimethyl-4-
oxohexahydrobenzo[d][1,3]dioxol-5-yl)acetonitrile (476). 
O
O
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To a clear and colorless solution of alcohol 478 (185 mg, 0.520 mmol) in methylene 
chloride (5.2 mL, 0.1 M) at room temperature was added commercial Dess-Martin 
periodinane (286 mg, 0.676 mmol, 1.3 equiv) in a single portion. The reaction mixture 
thickened to a white slurry within minutes of addition of DMP. The reaction was 
monitored by TLC analysis (hexanes/EtOAc 3:1, CAM) and another portion of DMP (44 
mg, 0.104 mmol, 0.2 equiv) was added after 3 h. After an additional 50 minutes alcohol 
478 was consumed based on TLC analysis and the reaction mixture was diluted with 
Et2O (6 mL), filtered and the filtered solid rinsed with Et2O (3 mL). The filtrate was 
concentrated in vacuo to yield 198 mg of crude material that was a slightly off-white 
solid. The material was chromatographed on silica gel (hexanes/EtOAc 3:1) to provide 
ketone 476 (113 mg, 62%) as a white solid. 
476: mp 73 – 75 ˚C (Et2O); Rf = 0..55 (hexanes/EtOAc 3:1, CAM); [α]D20 = +45.3 (c = 
0.3, CHCl3); IR (film) ν 2931, 2863, 1723, 1471, 1381, 1249, 1225, 1092, 839, 778, 665 
cm-1; 1H NMR (300 MHz, CDCl3) δ 4.41 (bs, 1H), 3.87 (d, J = 9.7 Hz, 1H), 3.67 (d, J = 
9.7 Hz, 1H), 2.91 – 2.81 (m, 1H), 2.76 (dd, J = 4.7, 17.0 Hz, 1H), 2.46 (dd, J = 8.1, 17.0 
Hz, 1H), 2.36 – 2.08 (m, 3H), 1.94 (dq, J = 3.6, 12.9 Hz, 1H), 1.36 (s, 3H), 1.34 (s, 3H), 
0.89 (s, 9H), 0.07 (s, 3H), 0.04 (s, 3H);  13C NMR (75 MHz, CDCl3) δ 209.1, 118.2, 
108.8, 84.4, 80.9, 66.5, 47.4, 27.1, 26.2, 25.8, 25.8, 18.2, 17.5, -5.7, -5.8;MS (+EI) m/z 
(%) 338 (5), 238 (50), 210 (17), 209 (18), 208 (100), 206 (16), 180 (35), 167 (11), 143 
(11), 89 (12), 75 (58), 73 (41), 59 (17), 43 (20), 41 (13); HRMS (+EI) calcd for 
C17H28O4NSi: 338.1788. Found: 338.1788; Anal. Calcd for C18H31O4NSi: C, 61.15; H, 
8.84. Found C, 61.18; H, 8.88. 
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2-((3aR,5R,7aR,E)-3a-((tert-Butyldimethylsilyloxy)methyl)-2,2-dimethyl-4-(2-
phenylhydrazono)hexahydrobenzo[d][1,3]dioxol-5-yl)acetonitrile (480). 
To a solution of 476 (24 mg, 0.067 mmol) in pyridine (0.3 mL) was added 
phenylhydrazine hydrochloride (98 mg, 0.678 mmol, 10 equiv) and the reaction mixture 
was heated to reflux with stirring. The reaction was monitored by TLC analysis 
(hexanes/EtOAc 3:1) and upon consumption of 476 Celite was added to the reaction 
mixture and the mixture was concentrated in vacuo. The material was purified by silica 
gel column chromatography (hexanes/EtOAc 5:1 → 3:1) and 480 was isolated as an 
orange oil, 19 mg (66%). 
480: Rf = 0.66 (hexanes/EtOAc 3:1); [α]D18 = -172.2 (c 0.5, CHCl3); FT-IR (film) ν 3320, 
2928, 2850, 2245, 1604, 1560, 1500, 1471, 1373, 1258, 1240, 1094, 840, 752 cm-1; 1H 
NMR (600 MHz, CDCl3) δ 9.84 (s, 1H), 7.26 (t, J = 7.8 Hz, 2H), 7.03 (d, J = 7.7 Hz, 
2H), 6.85 (t, J = 7.3 Hz, 1H), 4.33 (bs, 1H), 3.97 (d, J = 10.5 Hz, 1H), 3.78 (d, J = 10.5 
Hz, 1H), 2.95 (dd, J = 8.1, 19.6 Hz, 1H), 2.63 (dd, J = 7.3, 19.5 Hz, 2H), 2.27 (dd, J = 
2.4, 13.8 Hz, 1H), 2.00 – 1.73 (m, 3H), 1.46 (s, 3H), 1.39 (s, 3H), 0.91 (s, 9H), 0.08 (s, 
3H), 0.08 (s, 3H); 13C NMR (150 MHz, CDCl3) δ 145.3, 140.0, 129.2, 119.7, 119.5, 
112.6, 109.0, 84.3, 78.5, 63.2, 40.6, 26.8, 26.7, 26.0, 25.9, 25.5, 20.4, 18.3, -5.4, -5.6; MS 
(+EI) m/z (%) 444 (30), 443 (82), 329 (11), 238 (35), 298 (18), 241 (19), 240 (100), 236 
(23), 235 (13), 212 (30), 195 (22), 150 (26), 149 (13), 115 (15), 105 (11), 93 (42), 55 
O
O
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(92), 89 (37), 77 (38), 75 (61), 74 (10), 73 (87), 65 (23), 59 (24), 57 (13), 43 (25), 41 
(24); HRMS (+EI) calcd for C24H37O3N3Si: 443.2604. Found: 443.2592. 
 
2-((3aS,4R,5S,7aR)-4-(Benzyloxy)-3a-((tert-butyldimethylsilyloxy)methyl)-2,2-
dimethyl-3a,4,5,7a-tetrahydrobenzo[d][1,3]dioxol-5-yl) acetonitrile (510). 
To a clear and colorless solution of alcohol 409 (139 mg, 0.393 mmol, 1.0 equiv) in THF 
at room temperature was added NaH (60% dispersed in mineral oil; 17 mg, 0.432 mmol, 
1.1 equiv) as a single portion. Once the evolution of hydrogen ceased benzyl chloride 
(226 µL, 1.96 mmol, 5.0 equiv) and tetrabutylammonium chloride (145 mg, 0.393 mmol, 
1.0 equiv) was added in succession and the reaction mixture was heated to reflux for ~24 
h at which point TLC analysis (hexanes/EtOAc 3:1, CAM) indicated consumption of 409. 
The reaction mixture was cooled to room temperature, concentrated in vacuo, and 
reconstituted in EtOAc. The white precipitate was filtered and the mother liquor (clear 
and yellow) was concentrated to a non-viscous and orange oil, 355 mg. The crude 
material was chromatographed on silica gel (hexanes/EtOAc 5:1 → 3:1) to yield 120 mg 
(69%) of  510 and 17 mg (10%) of 519 as colorless oils.  
510: Rf = 0.68 (hexanes/EtOAc 3:1); [α]D18 = +91.7 (c = 0.4, CHCl3); IR (film) ν 2951, 
2926, 2855, 1469, 1456, 1378, 1365, 1251, 1213, 1160, 1084, 1054, 837, 776, 741, 665 
cm-1; 1H NMR (600 MHz, CDCl3) δ 7.37 (m, 5H), 6.03 – 6.00 (m, 1H), 5.85 (d, J = 10.9 
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Hz, 1H), 5.09 (d, J = 11.3 Hz, 1H), 4.72 (d, J = 3.8 Hz, 1H), 4.61 (d, J = 11.4 Hz, 1H), 
3.92 (d, J = 10.9 Hz, 1H), 3.89 (d, J = 11.0 Hz, 1H), 3.54 (d, J = 10.3 Hz, 1H), 2.71 – 
2.67 (m, 2H), 2.29 (dd, J = 9.7, 17.6 Hz, 1H), 1.61 (s, 3H), 1.49 (s, 3H), 0.91 (s, 9H), 
0.10 (s, 3H), 0.09 (s, 3H); 13C NMR (150 MHz, CDCl3) δ 138.2, 130.8, 128.6, 128.3, 
128.0, 125.6, 118.2, 109.5, 84.4, 81.2, 74.6, 74.3, 61.6, 38.3, 28.7, 26.5, 25.9, 20.3, 18.4, 
-5.4, -5.6; MS (+EI) m/z (%) 428 (2), 328 (10), 190 (8), 92 (27), 91 (100), 89 (10), 75 
(20), 73 (28), 57 (10), 43 (14); HRMS (+EI) calcd for C24H34O4NSi: 428.2257. Found: 
428.2261; Anal. Calcd for C25H37O4NSi: C, 67.68; H, 8.41. Found C, 67.80; H, 8.35. 
 
2-((3aS,4R,5S,7aR)-4-(Benzyloxy)-3a-(hydroxymethyl)-2,2-dimethyl-3a,4,5,7a-
tetrahydrobenzo[d][1,3]dioxol-5-yl)acetonitrile (518). 
To a clear and yellow solution of 510 (431 mg, 0.971 mmol) in THF (9.7 mL) at 5 ˚C was 
added a 1 M solution of tetrabutylammonium fluoride in THF (1.9 mL, 1.94 mmol, 2.0 
equiv) over two minutes. The reaction was monitored by TLC analysis (hexanes/EtOAc 
1:1) and 510 was consumed after 70 minutes. The reaction mixture was quenched with 
aqueous NH4Cl (satd, 2 mL) at room temperature. The white precipitate was filtered from 
the reaction mixture and the mother liquor concentrated in vacuo. The aqueous phase 
mixture was extracted with EtOAc (2x) and the organic phase was washed with brine 
(1x), dried over Na2SO4, and concentrated in vacuo to 403 mg of crude material. The 
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crude material was chromatographed on silica gel (hexanes/EtOAc 1:1) to yield 310 mg 
(97%) of 518 as a colorless oil that required no further purification. 
518: Rf = 0.50 (hexanes/EtOAc 1:1); [α]D18 = +155.9 (c 0.4, CHCl3); FT-IR (film) ν 
3479, 3033, 2987, 2935, 2886, 2247, 1497, 1455, 1424, 1402, 1380, 1249, 1216, 1166, 
1080, 1025, 910, 866, 813, 745, 699, 665 cm-1; 1H NMR (600 MHz, CDCl3) δ 7.40 – 7.32 
(m, 5H), 6.01 (td, J = 3.3, 9.8 Hz, 1H), 5.85 (d, J = 10.0 Hz, 1H), 5.10 (d, J = 11.2 Hz, 
1H), 4.64 (d, J = 4.0 Hz, 1H), 4.61 (d, J = 11.2 Hz, 1H), 4.10 (d, J = 12.1 Hz, 1H), 3.64 
(d, J = 9.8 Hz, 1H), 3.56 (d, J = 12.1 Hz, 1H), 2.67 (dd, J = 4.0, 16.7 Hz, 1H), 2.51 (t, J = 
9.4 Hz, 1H), 2.36 (dd, J = 8.3, 16.7 Hz, 1H), 1.64 (s, 3H), 1.51 (s, 3H); 13C NMR (150 
MHz, CDCl3) δ 137.7, 130.8, 128.6, 128.2, 128.2, 125.4, 117.8, 109.9, 84.4, 80.8, 75.0, 
73.8, 59.8, 38.1, 28.8, 26.7, 20.2; MS (+EI) m/z (%) 315 (1), 314 (3), 271 (3), 134 (7), 
107 (32), 91 (100), 43 (11); HRMS (+EI) calcd for C18H20O4N: 314.1396. Found: 
314.1392; Anal. Calcd for C19H23O4N: C, 69.28; H, 7.04. Found C, 69.41; H, 6.97. 
 
2-((3aS,4R,5S,7aR)-4-(Benzyloxy)-3a-((tert-butyldimethylsilyloxy)methyl)-2,2-
dimethyl-3a,4,5,7a-tetrahydrobenzo[d][1,3]dioxol-5-yl) acetonitrile (519). 
To a clear and colorless solution of alcohol 518 (31 mg, 0.094 mmol, 1.0 equiv) in THF 
at room temperature was added NaH (60% dispersed in mineral oil; 3 mg, 0.141 mmol, 
1.5 equiv) as a single portion. Once the evolution of hydrogen ceased benzyl chloride (75 
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µL, 0.658 mmol, 7.0 equiv) and tetrabutylammonium iodide (35 mg, 0.0.94 mmol, 1.0 
equiv) was added in succession and the reaction mixture was heated to 50 ˚C. The 
reaction was monitored by TLC analysis (hexanes/EtOAc 1:1, CAM) and additional 
Bu4NI (7 mg, 0.018 mmol, 0.2 equiv) and BnCl (21 µL, 0.188 mmol, 2.0 equiv) was 
added and consumption of 518 was observed. The reaction mixture was cooled to room 
temperature, concentrated in vacuo, and reconstituted in EtOAc. The white precipitate 
was filtered and the mother liquor (clear and yellow) was concentrated to a non-viscous 
and orange oil, 116 mg. The crude material was chromatographed on silica gel 
(hexanes/EtOAc 4:1) to yield 519 (27 mg, 70%) as a colorless oil.  
519: Rf = 0.52 (hexanes/EtOAc 3:1); [α]D18 = +119.6 (c = 0.4, CHCl3); IR (film) ν 3031, 
2987, 2867, 2245, 1496, 1454, 1379, 1251, 1215, 1163, 1092, 1057, 1028, 872, 738, 698, 
665 cm-1; 1H NMR (600 MHz, CDCl3) δ 7.40 – 7.31 (m, 10H), 6.01 (d, J = 9.7 Hz, 1H), 
5.85 (d, J = 10.0 Hz, 1H), 5.09 (d, J = 11.3 Hz, 1H), 4.78 (d, J = 3.7 Hz, 1H), 4.65 (d, J = 
12.1 Hz, 1H), 4.61 (d, J = 11.3 Hz, 1H), 4.56 (d, J = 12.1 Hz, 1H), 3.81 (d, J = 10.3 Hz, 
1H), 3.77 (d, J = 10.3 Hz, 1H), 3.55 (d, J = 9.7 Hz, 1H), 2.69 – 2.66 (m, 2H), 2.31 
(dd, J = 9.5, 17.6 Hz, 1H), 1.61 (s, 3H), 1.50 (s, 3H); 13C NMR (150 MHz, CDCl3) δ 
138.2, 130.8, 128.6, 128.3, 128.0, 125.6, 118.2, 109.5, 84.4, 81.2, 74.6, 74.3, 61.6, 38.3, 
28.7, 26.5, 25.9, 20.3, 18.4, -5.4, -5.6; MS (+EI) m/z (%) 405 (1), 404 (2), 270 (4), 107 
(14), 92 (16), 91 (100), 43 (8); HRMS (+EI) calcd for C25H26O4N: 404.1869. Found: 
404.1861; Anal. Calcd for C26H29O4N: C, 74.44; H, 6.97. Found C, 74.21; H, 6.96. 
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2-((3aS,4R,5S,7aR)-4-(Benzyloxy)-3a-(benzyloxymethyl)-2,2-dimethyl-3a,4,5,7a-
tetrahydrobenzo[d][1,3]dioxol-5-yl)-N-(3-chloropropyl)acetamide (521). 
A white and cloudy mixture of nitrile 519 (190 mg, 0.452 mmol) in aqueous NaOH (4 M, 
2.6 mL) and MeOH (2.6 mL) was heated to reflux for 22 h, at which time 519 was 
consumed as evidenced by analysis by TLC (EtOAc). The reaction mixture was cooled to 
room temperature and concentrated in vacuo to remove MeOH. The aqueous mixture was 
neutralized with 6 M aqueous HCl and then extracted with Et2O (4x). The organic phases 
were combined, dried over MgSO4, and concentrated in vacuo to obtain 178 mg (83%) of 
520 as a white foam-like solid that was used without further purification. 
 
2-((3aS,4R,5S,7aR)-4-(Benzyloxy)-3a-(benzyloxymethyl)-2,2-dimethyl-3a,4,5,7a-
tetrahydrobenzo[d][1,3]dioxol-5-yl)acetamide (520): Rf = 0.11 (hexanes/EtOAc 1:1); 
[α]D18 = +70.1 (c 0.65, CHCl3); FT-IR (film) ν 3604, 3583, 3032, 2986, 2929, 2868, 
1731, 1707, 1454, 1379, 1251, 1215, 1163, 1095, 1057, 1029, 873, 736, 697, 665 cm-1; 
1H NMR (300 MHz, CDCl3) δ 7.40 – 7.29 (m, 10H), 5.89 (ddd, J = 2.4, 4.0, 10 Hz, 1H), 
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5.78 (d, J = 9.8 Hz, 1H), 5.12 (d, J = 11.2 Hz, 1H), 4.79 (d, J = 3.8 Hz, 1H), 4.68 (d, J = 
12.1 Hz, 1H), 4.58 (d, J = 11.9 Hz, 1H), 4.55 (d, J = 11.9 Hz, 1H), 3.93 (d, J = 10.9 Hz, 
1H), 3.71 (d, J = 10.7 Hz, 1H), 3.54 (d, J = 9.9 Hz, 1H), 2.76 – 2.69 (m, 2H), 2.30 – 2.21 
(m, 1H), 1.60 (s, 3H), 1.51 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 177.9, 138.4, 138.2, 
133.2, 128.3, 128.0, 127.6, 127.5, 127.4, 123.5, 109.3, 84.4, 81.9, 74.6, 73.9, 73.8, 38.0, 
36.8, 28.7 26.4; MS (+ESI) m/z (%) 422 (25), 421 (100) 333 (7), 315 (14), 255 (25), 237 
(15), 181 (20), 165 (14). 
 To a clear and yellow solution of freshly prepared and crude primary amide 520 
(169 mg, 0.386 mmol) in DMF (3.8 mL) at room temperature was added sodium hydride 
(9 mg, 0.386 mmol, 1.0 equiv) with stirring. To this mixture was added 1-bromo-3-
chloropropane (152 µL, 1.54 mmol, 4.0 equiv) and the reaction was monitored by TLC 
analysis (hexanes/EtOAc 3:1 for 521; EtOAc for 520). Upon consumption of 520 the 
reaction mixture was quenched with aqueous NH4Cl (satd, 0.2 mL) and further diluted 
with H2O (10 mL). The aqueous phase was extracted with Et2O (3x) and the combined 
organic phases were washed with H2O (1x), brine (1x), and dried over MgSO4. The 
organic phase was concentrated in vacuo to yield 169 mg of crude material that was 
chromatographed on silica gel (hexanes/EtOAc 3:1) and yielded 112 mg (56%) of 521 as 
a colorless oil. 
521: Rf = 0.60 (hexanes/EtOAc 3:1); [α]D18 = +64.7 (c 0.75, CHCl3); FT-IR (film) ν 
3395, 3030, 2917, 2857, 1734, 1496, 1453, 1379, 1251, 1214, 1154, 1094, 1056, 1028, 
872, 736, 697, 665 cm-1; 1H NMR (600 MHz, CDCl3) δ 7.37 – 7.31 (m, 10H), 5.89 
(td, J = 3.2, 9.8 Hz, 1H), 5.78 (d, J = 9.9 Hz, 1H), 5.14 (d, J = 11.3 Hz, 1H), 4.81 (d, J = 
3.9 Hz, 1H), 4.69 (d, J = 12.1 Hz, 1H), 4.58 (dd, J = 5.1, 11.5 Hz, 2H), 4.19 – 4.10 
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(m, 2H), 3.94 (d, J = 10.7 Hz, 1H), 3.73 (d, J = 10.6 Hz, 1H), 3.58 – 3.50 (m, 2H), 2.78 
(dd, J = 8.35, 14.5 Hz, 1H), 2.71 (dd, J = 5.4, 15.4 Hz, 1H), 2.30 (dd, J = 8.3, 15.4 Hz, 
1H), 2.01 (quin, J = 5.7 Hz, 2H), 1.62 (s, 3H), 1.52 (s, 3H); 13C NMR (150 MHz, CDCl3) 
δ 172.1, 138.5, 138.3, 133.4, 128.4, 128.1, 127.7, 127.5, 127.4, 123.5, 109.3, 84.5, 82.0, 
74.7, 73.9, 73.8, 67.1, 61.2, 41.2, 38.2, 37.0, 31.5, 28.8, 26.4; MS (+ESI) m/z (%) 537 
(M+Na, 100), 515 (1), 514 (1), 457 (2), 409 (12), 331 (16), 326 (18), 319 (14), 284 (17), 
259 (12), 256 (36), 241 (17), 147 (9); Anal. Calcd for C29H36O5NCl: C, 67.76; H, 7.06. 
Found C, 67.41; H, 6.83. 
 
2-((1S,5S,6R)-6-(Benzyloxy)-5-(benzyloxymethyl)-5-hydroxy-4-oxocyclohex-2-enyl)-
N-(3-chloropropyl)acetamide (388). 
To a clear and colorless solution of acetonide 521(40 mg, 0.075 mmol) in CHCl3 (2 mL) 
at room temperature was added FeCl3SiO2 (~100 mg) with stirring and the reaction was 
monitored by TLC analysis (hexanes/EtOAc 1:1). The reaction slurry was filtered and the 
filtered solid was rinsed with CHCl3 and MeOH. The filtrate was concentrated in vacuo 
to provide 125 mg of crude material. The crude material was passed through a plug of 
silica gel (hexanes/EtOAc 1:1) to yield 21 mg (62%) of 522 as a colorless oil. The 
material was used directly for the next step. 
OH
OBn
BnO
H
NO
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2-((1S,4R,5R,6R)-6-(Benzyloxy)-5-(benzyloxymethyl)-4,5-dihydroxycyclohex-2-enyl)-
N-(3-chloropropyl)acetamide (522): Rf = 0.47 (hexanes/EtOAc 1:1); [α]D18 = +11.1 (c 
0.6, CHCl3); FT-IR (film) ν 3487, 3088, 3030, 2960, 2920, 2872, 1732, 1605, 1586, 
1496, 1453, 1391, 1361, 1302, 1258, 1208, 1169, 1094, 1028, 918, 850, 738, 698, 654 
cm-1; 1H NMR (600 MHz, CDCl3) δ 7.39 – 7.31 (m, 10H), 5.74 (d, J = 10.0 Hz, 1H), 5.67 
(d, J = 10.0 Hz, 1H), 4.73 (d, J = 11.7 Hz, 1H), 4.68 (d, J = 11.6 Hz, 1H), 4.54 (s, 2H), 
4.28 (bs, 1H), 4.23 (t, J = 5.9 Hz, 2H), 3.75 (d, J = 9.2 Hz, 1H), 3.67 (m, 2H), 3.59 (t, J = 
6.3 Hz, 2H), 3.10 (bs, 1H), 2.93 (bs, 1H), 2.76 – 2.72 (m, 2H), 2.45 (dd, J = 9.7, 19.0 Hz, 
1H), 2.08 (quin, J = 6.3 Hz, 2H); 13C NMR (150 MHz, CDCl3) δ 172.6, 138.4, 137.5, 
130.0, 128.6, 128.3, 128.0, 128.0, 129.0, 127.6, 127.2, 77.8, 74.4, 73.8, 73.2, 71.5, 67.8, 
61.2, 41.2, 37.1, 36.7, 31.5; MS (-ESI) m/z (%) 519 (M+HCOO-, 100), 113 (20). 
 To the freshly isolated allylic alcohol 522 (42 mg, 0.088 mmol) in CHCl3 (5 mL) 
at room temperature was added MnO2 (153 mg, 1.76 mmol, 20 equiv) as a single portion. 
The black slurry was stirred at room temperature and monitored by TLC analysis 
(hexanes/EtOAc 1:1). Another portion of MnO2 (76 mg, 0.88 mmol, 10 equiv) was added 
to the reaction mixture after 15 h. The reaction was stopped with 522 still present in the 
mixture and the reaction was filtered through a pad of Celite. The filtrate was 
concentrated in vacuo to yield 40 mg of a colorless oil. The crude material was subjected 
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to chromatography on silica gel (hexanes/EtOAc 3:1 → 1:1) to yield 23 mg (56%) of 
enone 388 and 12 mg (28%) recovered 522. 
388: Rf = 0.72 (hexanes/EtOAc 1:1); [α]D18 = +146.9 (c 0.25, CHCl3); FT-IR (film) ν 
3467, 2956, 2919, 2857, 1732, 1687, 1495, 1453, 1363, 1253, 1166, 1096, 1027, 738, 
698, 665 cm-1; 1H NMR (600 MHz, CDCl3) δ 7.38 – 7.26 (m, 10H), 6.81 (d, J = 10.3 Hz, 
1H), 6.17 (dd, J = 3.4, 11.0 Hz, 1H), 5.11 (d, J = 11.3 Hz, 1H), 4.61 (d, J = 11.2 Hz, 1H), 
4.57 (d, J = 12.4 Hz, 1H), 4.50 (d, J = 12.3 Hz, 1H), 4.18 (t, J = 5.9 Hz, 2H), 4.15 (s, 1H), 
3.93 (d, J = 9.8 Hz, 1H), 3.83 (d, J = 9.7 Hz, 1H), 3.71 (d, J = 9.8 Hz, 1H), 3.54 (dt, J = 
1.5, 9.3 Hz, 2H), 3.15 – 3.10 (m, 1H), 2.72 (dd, J = 4.8, 16.4 Hz, 1H), 2.40 (dd, J = 8.0, 
16.3 Hz, 1H), 2.04 (quin, J = 6.2 Hz, 2H); 13C NMR (150 MHz, CDCl3) δ 199.8, 171.3, 
150.8, 138.0, 137.7, 128.4, 128.4, 127.9, 127.5, 127.4, 126.6, 83.1, 81.2, 74.9, 73.7, 70.9, 
61.5, 41.1, 39.2, 35.8, 31.3; MS (+EI) m/z (%) 471 (1), 435 (3), 350 (2), 344 (9), 222 (5), 
208 (6), 207 (5), 152 (6), 123 (10), 111 (12), 107 (19), 100 (10), 99 (37), 97 (20), 95 (13), 
92 (23), 91 (100) 72 (20), 71 (23), 59 (53), 57 (40), 55 (39), 43 (57), 41 (31); HRMS 
(+EI) calcd for C26H30O5NCl: 471.1803. Found: 471.1812. 
 
2-((3aS,4R,5S,7aR)-4-(Benzyloxy)-3a-((tert-butyldimethylsilyloxy)methyl)-2,2-
dimethyl-3a,4,5,7a-tetrahydrobenzo[d][1,3]dioxol-5-yl)ethanamine (512). 
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To a slurry of LiAlH4 (10 mg, 0.270 mmol, 2.0 equiv) in Et2O (1.4 mL) at room 
temperature was added a solution of nitrile 510 (60 mg, 0.135 mmol) in Et2O (0.7 mL) in 
three portions. The reaction was monitored by TLC analysis (hexanes/EtOAc 2:1) and 
upon consumption of 510 the reaction mixture was quenched with Rochelle’s salt (satd, 
0.2 mL), the mother liquor was decanted from the inorganic precipitates and dried over 
Na2SO4 to yield 56 mg (93%) of 512 as a white solid. 
512: Rf = 0.46 (EtOAc/MeOH 4:1); mp = 97 – 101 ˚C (Et2O); [α]D18 = +64.2 (c 0.4, 
CHCl3); FT-IR (film) ν 3362, 2926, 2855, 1570, 1461, 1378, 1360, 1251, 1213, 1092, 
1019, 852, 778, 741, 665 cm-1; 1H NMR (600 MHz, CDCl3) δ 7.40 (d, J = 7.1 Hz, 1H), 
7.36 (t, J = 7.5 Hz, 2H), 7.30 (t, J = 7.5 Hz, 1H), 5.85 (ddd, J = 2.6, 4.1, 9.8 Hz, 1H), 5.80 
(d, J = 10.2 Hz, 1H), 5.11 (d, J = 11.3 Hz, 1H), 4.69 (d, J = 3.8 Hz, 1H), 4.60 (d, J = 11.3 
Hz, 1H), 4.04 (d, J = 11.0 Hz, 1H), 3.73 (d, J = 11.3 Hz, 1H), 3.51 (d, J = 10.0 Hz, 1H), 
2.78 – 2.73 (m, 1H), 2.70 – 2.66 (m, 1H), 2.27 (t, J = 8.7 Hz, 1H), 1.86 – 1.80 (m, 1H), 
1.59 (s, 3H), 1.48 (s, 3H), 0.91 (s, 9H), 0.08 (s, 3H), 0.07 (s, 3H); 13C NMR (150 MHz, 
CDCl3) δ 138.8, 134.4, 128.4, 128.2, 127.7, 122.5, 108.8, 85.3, 82.5, 74.9, 73.1, 60.5, 
39.4, 39.0, 35.8, 28.8, 26.7, 26.0, 18.4, -5.3, -5.6; MS (+EI) m/z (%) 448 (9), 390 (7), 115 
(7), 91 (100), 89 (18), 75 (25), 73 (93), 59 (16), 43 (12), 30 (25); HRMS (+EI) calcd for 
C25H42O4NSi: 448.2814. Found: 448.2883; Anal calcd for C25H41NO4Si: C, 67.07; H, 
9.23. Found: C, 66.17; H, 9.16. 
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N-(2-((3aS,4R,5S,7aR)-4-(Benzyloxy)-3a-((tert-butyldimethylsilyloxy)methyl)-2,2-
dimethyl-3a,4,5,7a-tetrahydrobenzo[d][1,3]dioxol-5-yl)ethyl)-3-chloropropanamide 
(513). 
To a clear and colorless solution of amine 512 (48 mg, 0.108 mmol) in methylene 
chloride (1 mL) at 5 ˚C was added Et3N (30 µL, 0.216 mmol, 2.0 equiv) followed by 3-
chloropropionyl chloride (20 µL, 0.216 mmol, 2.0 equiv). The reaction was monitored by 
TLC analysis (hexanes/EtOAc 2:1) and the mixture quenched with aqueous NH4Cl (satd, 
0.25 mL). The phases were separated and the organic phase was collected, washed with 
H2O (1x), brine (1x), and dried over Na2SO4. The organic phase was concentrated to a 
yellow oil, 50 mg, that was chromatographed on silica gel (hexanes/EtOAc 2:1) and 
yielded 37 mg (64%) of 513 as a colorless oil. 
513: Rf = 0.19 (hexanes/EtOAc 2:1); [α]D18 = +12.5 (c 0.3, CHCl3); FT-IR (film) ν 3402, 
2919, 2861, 1731, 1458, 1371, 1365, 1214, 1090, 1051, 1031, 873, 735, 662 cm-1; 1H 
NMR (600 MHz, CDCl3) δ 7.43 (d, J = 7.7 Hz, 2H), 7.36 (t, J = 7.4 Hz, 1H), 7.29 (t, J = 
7.2 Hz, 1H), 6.19 – 6.12 (m, 1H), 5.88 (d, J = 10.0 Hz, 1H), 5.86 – 5.82 (m, 1H), 5.53 
(dd, J = 3.4, 9.0 Hz, 1H), 5.10 (d, J = 11.2 Hz, 1H), 4.67 – 4.66 (rotamer; m, 2H), 4.01 
(dd, J = 11.1, 7.6 Hz, 1H), 3.82 (dd, J = 11.0, 13.6 Hz, 2H), 3.54 (dd, J = 10.0, 5.4 Hz, 
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1H), 3.39 – 3.29 (rotamer; m, 1H), 2.34 (bs, 1H), 2.03 – 1.96 (rotamer; m, 1H), 1.53 (s, 
3H), 1.43 (s, 3H), 0.91 (s, 9H), 0.10 (s, 3H), 0.09 (s, 3H); 13C NMR (150 MHz, acetone-
d6) 168.6, 164.5, 139.3, 133.7, 133.6, 131.9, 128.2, 127.9, 127.3, 124.2, 123.1, 122.9, 
108.5, 85.0, 84.9, 82.6, 82.5, 74.5, 73.5, 73.4, 61.0, 60.8, 40.6, 38.9, 38.8, 38.8, 36.4, 
36.8, 31.7, 28.3, 26.2, 25.5, 18.1, -6.0, -6.1; MS (+EI) m/z (%) 408 (1), 278 (5), 262 (7), 
207 (12), 105 (8), 91 (100), 77 (9), 75 (23), 73 (17), 55 (22), 43 (14), 41 (8); HRMS 
(+EI) calcd for C27H41O5NClSi: 522.2423. Found: 522.2442. 
 
N-(2-((1S,4R,5R,6R)-6-(Benzyloxy)-4,5-dihydroxy-5-(hydroxymethyl)cyclohex-2-
enyl)ethyl)-3-chloropropanamide (514). 
To a crude and hazy solution of acetonide 514 (1.59 g, 2.97 mmol; based on theoretical 
from a previous step) in MeOH (30 mL) at room temperature was added conc. HCl (1.5 
mL) with stirring. The reaction was monitored by TLC (EtOAc) and 514 was consumed 
after ca. 3 h. The mixture was neutralized with aqueous NaOH and filtered. The filtrate 
was concentrated to an oily white solid that was triturated with EtOAc, filtered again, and 
the filtrate concentrated in vacuo to yield a yellow-white foam, 1.17 g. The crude 
material was chromatographed on deactivated silica gel (hexanes/EtOAc 1:1 → EtOAc 
→ MeOH flush) to yield 0.70 g (61%) of 514 as a colorless oil. 
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514: Rf = 0.22 (EtOAc); [α]D18 = +41.1 (c 1.0, MeOH); 1H NMR (300 MHz, CDCl3) δ 
7.41 – 7.25 (m, 5H), 5.75 (s, 2H), 4.98 (d, J = 11.1 Hz, 1H), 4.64 (d, J = 11.1 Hz, 1H), 
4.15 – 4.08 (m, 1H), 3.90 (d, J = 11.5 Hz, 1H), 3.78 (t, J = 6.4 Hz, 1H), 3.68 (d, J = 7.4 
Hz, 1H), 3.53 (d, J = 11.4 Hz, 1H), 3.28 (d, J = 7.6 Hz, 1H), 2.61 (t, J = 6.3 Hz, 2H), 2.22 
(dd, J = 7.5, 12.8 Hz, 1H), 1.95 – 1.84 (m, 1H), 1.68 – 1.57 (m, 1H); 13C NMR (75 MHz, 
MeOH-d4) δ 170.9, 138.9, 131.1, 127.9, 127.8, 127.2, 126.4, 79.8, 75.6, 74.4, 67.1, 61.9, 
39.8, 38.9, 38.6, 36.6, 31.7; MS (+FAB) m/z (%) 384 (7), 214 (23), 176 (9), 155 (14), 138 
(19), 137 (43), 136 (41), 121 (13), 120 (15), 108 (10), 107 (28), 105 (14), 95 (10), 91 
(100), 81 (10), 77 (30), 69 (14), 57 (18), 55 (23), 43 (20), 41 (17), 39 (14); HRMS 
(+FAB) calcd for C19H27O5NCl: 384.1565. Found: 384.15778. 
 
N-(2-((1S,5S,6R)-6-(Benzyloxy)-5-hydroxy-5-(hydroxymethyl)-4-oxocyclohex-2-
enyl)ethyl)-3-chloropropanamide (515). 
To a clear and colorless solution of triol 514 (0.68 g, 1.77 mmol) in CHCl3 (25 mL) at 
room temperature was added MnO2 (2.30 g, 26.5 mmol, 15 equiv) over two minutes. The 
reaction mixture was stirred at room temperature and monitored by TLC (EtOAc). After 
22 h another portion of MnO2 (1.5 g, 17.7 mmol, 10 equiv) was added to the reaction 
mixture. After another 5 hours the reaction mixture was filtered (514 still remained) 
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through a pad of acid washed Celite. The pad of Celite was heavily rinsed with CHCl3 
(~300 mL). The brown colored filtrate was concentrated in vacuo to provide 477 mg of 
crude material that was purified by chromatography on silica gel (EtOAc) to yield 352 
mg (52%) of enone 515 as an orange oil. 
515: Rf  = 0.13 (hexanes/EtOAc 1:1.5); [α]D18 = +118.3 (c 0.25, CHCl3); FT-IR (film) ν 
3583, 3306, 2926, 2868, 1679, 1648, 1552, 1453, 1211, 1099, 1072, 745, 665 cm-1; 1H 
NMR (600 MHz, CDCl3) δ 7.40 (d, J = 4.3 Hz, 2H), 7.39 – 7.34 (m, 4H), 6.89 (d, J = 
10.2 Hz, 1H), 6.16 (dd, J = 2.7, 10.5 Hz, 1H), 5.71 (bs, 1H), 5.16 (d, J = 11.0 Hz, 1H), 
4.64 (d, J = 11.1 Hz, 1H), 4.26 (bs, 1H), 4.14 (d, J = 11.6 Hz, 1H), 3.81 (d, J = 11.6 Hz, 
1H), 3.80 – 3.71 (m, 2H), 3.69 (d, J = 9.4 Hz, 1H), 3.50 – 3.45 (m, J = 7.1 Hz, 1H), 3.09 
– 3.04 (m, J = 6.4 Hz, 1H), 2.66 (d, J = 3.7 Hz, 1H), 2.51 – 2.44 (m,  2H), 2.31 (bs, 1H), 
1.87 – 1.82 (m, J = 6.8 Hz, 1H), 1.75 – 1.69 (m, J = 6.9 Hz, 1H); 13C NMR (150 MHz, 
CDCl3) δ 200.0, 169.6, 151.9, 137.7, 128.7, 128.6, 128.2, 125.8, 83.9, 81.8, 75.0, 63.9, 
40.2, 39.8, 39.5, 36.7, 31.5; 
 
N-(2-((5S,6R,7S)-6-(Benzyloxy)-2,2-dimethyl-10-oxo-1,3-dioxaspiro[4.5]dec-8-en-7-
yl)ethyl)-3-chloropropanamide (387). 
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To a clear and orange solution of enone 515 (312 mg, 0.817 mmol) in acetone (8 mL) at 
room temperature was added 2,2-DMP (3.7 mL) and a crystal of p-TsOH with stirring. 
The reaction was monitored by TLC (EtOAc) and 515 was consumed after 1.5 h and the 
reaction mixture was quenched with aqueous NaHCO3 (satd, 5 drops). The acetone and 
2,2-DMP were removed in vacuo and the crude material was reconstituted in methylene 
chloride, washed with H2O (1x), brine (1x), and dried over  Na2SO4. The organic phase 
was then concentrated to 321 mg of crude orange oil that was purified by 
chromatography to yield 286 mg (83%) of enone 387 as a light brown oil. 
387: Rf = 0.13 (hexanes/EtOAc 1:1.5); [α]D18 = +130.4 (c 0.65, CHCl3); FT-IR (film) ν 
3309, 2984, 2936, 2875, 1694, 1651, 1547, 1454, 1380, 1370, 1256, 1222, 1101, 1069, 
860, 750, 665 cm-1;  1H NMR (600 MHz, CDCl3) δ 7.42 – 7.36 (m, 5H), 6.79 (dd, J = 
2.6, 10.2 Hz, 1H), 6.07 (dd, J = 3.6, 11.2 Hz, 1H), 5.43 (t, J = 6.6 Hz, 1H), 5.04 (d, J = 
11.6 Hz, 1H), 4.65 (d, J = 11.7 Hz, 1H), 4.40 (d, J = 8.7 Hz, 1H), 4.05 (d, J = 8.7 Hz, 
1H), 3.83 – 3.75 (m, 3H), 3.34 (ddd, J = 7.2 Hz, 1H), 3.03 – 2.97 (m, J = 6.4 Hz, 1H), 
2.56 – 2.49 (m, J = 6.2 Hz, 3H), 1.87 – 1.81 (m, J = 6.9 Hz, 1H), 1.68 (s, 3H), 1.64 – 1.58 
(m, J = 6.1 Hz, 2H), 1.52 (s, 3H); 13C NMR (150 MHz, CDCl3) δ 197.6, 169.4, 149.5, 
137.8, 128.6, 128.5, 128.1, 127.4, 112.2, 88.3, 79.4, 75.5, 66.4, 40.3, 40.2, 39.6, 36.6, 
30.9, 26.4, 26.0; MS (+EI) m/z (%) 406 (1), 385 (1), 278 (6), 277 (5), 255 (8), 236 (9), 
220 (14), 219 (18), 150 (8), 129 (43), 122 (6), 108 (10), 98 (7), 92 (15), 91 (100), 55 (34); 
HRMS (+EI) calcd for C22H28O5NCl: 421.1652. Found: 421.16560. 
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(3a'S,4S,4'R,7a'S)-4'-(Benzyloxy)-1'-(3-chloropropanoyl)-2,2-(3a'S,4S,4'R,7a'S)-4'-
(benzyloxy)-1'-(3-chloropropanoyl)-2,2-dimethylhexahydrospiro[[1,3]dioxolane-4,5'-
indol]-6'(1'H)-one (523).  
To a clear and colorless solution of enone 387 (22 mg, 0.052 mmol) in THF (5.2 mL) at 5 
˚C was added pentane-washed NaH (1 mg, 0.052, 1.0 equiv) with stirring. The reaction 
was monitored carefully by TLC (hexanes/EtOAc 1:1.5) and slowly warmed to room 
temperature. After 1 h the reaction was quenched with aqueous NH4Cl (sat’d, 10 drops). 
The reaction mixture was diluted with EtOAc and stirred with Na2SO4 for several 
minutes. The reaction mixture was filtered, the filtrate was concentrated in vacuo and 
dried under vacuum to yield 22 mg of crude material. The crude material was 
chromatographed on silica gel (hexanes/EtOAc 1:1 → 1:1.5) and provided 13 mg (62%) 
of 523 and 4 mg (18%) of 524. 
523: Rf = 0.51 (hexanes/EtOAc 1:1.5); [α]D18 = +35.2 (c 0.3, CHCl3); (Unresolved 
rotameric signals) 1H NMR (600 MHz, DMSO-d6) δ 7.38 – 7.36 (m, 2H), 7.30 – 7.32 (m, 
3H), 4.65 (d, J = 11.3 Hz, 1H), 4.58 (d, J = 11.4 Hz, 1H), 4.34 (d, J = 9.2 Hz, 1H), 4.25 
(dd, J = 7.5, 15.7 Hz, 1H), 3.96 (dd, J = 4.2, 16.7 Hz, 1H), 3.83 (dd, J = 9.1, 19.9 Hz, 
1H), 3.78 (t, J = 7.1 Hz, 1H), 3.65 (t, J = 9.2 Hz, 1H), 3.50 – 3.42 (m, 1H), 2.80 – 2.62 
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(m, 4H), 2.42 – 2.35 (m, 1H), 2.03 – 2.00 (m, 1H), 1.33 (s, 3H), 1.28 (s, 3H); 
(Unresolved rotameric signals) 13C NMR (150 MHz, DMSO-d6) δ 204.7, 168.4, 167.9, 
137.1, 136.9, 128.6, 128.6, 128.3, 128.1, 127.8, 127.7, 111.7, 111.5, 84.3, 83.7, 80.8, 
80.3, 72.4, 72.1, 67.2, 67.2, 56.8, 55.4, 46.1, 45.0, 41.7, 40.8, 40.2, 40.0, 39.7, 39.4, 37.4, 
37.1, 26.5, 26.4, 26.3, 26.3, 26.1, 23.8; MS (+EI) m/z (%) 421 (1), 278 (4), 272 (5), 221 
(4), 182 (4), 129 (6), 98 (16), 92 (10), 91 (100) 55 (23), 43 (14), 41 (6); HRMS (+EI) 
calcd for C22H28O5NCl: 421.1658. Found: 421.1656. 
 
 
 
 
 
 
 
 
 
 
 
 
  
 6.0 Selected Spectra
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 **  13C spectrum contains impurity signals from KOAc and CF3CO2K. ** 
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